Ways to ESKAPE: Identification of potential targets of the cell envelope of Pseudomonas aeruginosa for anti-virulence drug development by Klein, Kristina
  
 
 
 
Ways to ESKAPE: Identification of potential targets of the 
cell envelope of Pseudomonas aeruginosa for anti-virulence 
drug development  
 
 
 
 
Dissertation 
der Mathematisch-Naturwissenschaftlichen Fakultät 
der Eberhard Karls Universität Tübingen 
zur Erlangung des Grades eines 
Doktors der Naturwissenschaften 
(Dr. rer. nat.) 
 
 
 
 
vorgelegt von 
Kristina Klein 
aus Gehrden 
 
 
 
 
 
Tübingen 2019 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gedruckt mit Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Eberhard 
Karls Universität Tübingen. 
 
Tag der mündlichen Qualifikation:    07.02.2020 
Dekan:       Prof. Dr. Wolfgang Rosenstiel 
1. Berichterstatter:      PD Dr. Erwin Bohn 
2. Berichterstatter:      Prof. Dr. Ingo B. Autenrieth 
 
  
 
 
 
 
 
 
 
 
Für meine Eltern 
 
 
 
 
 
 
 
 
 
 
 
 
   
Table of contents 
Table of contents 
Abbreviations ............................................................................................................................ 1 
Abstract ..................................................................................................................................... 3 
Zusammenfassung .................................................................................................................... 4 
List of puplications ................................................................................................................... 6 
Contributions to publications .................................................................................................. 7 
1 Introduction ...................................................................................................................... 9 
1.1 The concept of anti-virulence drugs ............................................................................... 9 
1.2 Pseudomonas aeruginosa as a model organism for target identification in Gram- 
negative bacteria within the ESKAPE group ....................................................................... 10 
1.3 Virulence factors of Pseudomonas aeruginosa ............................................................ 11 
1.4 Antibiotic resistance mechanisms of Pseudomonas aeruginosa .................................. 13 
1.5 The cell envelope of Gram-negative bacteria............................................................... 15 
1.5.1 Composition and biogenesis of the outer membrane ........................................... 16 
1.5.2 Quality control for the biogenesis of OMPs by periplasmic chaperones ............. 17 
1.5.3 The BAM complex and integration of proteins into the outer membrane ........... 22 
1.5.4 Architecture, biosynthesis and recycling of the peptidoglycan cell wall ............. 25 
1.5.4.1 Architecture of the peptidoglycan cell wall ................................................. 25 
1.5.4.2 Biosynthesis of the peptidoglycan cell wall ................................................. 26 
1.5.4.3 Recycling of the peptidoglycan cell wall ..................................................... 27 
1.5.5 Peptidoglycan metabolism and the regulation of intrinsic β-lactamases ............. 30 
2 Aims of the thesis ............................................................................................................ 32 
3 Results and Discussion ................................................................................................... 33 
3.1 Deprivation of the periplasmic chaperones SurA reduces virulence and restores 
antibiotic susceptibility of a multidrug-resistant Pseudomonas aeruginosa ........................ 33 
3.2 Identification of drug-resistance determinants in a clinical isolate of Pseudomonas 
aeruginosa by high-density transposon mutagenesis ........................................................... 39 
Table of contents 
4 Graphic Summary .......................................................................................................... 45 
5 References ..................................................................... Fehler! Textmarke nicht definiert. 
6 Appendix ......................................................................................................................... 72 
 Accepted manuscripts………………………………………………………………...…………...73 
Danksagung………………………………………………………………………………………...127 
Eidesstattliche Erklärung………………………………………………………………………...129 
 
Abbreviations 
1 
 
Abbreviations 
Ampicillin/ sulbactam SAM 
Aztreonam ATM 
base pair bp 
Cefepime FEP 
Cefotaxime CTX 
Ceftazidime CAZ 
Ciprofloxacin CIP 
Cytoplasm C 
Endopeptidases EPs 
Erythromycin ERY 
Escherichia coli Ec 
Extended-spectrum-β-lactams ESBL 
Fosfomycin FOS 
High molecular mass HMM 
Imipenem IPM 
Imipenemase IMP 
Inner membrane IM 
kilo base pairs kbp 
Klebsiella pneumoniae Kp 
LB Lysogeny broth 
Levofloxacin LEV 
Low molecular mass LMM 
Lytic transglycosylases LTs 
Mega base pair Mbp 
Meropenem MEM 
Minimal inhibitory concentration MIC 
Multidrug-resistant MDR 
N-acetyl muramic acid MurNAc 
N-acetylglucosamine GlcNAc 
Nanometer nm 
New Dehli metallo-β-lactamase NDM 
Outer mebrane OM 
Penicillin binding protein PBP 
Peptidoglycan PG 
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Phospholipid PL 
Piperacillin PIP 
Piperacillin/Tazobactam TZP 
Pseudomonas aeruginosa Pa 
Ticaricillin/clavulanate TIM 
Transposon-Directed Insertion Sequencing TraDIS 
Vancomycin VAN 
Verona integron-encoded metallo-β-lactamase VIM 
Whole genome sequencing WGS 
Yersinia enterocolitica Ye 
β-barrel assembly machinery complex BAM 
β-barrel outer membrane proteins OMPs 
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Abstract 
Pseudomonas aeruginosa (Pa) is one of the main causative agents of nosocomial infections 
and the spread of multidrug-resistant Pa strains is rising. Therefore, new strategies for therapy 
are urgently needed. Hence, in this study two different strategies were used to identify 
possible targets for the development of anti-infective drugs.  
One strategy was to investigate proteins involved in the outer membrane assembly in order to 
disturb the outer membrane. The assembly of outer membrane proteins is managed by the 
BAM complex and periplasmic chaperones like SurA. Hence, in the first part of this study, 
deletion mutants of the BAM complex components BamB and BamC and of chaperones HlpA 
and SurA were generated and investigated. The constructed deletion mutants were analysed 
regarding their outer membrane permeability, outer membrane composition, morphology and 
their virulence in the Galleria mellonella infection model. The most profound effects were 
found upon depletion of SurA, including increased membrane permeability, enhanced 
sensitivity to antibiotics and reduced virulence in the Galleria mellonella infection model. 
More importantly, the SurA depletion in a multi-drug resistant Pa strain resensitized the strain 
to treatment with clinically relevant antibiotics. Depletion of BamB showed less changes in 
the outer membrane composition and hence less sensitivity against antibiotics and no relevant 
phenotypical effects. In addition, deletion of bamC or hlpA did not present any notable effects 
and none of these deletion mutants could prolong the survival of the Galleria mellonella 
larvae compared to infection with the wildtype strain. Thus, the data underline the importance 
of SurA in outer membrane biogenesis in Pa. 
The other strategy was to target non-essential genes that are not directly responsible for 
resistance mechanisms but essential under exposure to therapeutic antibiotic concentrations. 
Therefore, a high- density transposon (Tn) library in a multidrug-resistant Pa isolate was 
constructed and exposed to cefepime and meropenem. The depletion of Tn insertions was 
measured and revealed several interesting genes involved in peptidoglycan metabolism. 
Validation of in frame deletion mutants by measuring ampC expression, AmpC activity and 
antibiotic susceptibility confirmed their relevance regarding -lactam reistance and their role 
as promising targets for anti-infective drugs. 
To sum up, by using two different strategies, proteins of the cell envelope or proteins involved 
in the cell envelope assembly of Pa were identified, which may serve as potential targets to 
develop anti-infective drugs in order to combat the rise of multi-drug resistant pathogens. 
Zusammenfassung 
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Zusammenfassung 
Pseudomonas aeruginosa (Pa) ist eine der häufigsten Ursachen von nosokomialen 
Infektionen und die Ausbreitung von multiresistenten Pa Stämmen nimmt zu. Aus diesem 
Grund sind dringend Alternativen zur Behandlung von multiresistenten Erregern erforderlich. 
In dieser Studie wurden daher zwei verschiedene Strategien angewandt, um potentielle 
Zielproteine für die Entwicklung von Antiinfektiva zu finden.  
Eine Strategie bestand darin, Proteine zu identifizieren, die am Aufbau der bakteriellen 
Außenmembran beteiligt sind, um diese wieder durchlässig zu machen. Der Einbau von 
Außenmembranproteinen wird durch den BAM- Komplex und periplasmatischen Chaperonen 
wie SurA gesteuert. Im ersten Teil dieser Studie wurden daher von den BAM-Komplex 
Komponenten BamB und BamC und von den Chaperonen HlpA und SurA Mutanten 
hergestellt und in Bezug auf Außenmembran Durchlässigkeit und -Komposition, ihrer 
Morphologie und ihrer Pathogenität im Galleria mellonella Infektionsmodell untersucht. Den 
größten Effekt zeigte die Inaktivierung von SurA, mit einer erhöhten Membranpermeabilität, 
Antibiotikawirksamkeit und einer verringerten Pathogenität im Galleria mellonella-
Infektionsmodell. Noch bedeutender ist die Tatsache, dass durch die Inaktivierung von SurA 
in einem multiresistenten Pa Stamm, dieser wieder mit klinisch relevanten Antibiotika 
behandelbar wurde. Die Depletion von BamB weißte geringere Veränderungen in der 
Außenmembrankomposition auf und zeigte dementsprechend eine geringere Sensitivität 
gegenüber Antibiotika und keine relevanten phänotypischen Merkmale. Die Deletion von 
bamC oder hlpA zeigte hingegen keine nennenswerten Effekte und keiner der 
Deletionsmutanten konnte das Überleben der Galleria mellonella Larven im Vergleich zum 
Wildtyp Stamm verlängern. Die generierten Daten konnten damit die Relevanz von SurA für 
die Außenmembranbiogenese in Pa aufzeigen. 
Eine weitere Strategie bestand darin, nicht essentielle Gene zu finden, die nicht direkt für die 
Resistenzmechanismen verantwortlich, aber unter therapeutischen Antibiotikakonzentrationen 
relevant sind. Zu diesem Zweck wurde in einem multiresistenten Pa Isolat eine Transposon 
(Tn) -bibliothek konstruiert und unter Zusatz von Cefepim und Meropenem kultiviert. Die 
Depletion von Tn-Insertionen wurde anschließend gemessen und zeigte verschiedene 
interessante Gene auf, die am Peptidoglykanmetabolismus beteiligt sind. Die Validierung von 
Deletionsmutanten durch Messung von ampC-Expression, AmpC-Aktivität und Antibiotika 
Suszeptibilität konnte ihre Relevanz für β-Laktam Antibiotikaresistenz und als 
vielversprechende Kandidaten für Antiinfektiva bestätigen.  
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Zusammenfassend ist festzuhalten, dass unter Anwendung zweier unterschiedlicher 
Methoden, Zellhüllenproteine bzw. Proteine die am Aufbau der Zellhülle beteiligt sind in Pa 
identifiziert werden konnten, welche als potenzielle Kandidaten für die Entwicklung von 
Antiinfektiva dienen können, um die weitere Ausbreitung von multiresistenten 
Krankheitserregern zu verhindern. 
List of publications 
6 
 
List of puplications 
 
Liam Whiteley, Maria Haug, Kristina Klein, Matthias Willmann, Erwin Bohn, Salvatore 
Chiantia, Sandra Schwarz (2017) 
Cholesterol and host cell surface proteins contribute to cell-cell fusion induced by the 
Burkholderia type VI secretion system 5 
PLOS ONE 12(10): e0185715. https://doi.org/10.1371/journal.pone.0185715 
 
Kristina Klein, Michael S. Sonnabend, Lisa Frank, Karolin Leibiger, Mirita Franz-Wachtel, 
Boris Macek, Thomas Trunk, Jack C Leo, Ingo B. Autenrieth, Monika Schütz, Erwin Bohn 
(2019)  
Deprivation of the Periplasmic Chaperone SurA Reduces Virulence and Restores 
Antibiotic Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa.  
Front. Microbiol. 10:100. doi: 10.3389/fmicb.2019.00100, * equal contribution 
 
Erwin Bohn, Michael Sonnabend, Kristina Klein, Ingo B. Autenrieth (2019) 
Bacterial adhesion and host cell factors leading to effector protein injection by type III 
secretion system  
International Journal of Medical Microbiology 309:5. 
https://doi.org/10.1016/j.ijmm.2019.05.008 
 
M. S. Sonnabend*, K. Klein*, S. Beier, A. Angelov, R. Kluj, C. Mayer, C. Groß, K. 
Hofmeister, A. Beuttner, M. Willmann, S. Peter, P. Oberhettinger, A. Schmidt, I. B. 
Autenrieth, M. Schütz and E. Bohn (2019) 
Identification of drug-resistance determinants in a clinical isolate of Pseudomonas 
aeruginosa by high-density transposon mutagenesis 
Antimicrobial Agents and Chemotherapy, accepted Manuscript posted online 09.12.2019, 
doi:10.1128/AAC.01771-19, * equal contribution 
 
 
Contributions to publications 
7 
 
Contributions to publications 
Liam Whiteley, Maria Haug, Kristina Klein, Matthias Willmann, Erwin Bohn, Salvatore 
Chiantia, Sandra Schwarz 
Cholesterol and host cell surface proteins contribute to cell-cell fusion induced by the 
Burkholderia type VI secretion system 5 
I performed the flow cytometry analysis of RAW264.7 macrophages, which were treated with 
0.05% trypsin or 0.05% EDTA and created the corresponding figure and wrote the related 
part for the Methods section. 
 
 
Kristina Klein, Michael S. Sonnabend, Lisa Frank, Karolin Leibiger, Mirita Franz-Wachtel, 
Boris Macek, Thomas Trunk, Jack C Leo, Ingo B. Autenrieth, Monika Schütz, Erwin Bohn 
(2019)  
Deprivation of the Periplasmic Chaperone SurA Reduces Virulence and Restores 
Antibiotic Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa.  
I generated the deletion and conditional mutants of surA in PA14 and ID72 and the strain for 
the overexpression of bamB. Furthermore, I performed the bile salts assays, prepared the 
samples for Electron Microscopy, performed the growth curves in LB and iron-depleted 
medium. Moreover, I performed the overexpression and together with Karolin Leibiger the 
purification of BamB. In addition, Erwin Bohn and I performed Serum Killing assays. 
Furthermore, I mainly performed the RNA isolation with partial assistance by Michael 
Sonnabend. On the other hand, Michael Sonnabend mainly performed the qRT-PCR of the 
RNA samples with partial assistance from me. In addition, I partly conducted Western Blot 
analysis. Galleria mellonella experiments and antibiotic susceptibility testings were 
performed together with Michael Sonnabend in equal contribution. The manuscript was 
written by Erwin Bohn, Michael Sonnabend and me. All figures for the publication were 
designed by me. 
 
Erwin Bohn, Michael Sonnabend, Kristina Klein, Ingo B. Autenrieth (2019) 
Bacterial adhesion and host cell factors leading to effector protein injection by type III 
secretion system  
The review was mainly written by Erwin Bohn and supported by Michael Sonnabend and me. 
In addition, the included figure was generated by Erwin Bohn and me. 
 
Contributions to publications 
8 
 
 
M. S. Sonnabend*, K. Klein*, S. Beier, A. Angelov, R. Kluj, C. Mayer, C. Groß, K. 
Hofmeister, A. Beuttner, M. Willmann, S. Peter, P. Oberhettinger, A. Schmidt, I. B. 
Autenrieth, M. Schütz and E. Bohn (accepted and posted online 09.12.2019) 
Identification of drug-resistance determinants in a clinical isolate of Pseudomonas 
aeruginosa by high-density transposon mutagenesis 
In this study, I assisted Michael Sonnabend by generation of the ID 40 transposon library and 
partly performed the library preparation for TraDIS and partly conducted the statistical 
validation of the the experiments. Furthermore, I generated the deletion mutants of ctpA and 
ctpA/mepM1 and the complementation constructs of amgK, ctpA, mepM1 mltG and ygfB. In 
addition, I peformed the RNA isolation and mainly performed the antibiotic susceptibility 
testings. The manuscript was written in equal contribution by Erwin Bohn, Michael 
Sonnabend and me. In addition, I generated all figures for the publication. 
 
Introduction 
9 
 
1 Introduction 
 
1.1 The concept of anti-virulence drugs 
In the 21st century the rapid development of antimicrobial resistance has become one of the 
major challenges to mankind. According to the World Health Organisation (WHO) the spread 
of resistant pathogens increased in such a way that the possibility of scenarios of a pre-
antibiotic era becomes more realistic and that by 2050 more deaths are caused by drug-
resistant pathogens (10 million) than from cancer (8.2 million) (Calvert et al., 2018; O'Neill, 
2014; O'Neill, 2016). It remains to be seen if this prediction will become a reality, but so far 
the trend is running only in one direction (O'Neill, 2016). To circumvent the current 
antimicrobial crisis the development of anti-resistance adjuvants, which promote the effect of 
known conventional antibiotics, will be a promising tool to combat especially multidrug-
resistant (MDR) pathogens. It is well established that compounds such as β-lactamase 
inhibitors, as adjuvants supressing enzymatic resistance, in combination with β-lactam 
antibiotics increase the efficacy of the treatment. Successful combinations which have been 
used are penicillins with the β-lactamase inhibitors clavulanic acid, sulbactam or tazobactam. 
In addition, efflux pump inhibitors as capsaicin or outer membrane permeabilizers such as 
cationic peptides or EDTA were also used for treatment of several infections caused by MDR 
pathogens (Gill et al., 2015). 
Another promising strategy to circumvent the rise of MDR pathogens is the development of 
anti-virulence drugs. The aim of anti-virulence drugs is to disarm the pathogens virulence 
mechanism, but not growth or viability, and thereby maintaining the bacteria in a state in 
which they become susceptible to immune clearance or again susceptible to antibiotics 
(Johnson & Abramovitch, 2017). Targeting the virulence mechanisms instead of growth or 
viability leads to a reduction of selective pressure, which otherwise promotes the evolution of 
resistance mechanisms, and at best preserves the host’s gut microbiota (Maura et al., 2016; 
Heras et al., 2015). Furthermore, it would be advantageous if the targeted virulence factor is 
conserved between different pathogens to allow treatments against polymicrobial infections, 
whenever it is required (Fleitas Martínez et al., 2019). So far, several anti-virulence strategies 
have been developed, such as targeting functional membrane microdomains (FMMs), 
blocking adhesion or biofilm formation, interfering with quorum sensing (QS) or the 
neutralization of toxins (Calvert et al., 2018; Fleitas Martínez et al., 2019). Most of the anti-
virulence strategies developed against Pseudomonas aeruginosa (Pa) target the biofilm 
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formation and the QS (Fleitas Martínez et al., 2019). For instance, the furanone derivate C-30 
targets the LasR receptor in Pa or terrein, isolated from Aspergillus terreus, antagonizes QS 
receptors without affecting the cell growth (Hentzer et al., 2002; Kim et al., 2018). However, 
resistance against anti-virulence drugs has already been observed (Allen et al., 2014; García-
Contreras et al., 2015; Maeda et al., 2012; Imperi et al., 2019) and further examination is 
needed to find out whether the use of anti-virulence drugs alone is sufficiently effective or if a 
combinatorial therapy with existing antibiotics is preferable (Calvert et al., 2018). The 
success of such a co-therapy could be demonstrated by MICHAUD et al. combining a LecB-
specific antibiofilm dendrimer together with the antibiotic tobramycin to prevent dispersal 
and biofilm formation of Pa (Michaud et al., 2016).  
In sum, anti-virulence strategies offer promising and innovative opportunities to combat 
infectious diseases, but also face challenges such as development of resistance mechanisms 
(Maura et al., 2016). 
 
1.2 Pseudomonas aeruginosa as a model organism for target 
identification in Gram- negative bacteria within the ESKAPE group  
Pa is an aerobic Gram-negative bacterium, which is ubiquitously distributed in the 
environment and living sources including soil, plants, animals and humans. 
The rod shaped bacterium was first isolated by Gessard in 1882 and named Bacillus 
pyocyaneus, following the observation of its green coloration (Morrison & Wenzel, 1984; 
Lyczak et al., 2000). Besides its minimal growth requirements and ability to tolerate a vast 
number of physical conditions, Pa forms biofilms, harbours many defence mechanisms as 
well as intrinsic resistance mechanisms against antibiotics and disinfectants (Stover et al., 
2000). These characteristics allow the organism to persist in both community and nosocomial 
settings and made it to one of the top priority pathogens for which new and effective 
antibiotic treatments are urgently needed as listed by the WHO (Tacconelli et al., 2017). Pa is 
largely associated with hospital acquired infections, particularly in patients with compromised 
immune defense and is the main cause of morbidity and mortality in cystic fibrosis patients 
(Moradali et al., 2017; Giwercman et al., 1990). It is a common causative agent of pneumonia 
(including ventilator-associated pneumonia), blood stream infections and urinary tract, skin, 
and soft tissue infections (Moradali et al., 2017). Furthermore, reports on Pa strains resistant 
to almost all classes of commonly used antibiotics including aminoglycosides, 
cephalosporins, carbapenems and fluoroquinones (Poole, 2011; European Centre for Disease 
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Prevention and Control, 2017; European Centre for Disease Prevention and Control, 2015), 
underline that Pa more and more escapes from the lethal action of antibiotics. Pa is not the 
only pathogens capable of escaping the action of antibiotics, so that the Infectious Diseases 
Society of America highlighted a group of antibiotic resistant and most challenging 
nosocomial pathogens as members of the ESKAPE group (Enterococcus faecium, 
Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas 
aeruginosa and Enterobacter spp.) (Rice, 2008). The ESKAPE group is not only important 
due to its insistent presence in hospital settings. If we could understand the pathogenesis, 
transmission and resistance of at least one of the most tenacious and pathogenic bacteria, we 
may be able to apply our knowledge to other species. 
In this regard, Pseudomonas aeruginosa was used in the present study as a representative of 
the ESKAPE group to identify potential antiinfective drug targets in order to devise new 
strategies to treat especially infections caused by MDR Pa and to better understand its 
resistance mechanisms. 
The clinical isolate PA14 is a well-established laboratory strain, which is easy to manipulate 
and for which several infection models exist to study the bacterial characteristics. 
Furthermore, the AUSUBEL lab created a transposon insertion mutant library of PA14 to 
enable genome-scale screens (Liberati et al., 2005). In comparison to the other frequently 
used laboratory strain PAO1, the PA14 genome comprises a few more bases (6.5 Mb: 6.3 Mb) 
and encodes 5973 open reading frames including pathogenicity islands which contribute to 
the enhanced virulence of PA14 (Lee et al., 2006). 
The chromosome of the MDR bloodstream isolate ID40 (Willmann et al., 2018) is 6.86 Mb in 
size and encodes 6409 open reading frames. Moreover, ID40 carries a plasmid of 57446 bp 
comprising 59 open reading frames and in comparison, to PA14 and PAO1, is resistant to 
several β-lactam antibiotics (Sonnabend et al., accepted 25.11.2019). 
 
1.3 Virulence factors of Pseudomonas aeruginosa 
Pa harbours an array of virulence factors to counteract the host defence mechanisms, damage 
the host tissues or to remain competitive with other bacteria (Gellatly & Hancock, 2013).  
For the motility and the contact with the epithelium, flagella and pili are used. The 
appendages adhere to the epithelial surface glycolipid asialo-GM1 to facilitate the contact 
(Kipnis et al., 2006). In addition, flagella interact with Toll-like receptors TLR5 and TLR2 
and thereby activate an NFB dependent inflammatory response. Pili enable Pa to spread 
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along hydrated surfaces. This special kind of movement is called twitching. The twitching 
motility is an advantage for colonization of the airway-tissue (Kipnis et al., 2006).  
Another player mediating adherence is lipopolysaccharide (LPS) which forms the outer leaflet 
of the outer membrane and also interacts with asialo-GM1 to facilitate adherence to the host 
cell. Upon binding to host cell receptors (MD2 and CD14), LPS leads to activation of NFB 
and subsequently to the production of pro-inflammatory cytokines, inflammation and 
sometimes even to endotoxic shock (Gellatly & Hancock, 2013). After the irreversible 
adhesion by LPS, the type 3 secretion system (T3SS) is activated to secrete the effector 
proteins ExoY, ExoS, ExoT and ExoU , which promote cell injury e.g by activation of 
neutrophils or directly causing necrosis (Gellatly & Hancock, 2013). The expression of the 
four effector proteins varies between different Pa strains and isolates. ExoY and ExoT are 
present together in most strains, while the strains harbour either ExoU or ExoS, but not both 
(Hauser, 2009). Cytotoxic strains like PA14 express exoU and exoT, and sometimes exoY, 
whereas invasive strains express exoS, exoT and often exoY (e.g. PAO1, PAK, ID40) (Bleves 
et al., 2010). However, a group of Pa strains lacking the T3SS and the T3SS toxins has 
recently been reported (Roy et al., 2010; Basso et al., 2017). In contrast to other Pa strains, 
the PA7 group secretes exolysin A (ExlA), which forms a two-partner secretion system with 
the porin TpsB encoded by exlB. Furthermore, the pore-forming toxin ExlA requires type IV 
pili to get in contact with host cells and induce cell lysis (Basso et al., 2017).  
Other virulence factors, such as elastase B (LasB), endotoxin A (ExoA) or phospholipase C, 
are secreted by the type 2 secretion system (T2SS). These exoproteins also participate in 
cytotoxicity as they destruct tight-junctions and degrade flagellin (LasB), inhibit protein 
synthesis (ExoA), or break down phospholipids (phospholipase C) (Gellatly & Hancock, 
2013; Hauser, 2009; Kipnis et al., 2006; Casilag et al., 2016). 
Furthermore, Pa synthesizes the mucoid exopolysaccharide alginate, which is assumed to be 
involved in biofilm formation in CF lungs (Gellatly & Hancock, 2013; Kipnis et al., 2006) 
and pyocyanin, a blue redox-active metabolite, which impedes the host response and induces 
apoptosis in neutrophils (Managò et al., 2015). 
For its metabolism, Pa needs to chelate iron from the environment. The siderophore 
pyoverdine sequesters iron molecules and additionally acts as signalling molecule. The 
pyoverdine-iron complex interacts subsequently with the receptor FpvR which in turn 
activates a signalling cascade causing the production of ExoA, endoproteases and also 
pyoverdine (Lamont et al., 2002; Jimenez et al., 2012).  
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Moreover, the upregulation of the virulence genes in the whole population is coordinated by 
quorum sensing (QS) via acyl homoserine lactones, called autoinducers. Pa harbours at least 
four QS systems, including las, rhl, iqs and pqs, which are organized in a hierarchy with the 
las system at the top of the cascade (Lee & Zhang, 2015).  
In conclusion, Pa produces a great quantity of virulence factors modifying the immune 
system by adhesion, evading and destroying the tissue for progression of the disease and 
forming a barrier to antibiotics. Most of the virulence factors can cause acute and chronic 
infections, which renders Pa together with its diverse antibiotic resistance mechanisms (§ 1.4) 
a serious therapeutic problem for treatment of hospital- and community acquired infections. 
 
1.4 Antibiotic resistance mechanisms of Pseudomonas aeruginosa 
The treatment of Pa infections becomes increasingly more difficult because Pa is naturally 
resistant to a lot of antibiotics and has an extraordinary capacity to develop and acquire new 
resistance mechanisms (Moradali et al., 2017).  
Intrinsically resistance of Pa to certain antibiotics is enabled due to the low permeability of 
the outer membrane (OM), the activity of efflux pumps and the inducible expression of the 
chromosomally encoded β-lactamase, AmpC (Gellatly & Hancock, 2013).  
The lowered permeability of the OM is the result of a reduced number of large porin proteins 
like OprF and an increased number of more specific porin channels like OprD (Gellatly & 
Hancock, 2013; Moradali et al., 2017). This adaptation makes the OM of Pa 10- to 100-fold 
less permeable than that of Escherichia coli (Ec) (Hancock & Speert, 2000) and creates 
resistance to commonly used antibiotics such as carbapenems and cephalosporins. Resistance 
to the carbapenems imipenem (IPM) and meropenem (MEM) for instance is usually mediated 
through mutations, the loss or a reduced copy number of OprD (Trias & Nikaido, 1990; Kao 
et al., 2016). The high intrinsic resistance of the pathogen is further dependent on the rapid 
efflux by efflux pumps such as MexAB-OprM or MexDC-OprJ. So far, 12 resistance-
nodulation-division (RND) family efflux pumps have been genetically identified in Pa, but 
only 6 have been described (Schweizer, 2003; Poole, 2014). The expression of the efflux 
systems is regulated by several factors and varies under different conditions. The most 
clinically important efflux sets are MexAB-OprM and MexXY-OprM, as they have the 
broadest substrate profile for β-lactams and in addition facilitate resistance to 
chloramphenicol, fluoroquinolones, macrolides, novobiocin, sulfonamides, tetracycline, 
trimethoprim and aminoglycosides (Livermore, 2002; Avarain et al., 2013). Another 
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important player of intrinsic resistance is AmpC, an inducible chromosomal β-lactamase. It is 
typically expressed at basal levels, but subinhibitory concentrations of certain β-lactam 
antibiotics can lead to its induction (Gellatly & Hancock, 2013).  
Pa can acquire further resistance to antibiotics through horizontal gene transfer from other 
bacteria (plasmids) or through mutational changes in intrinsic genes.  
AmpC overproduction can be induced through mutational inactivation of ampD (repressor of 
ampC) or spontaneous mutations in the regulatory gene ampR leading to elevation of ampC 
expression and consequently to an increase of antibiotic resistance (Moradali et al., 2017).  
Another common mutation related to ampC derepression has been recognized in the gene 
dacB, encoding the nonessential low-molecular-weight penicillin binding protein 4 (PBP4) 
(Moya et al., 2009). The mutation of dacB has been shown to activate the CreBC two-
component regulator, which further increases the resistance levels. MOYA and colleagues 
further demonstrated that laboratory mutants and clinical isolates with mutated PBP4 
exhibited a significantly increased creD expression. CreD is regulated by the global regulator 
CreBC, but its role in ampC regulation has not been further characterized (Moya et al., 2009; 
Lister et al., 2009). Interestingly, the knockout of creBC decreased the resistance against 
penicillins, cephalosporins and aztreonam (ATM) in dacB mutants and displayed no changes 
in ampC levels, which led MOYA and colleagues to the suggestion that the CreBC system 
enhances resistance through another pathway as AmpC (Moya et al., 2009). Furthermore, it 
was recently evidenced that the CreBC system has an important impact on bacterial fitness 
and biofilm formation even in the absence of β-lactam antibiotics (Zamorano et al., 2014). 
Moreover, there exist mutations in a number of other genes encoding for other amidases 
(AmpDh2 and AmpDh3), other PBPs (PBP5 and PBP7) or e.g. lytic transglycosylases (SltB1 
and MltB) that have been shown to boost ampC expression (López-Causapé et al., 2018).  
In addition, ampC expression is tightly connected to the rebuilding of the peptidoglycan cell 
wall including many enzymes like AmpG permease, amidase AmpD or the N-
acetylglucosaminidase NagZ (Ropy et al., 2015), which will be further addressed in section 
1.5.4.  
Besides the described mutations leading to ampC overexpression, other antibiotic resistance 
mechanisms are also generated by mutational inactivation of intrinsic genes. As already 
mentioned above, reduction or loss of OprD results in greater resistance to carbapenems. In 
addition, loss-of-function mutations in the mexAB-oprM operon leads to the overproduction of 
MexAB-OprM and also enhances the resistance to carbapenems (Kao et al., 2016; Lister et 
al., 2009). Resistance to fluoroquinolones can also be mediated by overproduction of efflux 
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pumps (Poole, 2011; Morita et al., 2015) or by mutations in the fluoroquinolone target genes, 
DNA gyrases gyrA and gyrB or in the subunits ParC and ParE of topoisomerase IV (Lee et 
al., 2005). 
Resistance mechanisms acquired through plasmids or chromosomally integrated transposons 
confer resistance to several antibiotic classes such as extended-spectrum-β-lactams (ESBL) 
and carbapenems, fluoroquinolones and aminoglycosides (Moradali et al., 2017). 
Genes encoding ESBLs and carbapenemases have largely variable prevalence in each 
individual country but specific metallo-β-lactamase (MBL) as IMP, VIM and NDM have 
been found worldwide (Hong et al., 2015). In addition to ESBL and carbapenemase 
producing isolates, Pa also evolved a mechanism to survive treatment with colistin 
(polymyxin E), one of the last therapeutical options to clear carbapenem resistant Pa. The 
resistance mechanism is primarily caused by post-translational modifications of LPS 
molecules in the OM. In Pa the substitute 4-amino-4-deoxy-L-arabinose (L-Ara4N) is added 
to lipid A or the core polysaccharide leading to a negative charge of the phosphate residues 
preventing the binding of polymyxin molecules to the bacterial envelope. The LPS modifying 
genes are under the control of two-component systems such as PhoPQ, PmrAB, ParRS, 
CprRS and ColRS. Mutations in genes of the two-component systems cause a constitutive 
upregulation of the LPS modification and consequently to polymyxin resistance (Jeannot et 
al., 2017). However, recent findings demonstrated plasmid-mediated colistin resistance 
through the mcr-1 gene, which was first discovered in an Ec strain from agricultural products 
and mobilized to Klebsiella pneumoniae (Kp) and Pa (Liu et al., 2016). Thus, colistin 
resistance is mediated by a complex regulatory network of chromosomal genes or through the 
mobilisation of the plasmid-encoded gene mcr-1. Especially, the plasmid-mediated 
distribution of colistin resistance raises concern emergence of multi- or even pan-drug 
resistant Gram-negative bacteria and worsen the situation worldwide (Jeannot et al., 2017; 
Moradali et al., 2017). 
 
1.5 The cell envelope of Gram-negative bacteria 
The cell envelope of Gram-negative bacteria consists of an outer membrane (OM), a thin 
peptidoglycan (PG) layer within the periplasm, the inner membrane (IM) and the cytoplasm. 
The complex and dynamic cell envelope protects the bacteria from the environment, allows 
the entrance of nutrients and ensures the excretion of waste products from the inside (Silhavy 
et al., 2010). The main focus of this work is on outer membrane β-barrel protein (OMP) 
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biogenesis, in particular the periplasmic chaperone network and the β-barrel assembly 
machinery (BAM) complex, and additionally covers the PG synthesis and recycling. 
Consequently, transport across the IM or transport of lipoproteins or phospholipids to the OM 
will not be discussed in much detail. 
 
1.5.1 Composition and biogenesis of the outer membrane 
The OM is an asymmetric lipid bilayer, which serves as a platform for outer membrane β-
barrel proteins (OMPs) to perform their cellular functions and as frontline from which the 
bacteria interact with the environment or host. It is composed of phospholipids in the inner 
leaflet, lipopolysaccharide (LPS) in the outer leaflet, bilayer-anchored lipoproteins and 
integral OMPs (May & Silhavy, 2017).  
In E. coli, three mayor phospholipids (PLs) (phophatidylethanolamine, phosphatidylglycerol 
and cardiolipin) assemble in the cell envelope. How PLs are transported to the OM still needs 
to be clarified. So far, three systems have been identified in E. coli to maintain OM 
asymmetry by removal of mislocalized PLs. The phospholipase PdlA degrades mislocalized 
PLs, the palmitoyltransferase PagP uses mislocalized PLs as a substrate and transfers an acyl 
chain to lipid A, which contributes to OM stability, and the Mla pathway, composed of 
MlaABCDEF, that facilitates the retrograde PL trafficking (Dowhan, 2013; Malinverni & 
Silhavy, 2009; Narita & Tokuda, 2006). 
LPS is a negatively charged glycolipid which is composed of lipid A, a core oligosaccharide 
and an O-antigen polysaccharide chain (Sperandeo et al., 2017). Lipid A anchors the LPS into 
the OM and is well known to activate the innate immune system (Needham & Trent, 2013). 
Furthermore, lipid A of Pa differs from other species like Ec or Nm, in length and number of 
acyl chains (King et al., 2009). The core oligosaccharide of Pa is the most phosphorylated 
core among Gram-negative bacteria and has been associated to its pathogenesis and intrinsic 
resistance to antibiotics, such as novobiocin (King et al., 2009). 
The O-specific antigens are exposed on the OM, are highly immunogenic and differ from 
strain to strain. Most Pa strains produce two forms of O-antigens, known as common 
polysaccharide antigen and O-specific antigen. The differences in the O-units of the O-
specific antigen are the basis of antigenic serotyping in Pa and so far revealed twenty major 
serotypes, including PAO1 that belongs to serotype O5 and PA14 that belongs to serotype 
O10 (Lam et al., 2011; King et al., 2009).  
The transport of LPS across the IM starts with the ABC transporter MsbA, and is continued 
by the Lpt (lipopolysaccharide transport) system, which transfers LPS to the OM. The Lpt 
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system in Ec is composed of seven proteins (LptABCDEFG) that pushes LPS molecules 
continuously from the IM across the periplasm to the outer leaflet of the OM like a “PEZ 
candy dispenser” (May & Silhavy, 2017; Sperandeo et al., 2017). Studies in Neisseria 
meningitidis (Nm) showed that all proteins of the Lpt apparatus are essential for the LPS 
transport to the OM, except LptE (Bos et al., 2004; Bos & Tommassen, 2011; Tefsen et al., 
2005). Thus far, studies in Pa could confirm the essential role of LptD in LPS transport 
(Srinivas et al., 2010; Werneburg et al., 2012) and that LptH, the homologue of Ec LptA, is 
important for cell envelope biogenesis, growth and pathogenicity in various animal models 
(Fernández-Piñar et al., 2015). In addition, LptE plays a crucial role as a chaperone and plug 
for LptD and consequently affects the cell envelope stability, antibiotic resistance and 
virulence of Pa in Galleria mellonella infection model (Lo Sciuto et al., 2018).  
Lipoproteins and OMPs or proteins destined for the the periplasm are first targeted to the Sec 
translocon in the IM by an N-terminal signal sequence (Du Plessis et al., 2011). Upon entry 
into the periplasm, the transport of lipoproteins and OMPs diverge. Most of the mature 
lipoproteins are transported to the OM by the so called Lol (localization of lipoprotein) 
pathway, containing an ABC transporter (LolCDE) in the inner membrane, a periplasmic 
carrier protein LolA and a lipoprotein LolB. LolCDE recognizes and releases the lipoprotein 
in an ATP-dependent manner to LolA, forming a complex in the periplasm. The LolA-
lipoprotein complex then moves across the periplasm to interact with the OM anchored 
lipoprotein receptor LolB. Finally, LolB incorporates the lipoprotein into the inner leaflet of 
the OM (Narita & Tokuda, 2006). In contrast, OMPs are guided by periplasmic chaperones, 
such as SurA, Skp and DegP, to the BAM complex in the OM, that facilitates OM insertion. 
This is described in more detail in the following sections. 
 
1.5.2 Quality control for the biogenesis of OMPs by periplasmic 
chaperones 
Upon entry into the periplasm, unfolded OMPs are subjected to quality control by periplasmic 
chaperones and proteases to prevent their aggregation or misfolding, or to degrade misfolded 
OMPs, which dropped out of the folding pathway, respectively.  
Periplasmic chaperones bind to unfolded OMPs and guide them through the periplasm and 
peptidoglycan layer to the OM. There are three main classes of periplasmic chaperones that 
are known (Goemans et al., 2014; Rollauer et al., 2015):  
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(1) Peptidyl-prolyl cis-trans isomerases (PPIases), which interconvert the cis and trans 
isomers of peptidyl-prolyl bonds involving a proline residue, such as PpiA, FkpA and 
PpiD. 
(2) Disulfide bond catalysing enzymes, which ensure fast and correct folding in the oxidizing 
environment of the periplasm, such as DsbA, -B, -C and -D.  
(3) Proteins with general chaperone activity and impact on OMP biogenesis, such as SurA, 
Skp and DegP. 
Most peptide bonds are present in trans, due to their steric hindrance, but proline residues 
stabilize the cis configuration of peptide bonds. To accelerate the rate-limiting step in protein 
folding, PPIases catalyse the inter-conversion of peptidyl-prolyl imide bonds in protein 
substrates (Goemans et al., 2014). So far, a superfamily comprising three families of PPIases 
has been detected in Ec. The cyclophilin group was identified at first, including PpiA. The 
second group, named FKBP, includes FkpA and the third group harbours PpiD and SurA and 
is called parvulin group.  
Interestingly, experiments on a quadruple mutant of ppiA, ppiD, surA and fkpA in Ec showed 
no severe changes to the phenotype, indicating no important role of the PPIases in viability 
and that SurA and FkpA primarily act as periplasmic chaperones (Justice et al., 2005). The 
chaperone activity of FkpA was further demonstrated by improved expression of single-chain 
antibody fragments by co-expression of fkpA in a skp mutant (Bothmann & Plückthun, 2000) 
and by structural investigations showing that the N-terminus is required for chaperone activity 
(Saul et al., 2004). In addition, a fkpA skp double mutant revealed their role in folding of the 
OMPs LptD and FhuA, whereby FkpA can replace Skp to fold LptD (Schwalm et al., 2013).  
The exact role of PpiA in cell envelope protein quality control is still unknown and the 
regulation of the ppiA gene by the Cpx system (Pogliano 1997), which activates proteases and 
folding catalyst in response to damage of the cell envelope, is the only indication for its 
contribution to the quality control of cell envelope proteins (Goemans et al., 2014). PpiD is 
associated with the IM and is thought to interact with unfolded polypeptides exiting the Sec 
translocon. Thereby it influences the OMP translocation across the IM (Antonoaea et al., 
2008). The protein harbours three soluble domains, of which the first and third have 
chaperone activity, and the second is very similar to the parvulin domain of SurA. Despite its 
parvulin domain, PpiD has no mayor role in OMP biogenesis in Ec, cannot compensate loss 
of SurA, and is not necessary for growth (Justice et al., 2005; Antonoaea et al., 2008; Matern 
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et al., 2010). Thus, the role of PpiD remains unclear, besides its assistance in OMP 
translocation. 
The second rate-limiting step in protein folding is the disulfide bond formation. This 
modification is mainly performed on proteins that are exported to the cell envelope or beyond, 
including proteins involved in virulence like toxins, flagella, pili, adhesins or type I & III 
secretion systems (Landeta et al., 2015). Two mayor pathways are formed by the Dsb 
enzymes; an oxidative pathway which catalyzes the formation of disulfide bonds into the 
folding proteins, and an isomerase pathway which repairs incorrectly tied disulfide bonds. In 
Ec, DsbA and DsbB are part of the oxidative pathway, where DsbA reacts with the unfolded 
OMPs to oxidize them and introduce disulfide bonds, and DsbB re-oxidizes DsbA (Smith et 
al., 2016). The isomerisation pathway consists of DsbC and DsbD, and results in a process in 
which DsbC corrects the disulfide bonds and DsbD reduces its periplasmic substrate DsbC 
(Goemans et al., 2014). Due to the involvement in disulfide formation in many virulence 
factors, loss of dsbA shows a pleiotropic phenotype, reduced fitness in animal models and 
attenuated virulence. In particular, without DsbA, toxin subunits cannot fold into their native 
structures, pili subunit assembly or flagella mediated motility is impaired or T3SS effectors 
cannot be secreted, because intramolecular disulfide bonds in OM secretins within the T3SS 
in e.g. Yersinia pestis, are not folded correctly (Smith et al., 2016).  
In Pa, the disulfide bond machinery consists of multiple Dsb proteins, including two DsbA 
proteins (DsbA1 & DsbA2) and two DsbB (DsbB1 & DsbB2) proteins. DsbA1 is the major 
disulfide bond catalysing enzyme in Pa and is re-oxidized by both, DsbB1 and DsbB2. 
Hence, only the simultaneous deletion of both DsbB proteins leads to misfolding of several 
virulence factors and consequently to reduced pathogenicity of Pa (Arts et al., 2013). 
Furthermore, ARTS et al. identified 22 new potential substrates of DsbA1, including 
periplasmic binding proteins, putative periplasmic enzymes involved in peptidoglycan 
remodelling and potential virulence factors (Arts et al., 2013). 
 
Periplasmic chaperones with general chaperone activity, including Skp, DegP and SurA, are 
thought to play important roles as chaperones in the OMP biogenesis as indicated by the fact 
that the gene expression of the chaperones is regulated by the σE envelope stress response 
(Sklar, Wu & Kahne et al., 2007). Two folding pathways are assumed to prevent the 
aggregation of OMPs and enable a safe passage across the periplasm to the OM. In Ec, SurA 
has been shown to transport the bulk mass of OMPs to the OM, whereas in a parallel pathway 
Skp and DegP rescue OMPs that have fallen of the normal assembly pathway or even 
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compensate the absence of SurA (Hagan et al., 2011). The role of Skp and DegP under 
normal growth conditions is therefore negligible (Sklar, Wu & Kahne et al., 2007). 
The periplasmic chaperone SurA was originally identified as a protein essential for survival in 
stationary phase (Tormo et al., 1990) and is now known to have both, chaperone activity to 
assist in OMP assembly (Rouvière & Gross, 1996; Lazar & Kolter, 1996) and PPIase activity 
to catalyse cis-trans isomerization of peptide bonds (Behrens et al., 2001). SurA displays a 
four domains architecture with a N-terminal domain, two PPIase domains of the parvulin 
family (P1 and P2) and a C-terminal domain. In the crystal structure, the first PPIase domain 
is surrounded by the N- and C-terminal domain, forming a core module, so that the second 
PPIase domain sticks out from the core, extended by two polypeptide linkers (Rollauer et al., 
2015; Goemans et al., 2014). The peptide binding activity of SurA was located in the first 
PPIase domain P1 (Xu et al., 2007), whereas the PPIase activity resides exclusively in P2 
(Behrens et al., 2001). Surprisingly, deletion of both parvulin domains has no impact on the 
chaperone function of SurA in vitro and was shown to almost completely complement the in 
vivo function of native SurA (Behrens et al., 2001). Thus, the parvulin domains promote the 
efficiency of OMP assembly rather than contribute to the chaperone activity of SurA. 
Deletion of surA in Ec leads to reduced OMP levels and consequently to a highly defective 
cell envelope which is sensitive to antibiotics, bile salts and detergents and additionally leads 
to impaired virulence (Lazar & Kolter, 1996; Rouvière & Gross, 1996; Sydenham et al., 
2000; Weirich et al., 2017). Several studies in Ec have shown that in the absence of SurA, 
porins like LamB, OmpA, OmpC, OmpF, OmpX and other OMPs like FadL, FecA, FhuA and 
LptD are not correct folded (Rouvière & Gross, 1996; Lazar & Kolter, 1996; Sklar, Wu & 
Kahne et al., 2007; Vertommen et al., 2009). Interestingly, only FhuA (ferrichrome receptor) 
and LptD are true substrates of SurA and do not correlate with the decreased mRNA levels 
caused by σE envelope stress response (Goemans et al., 2014). LptD is an essential β-barrel 
protein, which associates with the lipoprotein LptE to initiate the transport of LPS to the OM 
(§1.5.1). The phenotype which is observed upon loss of LptD resembles that of a surA 
mutant, which led to the suggestion that the impaired OM in a surA mutant is mainly caused 
by the reduced LptD levels. Furthermore, it is interesting to mention that lptD and surA are 
organized together in an operon (Vertommen et al., 2009). However, further studies have 
demonstrated the requirement of SurA also for other OMPs like the autotransporters EspP 
(Enterobacteriacae), Hbp (Ec) and IcsA (Shigella flexneri), as well as for the adhesin intimin 
(enteropathogenic Ec) (Purdy et al., 2007; Bodelón et al., 2009; Ruiz-Perez et al., 2009; Sauri 
et al., 2009), and additionally for pilus - (Justice et al., 2005) and fimbrial assembly (Ec) 
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(Palomino et al., 2011). Moreover, SurA has been demonstrated to be essential for 
pathogenesis in Yesinia pestis (Southern et al., 2016), Yersinia pseudotuberculosis (Obi et al., 
2011), Yersinia enterocolitica (Ye) (Weirich et al., 2017), Shigella flexneri (Purdy et al., 
2007), uropathogenic Ec (Justice et al., 2006; Watts & Hunstad, 2008) and Salmonella 
enterica (Sydenham et al., 2000). 
Skp (Seventeen kilodalton protein) shows a jellyfish-like architecture with three α-helical 
tentacles protruding from a β-barrel core domain. Its relatively small substrate-binding site is 
located in an inner cavity which is defined by the three tentacles (Walton & Sousa, 2004). The 
small cavity inside Skp is rather suitable for the binding of precursor OMPs containing 
aromatic and hydrophobic residues than for OMPs with periplasmic or extracellular domains 
such as OmpA (Rollauer et al., 2015). Nevertheless, it was shown that Skp binds the β-barrel 
domain of OmpA in an unfolded state, whereas the periplasmic domain of OmpA resides 
outside the cavity in a completely folded state (Walton et al., 2009; Qu et al., 2009). 
However, deletion of Skp in Ec does not affect the presence of OMPs significantly, although 
Skp has an array of substrates including porins, autotransporters and also intimin (Ruiz-Perez 
et al., 2009; Bodelón et al., 2009). In contrast, depletion of Skp in an Ec surA mutant results 
in a bulk of unfolded OMPs and finally leads to cell death emphasizing that Skp and SurA 
have many OMP substrates in common (Ricci & Silhavy, 2012). In contrast, deletion of skp in 
Nm caused reduced levels of the OMPs PorA and PorB, which was not observed in a surA 
mutant, indicating a less relevant role of SurA in Nm (Volokhina et al., 2011). Furthermore, 
skp mutation attenuates Salmonella enterica in vivo during mice infection (Rowley et al., 
2011) and indirectly leads to decreased cell spread in Shigella flexneri (Wagner et al., 2009).  
The periplasmic serine protease DegP functions in the same pathway as Skp and its synthesis 
is activated by the σE or Cpx system in response to heat shock or other envelope stresses 
(Ricci & Silhavy, 2012). DegP recognizes unfolded, misfolded or aggregated OMPs to refold 
or degrade them (Hagan et al., 2011). The protein consists of a N-terminal chymotrypsin-like 
protease domain with a His-Asp-Ser catalytic site and of two C-terminal PDZ domains (PDZ1 
and PDZ2), which are protein interaction modules found in diverse signalling proteins in 
prokaryotes, eukaryotes and viruses. PDZ1 is essential for the protease activity by recognizing 
and offering the substrates to the protease domain at the N-terminus (Iwanczyk et al., 2007). 
Besides its protease activity, DegP seems to displays also chaperone activity, because its 
deletion in an Ec surA mutant is not viable (Rizzitello et al., 2001). It is thought that the 
chaperone activity of DegP primarily functions at lower temperatures (below 28°C) and that 
the protease activity dominates at increasing temperatures (Ricci & Silhavy, 2012). The 
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substrate spectrum of DegP includes PhoA, PapA, Mals (Kadokura et al., 2001; Jones et al., 
2002; Skorko-Glonek et al., 2007) or OMPs like OmpA, OmpC, OmpF and LamB (Krojer et 
al., 2008). The folding of the α-amylase MalS, for instance, is promoted by DegP under low 
temperatures, but at higher temperatures MalS is degraded by DegP. Moreover, it could be 
demonstrated that DegP acts as a protector of OMP monomers to prevent their degradation by 
other proteases (Krojer et al., 2008). In addition, DegP was shown to be important for 
survival at elevated temperature and for virulence of Salmonella enterica (Mo et al., 2006), as 
well as of Brucella abortus (Elzer & Roop, 1996), Brucella melitensis (Phillips et al., 1995), 
Ye (Li et al., 1996), Kp (Cortés et al., 2002) and Pa (Yorgey et al., 2001). Despite that, how 
DegP exactly acts as chaperone in OMP biogenesis is not well understood and remains to be 
determined.  
To sum up, three classes of periplasmic chaperones, including SurA, Skp and DegP, build a 
network with two parallel pathways to control the assembly of OMPs. In this network, SurA 
plays the pivotal role for OMP assembly and Skp and DegP rescue the OMPs that fall off the 
SurA pathway. Nevertheless, there can be species specific differences in importance of the 
chaperones for OM integrity, bacterial fitness and virulence.  
 
1.5.3 The BAM complex and integration of proteins into the outer 
membrane 
After transport of newly synthesized nonlipidated OMPs across the IM by the Sec translocon 
and through the periplasm by chaperones SurA, Skp and DegP, OMPs are assembled into the 
OM by the so-called BAM complex. 
The BAM complex consist of BamA, an OMP itself, and the four lipoproteins BamB, BamC, 
BamD and BamE, that bind to the N-terminal periplasmic domain of BamA (Sklar, Wu & 
Kahne et al., 2007; Wu et al., 2005; Voulhoux et al., 2003).  
BamA was original identified in Nm and displays the central and essential component of the 
BAM machinery (Voulhoux et al., 2003). BamA belongs to the Omp85 protein superfamily 
and forms a 16 stranded β-barrel, spanning the OM. The protein is conserved across all Gram-
negative bacteria and orthologs of the protein can be found in mitochondria and chloroplasts 
(Hagan et al., 2011). Gram-negative BamA proteins contain five polypeptide transport-
associated (POTRA) domains, whereas in chloroplasts and mitochondria only three or one 
POTRA domains can be found, respectively (Hagan et al., 2011). These periplasmic POTRA 
domains are the binding sites for the four lipoproteins of the BAM complex. BamC, -D and -E 
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bind to POTRA domain 5 (P5) and BamB interacts with P2-P5, indicating a separate 
assembly of BamA and BamB (Kim et al., 2007). However, BENNION and colleagues could 
demonstrate that the periplasmic chaperone SurA of Ec binds to the P1 domain (Bennion et 
al., 2010). Moreover, some of the POTRA domains are essential for viability, as shown for 
Ec, where deletion of P1 and/or P2 can be tolerated, but single deletion of P3, P4 or P5 leads 
to a defect in OMP assembly and increased mortality of the bacteria (Kim et al., 2007). In 
contrast, deletion of P1-P4 in BamA of Nm does not affect the viability and may be explained 
by the fact that LptD, which usually requires the POTRA domains P1-P4 for its assembly, is 
also dispensable in Nm (Ricci & Silhavy, 2012). 
BamB displays an eight-bladed β-propeller structure in which each propeller is formed by 
four antiparallel β-sheets forming together a ring-like architecture (Noinaj et al., 2011; Kim & 
Paetzel, 2011). This nonessential component of the BAM complex is bound via its N-terminal 
lipid anchor to the periplasmic side of the OM (Charlson et al., 2006) and crystallization 
experiments in Ec indicated that BamB may bind unfolded OMPs by β-augmentation (Wu et 
al., 2005; Kim et al., 2007). Despite its irrelevant role for viability, deletion of BamB results 
in significantly aberrant OM biogenesis and consequently to increased sensitivity to 
lysozyme, detergents and antibiotics or to decreased adherence and reduced virulence in 
different species (Weirich et al., 2017; Lee et al., 2017; Hsieh et al., 2016). Thus, BamB plays 
an important role in OMP biogenesis although it is not essential.  
Analysis of BamC revealed a modular structure containing a N- and C-terminal domain and 
additionally a disordered region of 75 amino acids at the N-terminus (Knowles & McClelland 
et al., 2009; Albrecht & Zeth, 2010; Kim & Paetzel, 2011; Kim, K. H. et al., 2011). 
Furthermore, the C-terminal domain of BamC is exposed to the cell surface (Webb et al., 
2012). Deletion of BamC has no striking impact on the OM composition and assembly of 
OMPs is still possible (Fardini et al., 2009; Onufryk et al., 2005). Interestingly, BamC is not 
ubiquitous throughout Gram-negative bacteria and does not show sequence similarity to any 
known protein (Knowles & Scott-Tucker et al., 2009). 
In contrast to the other lipoproteins BamD is the only essential lipoprotein of the BAM 
machinery, leading to cell death when absent. It is composed of five tetratricopeptide repeat 
(TPR) domains and presents an overall α-helical structure (Kim, Kelly H. et al., 2011; 
Albrecht & Zeth, 2010). BamD is highly conserved and according to the current knowledge is 
thought to initially recognize the C-terminal targeting sequence of OMP precursors (Albrecht 
& Zeth, 2010). Within the complex, BamD mediates the interaction of BamC and -E with 
BamA, demonstrated by failed interactions of the lipoproteins caused by C-terminal 
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truncations of BamD (Sklar, Wu & Gronenberg et al., 2007). In more detail, the disordered N-
terminus of BamC is required for the interaction with BamD, by binding in that region of 
BamD that is believed to target OMP precursors. So, BamC might have a regulatory role, 
blocking or exposing the targeting sequence-binding site of BamD (Kim, Kelly H. et al., 
2011).  
BamE interacts with the TPR domains 4 and 5 of BamD and additionally was shown to 
interact with P5 of BamA, supporting the interplay of BamD and BamA (Sklar, Wu & 
Gronenberg et al., 2007; Sklar, Wu & Gronenberg et al., 2007; Fardini et al., 2009). 
Furthermore, BamD binds to the P1 and P2 domain of BamA, further stabilizing the complex 
structure (Bakelar et al., 2016). Moreover, a recent study showed, that the absence of BamE 
leads to the accumulation of the surface exposed lipoprotein RcsF (regulator of capsule 
synthesis protein F) on BamA causing the inactivation of the BAM complex (Tata & 
Konovalova, 2019). Thus, BamE is responsible for a correct interaction of RcsF-bound BamA 
together with BamD to enable the assembly of OMP/RcsF complexes (Tata & Konovalova, 
2019). Maybe this explains the more severe changes in OM integrity and OMP level upon 
bamE deletion compared to the minor changes upon bamC deletion (Sklar, Wu & Gronenberg 
et al., 2007; Fardini et al., 2009). 
Hence, a lot of structural and biochemical data have led to a good knowledge of the 
interactions between the single components of the BAM complex, but how the folding and 
insertion of the OMPs into the OM takes place is still not fully understood. At the moment 
two models have been suggested, both based on BamA features between the β1 (N-terminus) 
and β16 (C-terminus) strands of the β-barrel (Leo & Linke, 2018; Zhang et al., 2019). 
The first, named budding model, implies that BamA opens a lateral gate and interacts with the 
growing OMP, forming a β-sheet hybrid. Once the lateral gate of BamA is open, β-hairpins 
bind to the N-terminus of BamA via β-augmentation. This means that β-strands of the newly 
formed OMP align with the β-sheet of BamA and that the OMP is directly integrated into the 
barrel of BamA while hydrophobic residues face the outside and hydrophilic residues the 
inside (Navarro-Garcia, 2019). Finally, the newly formed OMP “buds” away and leaves 
behind the BAM complex, once more ready for use (Zhang et al., 2019; Navarro-Garcia, 
2019). The second, called assisted model, claims a self-insertion of the OMPs caused by 
decreased hydrophobicity near the lateral gate of BamA. More precisely, the hydrophobic 
region between BamA and the OM seems to disorder the lipid bilayer and thereby generates a 
region for a more efficient insertion of folded OMPs into the OM. For its insertion, the OMP 
forms β-hairpins invading the OM step by step until the full β-barrel is formed. So, the role of 
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the BAM complex in this model is to catalyse the process and destabilize the OM bilayer and 
guide the unfolded OMPs to the intended region (Navarro-Garcia, 2019). 
However, recent investigations of HÖHR et al. on the BamA homolog Sam50 in 
Saccharomyces cerevisiae revealed a mechanism combining both models: formation of a β-
sheet hybrid and insertion of β-hairpins into the lateral gate, and subsequent insertion into the 
thinned membrane (Höhr et al., 2018).  
Furthermore, the BAM complex is also crucial for the assembly of autotransporter proteins, 
consisting of a C-terminal translocator domain (β-domain) that supports the transport of the 
N-terminal passenger domain through the OM to the cell surface (van Ulsen et al., 2018). The 
passenger domain harbours the biological function and can interact as protease, toxin, adhesin 
or shows other functions that cause virulence (Henderson & Nataro, 2001). In Pa, several 
autotransporters have been identified like PlpD, EstA, AaaA and EprS (da Mata Madeira et 
al., 2016; Wilhelm et al., 2007; Kida et al., 2013; Luckett et al., 2012). Both, the translocator 
and passenger domain of autotransporters interact with chaperones to fold the translocator 
domain in the periplasm and fuse it to the BamA barrel. Moreover, interactions with BamB 
and BamD could also be demonstrated (Ieva et al., 2011). Subsequently, the C-terminus of the 
passenger domain forms a hairpin like conformation and is pulled through the pore of BamA 
(Leo et al., 2012). Eventually, the passenger domain is cleaved off and finally the translocator 
domain is released from the BAM complex (Leo et al., 2012).  
 
To sum up, transport and insertion of OMPs, including autotransporters, occurs by a group of 
periplasmic chaperones (§ 1.5.2) and five OM BAM proteins (§4 Figure 1). The mechanism 
of OMP insertion is still controversially discussed and needs to be further analysed. 
 
1.5.4 Architecture, biosynthesis and recycling of the peptidoglycan cell wall 
1.5.4.1 Architecture of the peptidoglycan cell wall 
The Gram-negative peptidoglycan (PG), also called murein or sacculus, was first detected in 
1964 by Wolfhard Weidel and his group in Tübingen (Braun, 2015). It is composed of 
repeating disaccharides of N-acetyl muramic acid (MurNAc) and N-acetylglucosamine 
(GlcNAc) that are linked by β 1-4 glycosidic bonds. Attached to the muramyl moiety of the 
disaccharide chain protrude peptide chains containing up to five amino acids. The peptide 
chains typically consist of L-alanine, D-glutamic acid, meso-diaminopimelic acid (mDAP) or 
lysine and two D-alanine and enable a cross-linking between the glycan strands (Koraimann, 
2003). Normally, the cross-linking takes place between the mDAP of one peptide chain and 
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the fourth D-Alanine of the other peptide chain, but cross links are also formed between the 
mDAPs of both peptide chains (Irazoki et al., 2019; Dhar et al., 2018; Vollmer et al., 2008). 
Thus, a multi-layered meshwork of glycan strands and peptides is formed and embedded in 
the periplasmic space. In contrast to the PG of Gram-positive bacteria (up to 80 nm), the PG 
of Gram-negative bacteria has a thickness of approximately 6 nm  (Ec, 6.35  ± 0.53 nm; Pa 
2.41 ± 0.54 nm (Matias et al., 2003)) and withstands the osmotic pressure to maintain cell 
integrity, keeps the regular bacterial shape and provides to a certain degree the escape of 
antibiotic action (Dhar et al., 2018; Juan et al., 2018; Zeng & Lin, 2013). The stability of the 
Gram-negative cell wall is further improved by a covalent linkage to the OM via Braun’s 
lipoproteins (Hantke & Braun, 1973) or other murein lipoproteins such as the PG-associated 
lipoprotein (Pal) (Juan et al., 2018). Consequently, the architecture and the correct synthesis 
and maintenance of the PG is essential for a proper protection against environmental threats, 
viability and virulence of the bacteria. Any interruption in PG biosynthesis or even 
degradation during cell growth results in cell lysis (Vollmer et al., 2008). During cell growth 
and cell division the PG is subjected to comprehensive transformation and the synthesis and 
recycling of the cell wall components is well coordinated to maintain cell integrity (Dhar et 
al., 2018). Up to 50 % of the murein components are recycled for murein biosynthesis during 
active bacterial growth and it was demonstrated that an existing glycan strand, first serving as 
a kind of docking station, is replaced by three new cross-linked glycan strands, giving a 
“three-for-one model” (Höltje, 1998).  
 
1.5.4.2 Biosynthesis of the peptidoglycan cell wall 
The biosynthesis of new glycan strands requires several enzymatic reactions which can be 
separated into three main steps: (I.) the synthesis of the uridine-diphophate (UDP)-MurNAc 
pentapeptide precursor, (II.) the attachment of the precursor to a lipid (lipid I) in the 
cytoplasmic leaflet of the IM, generating PG precursor lipid II, and (III.) the transfer of 
lipid II into the periplasm by a flippase and subsequent incorporation into the existing glycan 
strand and cross-linking by high molecular mass penicillin-binding proteins (HMM PBPs) 
(Zeng & Lin, 2013; Vermassen et al., 2019) (see also Sonnabend et al., Figure 3 for an 
simplified overview of PG synthesis and recycling). 
More precisely, the UDP-MurNAc pentapeptide synthesis starts in the cytoplasm with the 
conversion of fructose-6-phosphate to UDP-GlcNAc by the enzymes GlmS, GlmU and GlmM 
(Dhar et al., 2018). Homologs of Ec glucosamine synthetase GlmS, N-acetylglucosamine-1-
phosphate uridyltransferase GlmU and phosphoglucosamine mutase GlmM are also present in 
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Pa (PA5549, PA4749 and PA5552, respectively). Subsequently, UDP-GlcNAc is 
enzymatically transformed by the Mur enzymes A-F to UDP-MurNAc pentapeptide, which is 
further modified by MraY, adding the aliphatic moiety undecaprenyl pyrophosphate (UndP) 
to enable the binding to the cytoplasmic leaflet of the IM, and forming lipid I (Dhar et al., 
2018). The generation of lipid I by MraY is reversible, but proceeds immediately with the 
addition of GlcNAc to the MurNAc moiety of lipid I by glycosyltransferase MurG, generating 
lipid II (Bouhss et al., 2004). Because MraY and MurG both are essential enzymes in PG 
synthesis and conserved in Gram-negative and Gram-positive bacteria they are promising 
targets for new antibacterial agents (Zawadzke et al., 2003; Fer et al., 2018). 
The third step of PG synthesis starts with the transfer of lipid II into the periplasm, catalysed 
by a flippase enzyme. The flipping of lipid II has been discussed controversially and in Ec 
RodA, FtsW and MurJ have been reported to perform this reaction (Ruiz, 2015; Taguchi et 
al., 2018; Bolla et al., 2018; Meeske et al., 2016; Cho et al., 2016; Sham et al., 2014; 
Mohammadi et al., 2014). Recent analysis now suggests a model for lipid II flipping in which 
MurJ is recruited by its substrate lipid II and depends on FtsW/PBP3 (Liu et al., 2018). 
Finally, GlcNAc-MurNAc pentapeptides of lipid II are incorporated into the growing PG 
sacculus by HMM PBPs with transglycosylase (TG) and/or transpeptidase (TP) activities. In 
Pa, there exist PBP1a, PBP1b, PBP2, PBP3 and PBP3b/3x, whereas PBP3b/3x was 
demonstrated to be the only essential HMM PBP in Pa (Chen et al., 2017).  
 
1.5.4.3 Recycling of the peptidoglycan cell wall 
The recycling process of the PG cell wall involves three types of lytic enzymes, including low 
molecular mass (LMM) PBPs, lytic transglycosylases (LTs) and amidases (Dhar et al., 2018). 
LMM PBPs can act as carboxypeptidases or endopeptidases, whereas the latter activity 
facilitates the hydrolysis of cross-links to ensure the continuing PG maturation and recycling.  
Ec harbours five LMM PBPs, called PBP4/DacB, PBP5/DacA, PBP6/DacC, PBP6b/DacD 
and PBP7/8/PbpG (Dhar et al., 2018; Sauvage et al., 2008). PBP5, attached to the IM, mainly 
fullfils carboxypeptidase activity and its loss provokes abnormalities in the PG layer and 
increases the presence of free pentapeptides (Nelson & Young, 2000). Pa only harbours three 
LMM PBPs, PBP4/DacB, PBP5/DacC and PBP7/Pbp, and these share the same 
carboxypeptidase- and/ or endopeptidase activity as their homologs in Ec. Moreover, PBP5 of 
Pa is very similar to PBP5 and PBP6 of Ec and deletion of PBP5 in Pa also evidenced its role 
as major carboxypeptidase as shown by increased pentapeptide levels (Ropy et al., 2015). 
Furthermore, loss or mutation of the dacB encoded PBP4 is the mayor cause of ampC 
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overexpression in Pa resulting in high level β-lactam resistance and similarly to increased 
expression of creBC and creD (Moya et al., 2009) (see also § 1.4). Other enzymes, cleaving 
the cross-bridges, are DD-endopeptidases like MepA, MepH (YdhO), MepM (YebA), MepS 
(Spr) and the recently identified MepK (Singh et al., 2012; Chodisetti & Reddy, 2019). Loss 
of the three DD-endopeptidases mepH, mepM and mepS have been reported to cause a severe 
defect in PG assembly, leading to cell lysis (Singh et al., 2012). The regulation of these PG 
hydrolases is not known well, but recently it could be shown that Pa harbours a homolog of 
the Ec Carboxy-terminal processing protease (CTP) Prc, (Reiling et al., 2005) and a second 
CTP, named CtpA, which could be shown to regulate four proteins involved in PG hydrolysis, 
namely MepM1 (PA0667), MepS/MepH2 (PA1198), MepH1 (PA1199) and MepM3 
(PA4404) (Srivastava et al., 2018). Thus, Pa seems to have two CTPs that help to constrain 
the PG hydrolysis.  
LTs catalyse the non-hydrolytic cleavage of the β-1,4-glycoside bonds between MurNAc and 
GlcNAc, forming 1,6-anhydroMurNAc, which is the inducer of ampC expression 
(Domínguez-Gil et al., 2016). Ec harbours eight LTs encoded by mltA, mltB, mltC, mltD, 
mltE, mltF, mltG and slt70 (Scheurwater & Clarke, 2008; Scheurwater et al., 2008; Yunck et 
al., 2016). Pa owns eleven LTs, including MltA, MltB, MltD, MltF, MltF2, MltG, Slt, SltB1, 
SltB2, SltH/SltB3 and RlpA. Deletion of LTs are known to reduce the levels of ampC 
inducing 1,6-anhydroMurNAc, leading to decreased minimal inhibitory concentrations 
(MICs) for β-lactam antibiotics. However, loss of MltA, SltG or MltF in Pa had no effect on 
the resistance phenotype or even worse double deletion of sltB1 and mltB caused an increase 
of resistance, although no increase of ampC expression could be detected (Cavallari et al., 
2013; Lamers et al., 2015). Thus, the loss of LTs can also contribute to a further increase of 
AmpC production (Lamers et al., 2015), making it difficult to use an unspecific LT inhibitor 
to treat antibiotic resistance.  
Periplasmic amidases hydrolyse the amide bond between MurNAc and L-alanine, separating 
the glycan strand from the stem peptide, as well as between recycling by-products like 
GlcNAc-1,6-anhydro-MurNAc peptides (Vermassen et al., 2019; Dhar et al., 2018). Loss of 
amidases in Gram-negative bacteria has been shown to increase the sensitivity to antibiotics, 
detergents and defensins (Heidrich et al., 2002; Yakhnina et al., 2015). Ec harbours the three 
periplasmic amidases AmiA, AmiB and AmiC and the OM bound amidase AmiD. The 
periplasmic amidases in Pa are AmiA and AmiB and two additional periplasmic amidases, 
AmpDh2 and AmpDh3, which share homology with Ec AmiD. However, this unique feature 
of Pa allows the PG turnover already in the periplasm and is advantageous since loss the 
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cytoplasmic amidase AmpD does not result in decreased fitness or virulence due to the 
presence of the extra amidases (Moya et al., 2008). Furthermore, it could be demonstrated 
that AmpDh3 contributes more than AmpDh2 to ampC repression in an ampD mutant (Juan et 
al., 2006) and additionally, AmpDh3 was very recently identified to be delivered to the 
periplasm of prey bacteria (Ec or Yersinia pseudotuberculosis) by the type 6 secretion system 
locus 2 (H2-T6SS) of Pa, and to kill it by hydrolysing the PG (Wang et al., 2019, prereleased, 
but not yet peer-reviewed manuscript).  
In the next step the generated muropeptides in the periplasm are transported across the IM by 
the permease AmpG or less frequently by the permease system OppBCDF or by NagE and 
MurP (MurP not in Pa) (Park, 1993). Pa harbours the two permeases AmpG and AmpP 
(Kong et al., 2010). Depletion of AmpP in PAO1 did not alter its resistance profile (Kong et 
al., 2010), but lack of AmpG leads to a reduced transfer of the AmpC inducer 1,6-
anhydroMurNAc into the cytoplasm and consequently restored the susceptibility to β-lactam 
antibiotics even in highly resistant clinical isolates (Kong et al., 2010; Zamorano et al., 2011).  
In connection with the AmpG mediated transport of GlcNAc-1,6-anhydro-MurNAc into the 
cytoplasm, the β-N-acetylglucosaminidase NagZ, amidase AmpD and LD-carboxypeptidase 
LdcA divide the muropeptides into the components GlcNAc, anhydro-MurNAc, and L-
alanine-D-glutamic acid-mDAP and D-Ala (Dhar et al., 2018). Deletion of NagZ does not 
affect the growth, but prevents the production of 1,6-anhydro-MurNAc and consequently 
leads to low AmpC levels (Asgarali et al., 2009; Zamorano et al., 2010). Loss of AmpD 
causes an increase of 1,6-anhydro-MurNAc-tripeptides and loss of LdcA leads to an increase 
in 1,6-anhydro-MurNAc-tetrapeptides (Höltje et al., 1994; Templin et al., 1999).  
Consequently, the muropeptides are further processed through different pathways in Ec and 
Pa. In Ec, 1,6-anhydro-MurNAc is processed by the AnmK kinase, the etherase MurQ and by 
NagA to GlcN-6-P and subsequently is catalysed to fructose-6-P by NagB, the starting 
product of PG biosynthesis, or is further synthesized to UDP-GlcNAc by GlmM and GlmU 
(Gisin et al., 2013; Uehara et al., 2005). In Pa, a homolog of AnmK, but not of MurQ can be 
found. So, 1,6-anhydro-MurNAc is also processed by AnmK, but subsequently the 
phosphatase MupP converts MurNAc-6P to MurNAc (Borisova et al., 2014; Borisova et al., 
2017). This salvage pathway, which bypasses the de novo biosynthesis of UDP-MurNAc, 
proceeds with the phosphorylation of MurNAc to MurNac-α-1P by the anomeric MurNAc- 
and GlcNAc kinase AmgK. Finally, the uridyltransferase MurU modulates the latter to UDP-
MurNAc (Borisova et al., 2017). Thus, the presence of AmgK and MurU compensates the 
absence of MurQ and related synthesis steps for UDP-GlcNAc by NagA, NagB, GlmM and 
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GlmS (Dhar et al., 2018). Furthermore, the salvage pathway bypasses the need for MurA and 
MurB and thereby confers intrinsic resistance to fosfomycin, which normally inhibits the 
UDP-MurNAc synthesis by covalent binding of MurA (Borisova et al., 2017). In addition, 
distribution analysis indicated that amgK and murU homologs are mainly present in α-, β-, 
and γ-proteobacteria but not in enterobacteria like Ec or Kp (Gisin et al., 2013). 
 
1.5.5 Peptidoglycan metabolism and the regulation of intrinsic β-
lactamases 
One of the most striking characteristics of Pa is its β-lactam resistance mechanism mediated 
by the chromosomal β-lactamase AmpC. Regulation of ampC expression depends on the PG 
recycling (Torrens et al., 2017). β-lactam antibiotics are the most common administered 
antibiotics and by mimicking the last two D-Alanine residues of the peptide side chains they 
prevent binding of HMM PBPs and subsequently prevent the cross-linking of the PG, hence 
leading to cell lysis (Dhar et al., 2018). In many Gram-negative bacteria, including Pa, 
Neisseria gonorrhoeae, Enterococcus cloacae and Citrobacter freundii, the AmpC levels can 
be induced by the presence of β-lactam antibiotics (Juan et al., 2018). So far, it is assumed 
that under normal growth UDP-MurNAc-pentapeptide binds to the LysR-type transcriptional 
regulator AmpR and acts as corepressor to repress ampC expression.  The presence of β-
lactam antibiotics increases the amount of PG derived fragments, so that AmpD may get 
saturated, the level of 1,6-anhydro-MurNAc-tripeptide increases and competes for the binding 
of AmpR. Subsequently, AmpR performs a conformational change and activates ampC 
expression (Jacobs et al., 1994; Jacobs et al., 1997; Domínguez-Gil et al., 2016).  
In addition, the AmpR regulated induction of ampC expression requires the products of 
AmpG, AmpD, NagZ, AmpDh2 and AmpDh3, since they play important roles in the PG cell 
wall synthesis and recycling as described in the previous section. 
The inactivation of AmpD is one of the main drivers of β-lactam resistance in Pa clinical 
strains as well as in Enterobacteriaceae and leads to ampC overexpression, even in the 
absence of β-lactam antibiotics (Juan et al., 2006). Deletion of all three genes ampD, ampDh2 
and ampDh3 renders the situation even worse due to a constant hyperexpression of ampC 
(Moya et al., 2008). AmpG and NagZ are further key players in ampC mediated β-lactam 
resistance, since they allow the entrance of muropeptides into the cytoplasm and their 
modulation to ampC inducing molecules (Juan et al., 2018). Interestingly, NagZ inactivation 
attenuates β-lactam resistance in ampD and dacB mutants due to the inability to produce 1,6-
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anhydro-muropeptides or blocking the overexpression of creD, respectively (Zamorano et al., 
2010).  
The second main driver of AmpC hyperproduction is the mutational inactivation of dacB, 
encoding PBP4. If dacB is disrupted, the CreBC two-component system, including the IM 
effector protein CreD, is activated and indirectly triggers the AmpR-dependent 
overproduction of AmpC. The CreBC system is another essential player in the interplay of 
intrinsic β-lactamase induction and PG metabolism and acts as a global regulator, especially 
under stress conditions such as exposure to β-lactams. Nevertheless, the association of this 
system and β-lactam resistance has been documented only in dacB mutants and not in other 
AmpC hyperproducing strains carrying mutations in ampD, ampDh2 or ampDh3 (Moya et al., 
2009). Interestingly, inactivation of ampC in the dacB mutant affects the creD activation, but 
nagZ or ampG deletions showed no impact, indicating that ampC expression itself drives the 
creD inducibility and that blocking PG cell wall metabolites attenuates creD expression 
(Zamorano et al., 2014). However, the hyperproduction of AmpC always depends on the 
regulator AmpR, since it directly controls the ampC expression through the formation of an 
AmpR-DNA complex. Loss of AmpR causes a significant increase in β-lactam resistance and 
additionally leads to the activation of other virulence genes (Kong et al., 2005). AmpR was 
shown to be involved in the regulation of the MexEF-OprN efflux pump (efflux of 
fluoroquinolones, chloramphenicol and trimethoprim), biofilm formation, QS-regulated 
virulence factors and to control the transcription of PoxB β-lactamase, underlining its role as 
global regulator in Pa (Kong et al., 2005; Balasubramanian et al., 2012). For instance, 
inactivation of AmpR reduced virulence as shown by Caenorhabditis elegans paralytic assays 
(Balasubramanian et al., 2012), or caused a decreased  aminoglycoside resistance 
(Balasubramanian et al., 2014).  
To sum up, the interplay between the PG cell wall recycling and the induction of β-lactamase 
AmpC production is very complex and requires the global transcriptional regulator AmpR, 
the three AmpD amidases, AmpG and NagZ. In addition, AmpR also regulates resistance to 
non-β-lactam antibiotics, biofilm formation and QS-regulated virulence factors. Moreover, the 
CreBC two-component system plays a decisive role in β-lactam resistance in dacB mutants 
and additionally acts as a global regulator. 
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2 Aims of the thesis 
Pa is one of the main causative agents of nosocomial infections such as pneumonia, urinary 
tract infection, wound infections and potentially life-threatening blood stream infection. Pa 
can be intrinsically resistant to certain antibiotics due to a low permeability of the OM, the 
activity of efflux pumps and the inducible expression of the chromosomal β-lactamase AmpC. 
Furthermore, the spread of MDR Pa strains is rising and therefore new strategies for therapy 
are urgently needed.  
The OM serves as a platform for OMPs, including virulence associated proteins, to perform 
their cellular functions and as frontline from which the bacteria interact with the environment 
or host. Therefore, one strategy is to define targets for anti-virulence adjuvants that are 
associated with the OM assembly and its maintenance. In this respect, the main aim of the 
current work was to investigate the suitability of several proteins involved in the OM 
assembly as potential targets in order to possibly develop new strategies to treat Pa infections. 
Thus, single gene deletion mutants of the non-essential BAM complex components BamB and 
BamC, of the periplasmic chaperones HlpA as well as a conditional mutant of the periplasmic 
chaperone SurA were generated and investigated with regards to membrane integrity, 
antibiotic susceptibility, sensitivity to bile salts, serum resistance and virulence in a Galleria 
mellonella infection model. 
A second strategy to define targets for anti-virulence adjuvants is to target chromosomal non-
essential genes that are not directly responsible for resistance mechanism but essential under 
therapeutic antibiotic concentrations, summarized herein as the “secondary resistome”. 
Therefore, a high- density transposon (Tn) insertion mutant library in a MDR Pa bloodstream 
isolate (ID40) was generated and subjected to cefepime (FEP) and MEM. Subsequently, 
Transposon-Directed Insertion Sequencing (TraDIS) was performed and revealed several 
known and unknown non-essential candidate genes as possible targets. Moreover, some 
candidates were further validated by analysing their respective deletion mutants for antibiotic 
susceptibility, β-lactamase activity and ampC expression. 
The gained knowledge may help to develop new anti-virulence adjuvants to circumvent 
antimicrobial resistance and to further highlight the species-specific differences, which render 
the identification of a potential anti-virulence drug target, which is present in several Gram-
negative species, more difficult, but at the same time might facilitate high-precision infection 
therapy.  
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3 Results and Discussion 
 
3.1 Deprivation of the periplasmic chaperones SurA reduces virulence and 
restores antibiotic susceptibility of a multidrug-resistant Pseudomonas 
aeruginosa  
Pa is one of the main causative agents of nosocomial infections and belongs to the so called 
ESKAPE group of multidrug-resistant pathogens for which new strategies for therapy are 
urgently needed (Rice, 2008). Pa harbours several intrinsic and acquired resistance 
mechanisms against antibiotics including enzymatic and mutational resistance mechanisms 
like the production of β-lactamases, overexpression of efflux-pumps, and the OM, that limits 
the entrance of antibiotic molecules through its low permeability  (Gellatly & Hancock, 2013; 
Klein et al., 2019). Especially, the passage of drugs across the OM of Pa and other Gram-
negative bacteria is the major challenge and needs to be resolved (Klein et al., 2019).  
The OM is an asymmetric lipid bilayer, composed of phospholipids in the inner leaflet, LPS 
in the outer leaflet and bilayer-anchored lipoproteins and OMPs (May & Silhavy, 2017). Most 
of the OMPs are porins and autotransporter proteins that comprise a β-barrel domain and 
allow the passage of solutes and contribute to the interaction with the environment or host 
(Silhavy et al., 2010; Henderson & Nataro, 2001). The insertion of the OMPs into the OM is 
enabled by a machinery composed of periplasmic proteins like Skp (HlpA), SurA and DegP 
(MucD) that serve as quality control and guidance for the proteins during the transport across 
the periplasm, and the BAM complex, consisting of BamA-E, which assembles the OMPs 
into the intended region in the OM. The important role of periplasmic chaperones and the 
BAM complex in membrane integrity and antibiotic resistance has been investigated already 
in other species such as Ec, Ye and Nm and thereby revealed species-specific differences. 
Investigations in Ec and Ye demonstrated a major role for SurA and a minor role for Skp in 
folding and OMP assembly (García-Contreras et al., 2015; Sklar, Wu & Kahne et al., 2007; 
Weirich et al., 2017), but in Nm Skp plays the prominent role for OMP assembly (Volokhina 
et al., 2011). Furthermore, deletion of non-essential lipoproteins of the BAM complex or 
periplasmic chaperones leads to altered OMP composition resulting in disturbed OM integrity 
that renders the bacteria more susceptible to antibiotics, human serum, bile salts or detergents 
(Lee et al., 2017; Weirich et al., 2017; Navarro-Garcia, 2019; Klein et al., 2019).  
Thus, the aim of this study was to investigate the role of the non-essential BAM components 
BamB and BamC as well as the periplasmic chaperones SurA and the Skp homolog HlpA in 
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Pa PA14 and additionally the depletion of SurA in the MDR bloodstream isolate ID72, for 
OM integrity and composition, antibiotic resistance and virulence. 
The OM integrity of the mutants was tested on the one hand by using N-phenylnaphthylamine 
(NPN) and on the other hand by growth in bile salts. NPN fluoresces only in hydrophobic 
environments like the phospholipid bilayer of the inner leaflet of the OM, so higher 
fluorescence values indicate a reduced OM integrity. The outcome of the experiments 
revealed a significant entrance of NPN into the conditional surA mutant, but not into the 
bamB, bamC or hlpA mutant compared to the PA14 WT. The complementation of the surA 
mutant (surA SurA+) by the addition of 0.2 % arabinose could restore the NPN fluorescence 
signal to WT levels (Klein et al., 2019). Moreover, the growth studies in LB containing 0.3 % 
bile salts revealed a significantly reduced growth of the conditional surA mutant, as well as of 
the bamB and bamC mutant. In contrast, the growth of the hlpA mutant and surA SurA+ was 
not affected. For complementation of the bamB deletion mutant, bamB was expressed from a 
plasmid containing an arabinose inducible promoter (bamB BamB+). The addition of 0.2 % 
arabinose caused a decrease in growth reduction almost to WT level, but not significantly 
(Klein et al., 2019). Hence, the depletion of SurA and BamB showed the most impact on OM 
integrity.  
To see if the altered OM integrity results in morphological changes, transmission electron 
microscopy pictures were taken from the conditional surA mutant in the presence and absence 
of arabinose as well as from the bamB mutant and PA14 WT. Here, the bamB mutant revealed 
numerous vesicles attached to the cell surface and in the absence of arabinose the conditional 
surA mutant showed also vesicles and additionally the cells looked slightly bloated. 
Comparable results in sensitivity to bile salts and morphological changes were obtained for 
surA and bamB deletion mutants in Ye (Weirich et al., 2017). 
To further analyse the changes in the OM of the different mutants, OM fractions were 
prepared and analysed by LC-MS/MS. The data displayed only minor changes in the OM 
composition of the bamB, bamC and hlpA mutants, whereas the depletion of SurA showed 
major alterations in the OM composition. In the hlpA mutant only HlpA itself was not 
detectable. The deletion of bamC only reduced the level of porin OmpH, whereas the deletion 
of bamB caused the reduction of more proteins like FecA, OprB and PlpD, but without 
significance (Klein et al., 2019). However, the depletion of SurA altered the levels of 42 
proteins, including TonB dependent receptors, siderophore receptors, autotransporters, BAM 
complex components and porins (Klein et al., 2019). Many porins, important for the nutrient 
uptake, especially members of the OprD family (OpdO, OpdN, OpdP and OprD), were 
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reduced in the absence of SurA. Additionally, autotransporter proteins such as PlpD, AaaA, 
EprS or EstA showed reduced amounts or were absent upon SurA depletion. Thus, the 
decreased levels of OMPs in the conditional surA mutant can explain the higher permeability 
of the OM, demonstrated by the stronger fluorescence signal in the NPN assay and indicate 
that SurA in Pa seems to play the major role for OMP biogenesis like in Ec and Ye (Sklar, Wu 
& Kahne et al., 2007; Weirich et al., 2017; Klein et al., 2019). Moreover, the induced changes 
of siderophore receptors (FpvA, FecA, FiuA) in the conditional surA mutant influenced the 
fitness of the bacteria, which could be demonstrated by monitoring the growth of the 
conditional surA mutant and the WT in the presence of the iron chelator 2,2’-Bipyridyl (BiP). 
The loss of SurA resulted in a significant BiP dose-dependent growth reduction compared to 
WT (Klein et al., 2019) . This result completes previous findings on the siderophore receptor 
FiuA, which showed upon loss of the receptor significant pleiotropic effects like reduced 
virulence and decreased biofilm formation (Lee et al., 2016). Additionally, the proteomics 
data revealed significantly reduced amounts of the LptD/E complex, which is important for 
the LPS assembly. Together with other proteins like OprD and PlpD, LptD could be 
confirmed as a true substrate of SurA (qRT-PCR) as already shown in Ye and Ec (Vertommen 
et al., 2009; Weirich et al., 2017). In addition, LO SCIUTO et al. could show that loss of LptE 
affects the functionality of LptD resulting in impaired cell envelope stability, reduced 
virulence and decreased antibiotic resistance (Lo Sciuto et al., 2018). Thus, the inhibition of 
SurA affects several biological functions/pathways such as iron uptake and LPS transport and 
generally leads to reduced abundance of OMPs in the OM, probably caused by enhanced 
degradation of the proteins in the periplasm. Moreover, HlpA could not be identified as a 
substrate of SurA, assuming that HlpA might compensate to a certain level the loss of SurA 
(Klein et al., 2019).  
To further validate the proteomics data, SurA, OprD, and PlpD were additionally detected in 
PA14 WT and the mutant strains by Western Blot analysis of whole cell lysates (Klein et al., 
2019). In the absence of arabinose, no SurA could be detected indicating a functional 
depletion of SurA. In addition, the presence of arabinose partially recovered the SurA level to 
64 % compared to WT. Moreover, the decreased amounts of OprD (15 %) and PlpD (24 %) in 
the absence of arabinose further confirmed the proteomics data of the conditional surA mutant 
(Klein et al., 2019). 
Next, all mutant strains were exposed to human serum to investigate if the OM composition 
influences the serum resistance. The treatment with 10 % human serum revealed that only the 
depletion of SurA had an impact on the serum resistance, since the conditional surA mutant 
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was immediately killed after exposure to human serum. More importantly, the mutant strains 
were investigated for their virulence using the Galleria mellonella infection model. The 
analysis demonstrated that only the depletion of SurA led to a significantly delay in time to 
death compared to the WT (Klein et al., 2019). However, application of arabinose was not 
practicable in this experiment, so that the conditional surA mutant was grown in the presence 
(SurA +) or absence (SurA-) of arabinose just prior to infection. No significant difference 
between the survival curves were observed, indicating that without continuous addition of 
arabinose, the SurA production drops rather fast. Hence, it could not be shown if the 
conditional surA mutant regains its full virulence in the presence of arabinose. Despite that, it 
could be shown that SurA of Pa is crucial for virulence in G. mellonellla (Klein et al., 2019).  
Alltogether, it can be assumed that the inhibition of SurA and the accompanying affected LPS 
transport and the reduced level of siderophore receptors are the main drivers causing the 
reduced resistance to complement mediated killing (Hancock 1983, Larmann 2012), reduced 
fitness under iron depleted conditions and the prolonged survival of the G. mellonella larvae 
(Lo Sciuto et al., 2018). 
Since the conditional surA mutant and the bamB mutant showed the most promising effects 
on OM integrity, it was analysed if the depletion of SurA or BamB affects the susceptibility to 
antibiotics. Additionally, a conditional surA mutant of a clinical MDR Pa bloodstream isolate 
ID72 was tested. The mutant strains and the PA14 and ID72 WT strains were subjected to E-
test of penicillins, cephalosporins, carbapenems, fluoroquinolones and antibiotics which are 
not used against Gram-negative bacteria such as vancomycin (VAN). In the bamB deletion 
mutant the MIC values for ampicillin/sulbactam (SAM), ceftazidime (CAZ), fosfomycin 
(FOS) and VAN were at least 4-fold reduced and could be restored in the presence of 
arabinose, except for FOS (Klein et al., 2019). However, the depletion of SurA in PA14 as 
well as in ID72 reduced the MIC at least 4-fold for ticaricillin/clavulanate (TIM), CAZ, 
levofloxacin (LEV), ciprofloxacin (CIP) and VAN. Depletion of SurA in PA14 additionally 
reduced the MIC for SAM and in ID72 additionally for FEP but not vice versa. More 
importantly, the SurA depletion in the MDR Pa strain ID72 resensitized the strain to 
treatment with the clinically relevant antibiotics FEP, CAZ and LEV, highlighting the crucial 
role of SurA for OM integrity (Klein et al., 2019). Thus, the higher permeability of the OM 
might again be the reason for these effects. 
Furthermore, due to the obtained effects and the fact that we did not succeed in generating an 
in frame deletion of surA and that transposon (Tn) libraries of different Pa strains did not 
detect a viable surA Tn mutant (Skurnik et al., 2013; Lee et al., 2015; Turner et al., 2015), we 
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suggest that surA might be essential in Pa (Klein et al., 2019). However, the Tn library of 
PA14 by LIBERATI et al. includes three Tn mutants of surA (Liberati et al., 2006). The Tn 
insertion of mutant ID38436 starts already after 17 bps and the Tn mutant displayed similar 
characteristics as the conditional surA mutant and in addition SurA could not be detected by 
Western blot analysis (data not shown). We speculate that in this Tn mutant other mutations 
occurred which on the one hand compensated the loss of SurA to enable viable cells, but on 
the other hand still possessed defects in the OM, showing a similar phenotype (Klein et al., 
2019).  
The less dramatic phenotype of the bamB mutant (reduced sensitivity to bile salts and higher 
susceptibility to antibiotics) matches to the minor changes in OMP composition given by the 
proteomics data (Klein et al., 2019). Minor changes in the OMP composition were also 
detected in bamB mutants of Ec, Ye and Kp (Charlson et al., 2006; Weirich et al., 2017; Hsieh 
et al., 2016). In all species, especially the number of porins and autotransporter proteins with 
large numbers of β-strands was affected by the deletion of bamB. In Pa, porins OpdO and 
OprB, as well as autotransporters like AaaA and PlpD were less abundant in the OM upon 
bamB deletion (Klein et al., 2019). This might be reasoned in the observation that BamB is 
more important for the biogenesis of OMPs that have a large number of β-strands (Palomino 
et al., 2011; Weirich et al., 2017). However, the consequences on the phenotype strongly 
differ between the species. A recent study in Kp showed that the deletion of bamB caused a 
15-fold reduction in adherence to and invasion to host cells and additionally was attenuated 
for virulence in a Kp model of bacteremia. Moreover, the bamB mutant in Kp displayed 
significantly decreased resistance to VAN and erythromycin (ERY) (Hsieh et al., 2016). In 
Ye, loss of bamB also lead to attenuated virulence and reduced MICs for several antibiotics 
such as VAN. In addition, the Ye bamB mutant was sensitive against bile salts and 
complement activity (Weirich et al., 2017). The latter and the attenuation of virulence could 
not be observed for the bamB mutant in Pa (Klein et al., 2019). In contrast, another study 
could show that deletion of bamB in Pa PAO1 leads to sensitization against lysozyme and 
against VAN and cefotaxime (CTX) (Lee et al., 2017). The sensitivity against the antibiotics 
could be confirmed by the constructed PA14 bamB mutant. However, the effects of the bamB 
deletion in Pa PA14 are not that promising and do not justify to consider BamB as a potential 
drug target, since the deletion has no impact on the virulence or serum resistance (Klein et al., 
2019). Deletion of bamC and the skp homolog hlpA showed neither distinct phenotypes nor 
attenuation of virulence in the G. mellonella infection model, so that they are not suitable as 
drug targets (Klein et al., 2019). 
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In sum, the most profound changes in the OM composition were detected upon depletion of 
SurA, collectively causing a reduced fitness and consequently leading to reduced virulence in 
the G. mellonella infection model. This underlines the importance of SurA in OMP biogenesis 
and its suitable role as anti-infective drug target in order to reduce the spread of MDR Pa. 
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3.2 Identification of drug-resistance determinants in a clinical isolate of 
Pseudomonas aeruginosa by high-density transposon mutagenesis 
The spread of antimicrobial resistance in Gram-negative pathogens, particularly for β-lactams, 
is rising and causes thousands of deaths due to nosocomial infections by pathogens such as Pa 
(Torrens et al., 2017). Among its intrinsic and acquired resistance mechanism, the β-lactam 
resistance mediated by chromosomal β-lactamase AmpC is notable. The regulation of ampC 
is tightly linked to the PG recycling and therefore mutations of different PG recycling 
components such as the transcriptional regulator ampR, amidase ampD or dacB, encoding 
PBP4, can increase the expression levels of ampC and lead to clinical resistance to β-lactam 
antibiotics (Juan et al., 2006; Moya et al., 2009; Balasubramanian et al., 2012). Moreover, the 
upregulation of β-lactamase AmpC can be triggered by the application of β-lactam antibiotics 
and β-lactamase inhibitors (Sanders & Sanders Jr, 1986). 
However, the use of β-lactam-β-lactamase inhibitor combinations is one way to combat MDR 
Pa strains, but resistance against β-lactamase inhibitors have already been demonstrated and 
are increasing (Drawz & Bonomo, 2010). Consequently, new therapeutic solutions are needed 
to at least render the infections less harmful for the patient without blocking or reverse 
pathways leading to β-lactam resistance (Juan et al., 2018). Hence, one strategy is to use a 
different class of antibiotic adjuvants, which do not act on primary resistance mechanisms, but 
on genes essential under low antibiotic concentrations as previously peformed by JANA et al. 
by subjecting Kp to colistin, CIP and IPM (Jana et al., 2017). Therefore, Transposon-Directed 
Insertion Sequencing (TraDIS) of the clinical bloodstream isolate ID40 (Willmann et al., 
2018) was performed, previously subjected to subinhibitory concentrations of FEP and MEM, 
to identify the secondary resistome of Pa (Sonnabend et al., accepted). 
In a first step, to identify the secondary resistome of ID40, the WGS of ID40 was annotated 
and revealed a chromosome of 6.86 Mbp encoding 6409 open reading frames and the 
presence of a plasmid of 57446 bp containing 59 putative genes (https://www.ebi.ac.uk/ena; 
accession number PRJEB32702) (Sonnabend et al., accepted). Analysis by the ResFinder 
(Zankari et al., 2012) identified resistance genes against aminoglycosides (aph(3’)-IIb (neo)), 
β-lactam antibiotics (blaOXA-486 (bla/poxB) and OXAPAO1 (ampC)), fluoroquinolones (crP 
(crp)) and fosfomycin (fosA (fosA_1)). Furthermore, a point mutation in dacB could be 
detected, which is known to be responsible for upregulating AmpC levels as mentioned 
above. Other gene mutations which could explain resistance mechanisms like mutations in 
oprD or genes encoding efflux pumps were not specifically taken into account, but sequence 
analysis of OprD did not point to a dysfunctional protein.  
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Thus, the different resistance phenotypes of ID40 and PA14, which shares the same resistance 
genes, but is sensitive to all β-lactams, may be explained by the mutation of dacB (Sonnabend 
et al., accepted). 
The constructed TraDIS library showed with 100000 Tn insertions across the genome a 
homogenous distribution and with on average 18 Tn insertions per 1 kbp of coding sequences 
a homogenous coverage of the whole genome. Furthermore, the Tn library of ID40 grown in 
LB, showed that 697 of 6468 genes were determined to be essential and only nine genes were 
determined to be ambiguous (Sonnabend et al., accepted). 
The exposure to subinhibitory concentrations of FEP and MEM, showed that under the 
defined criteria the read counts of 140 genes upon MEM treatment and 102 genes upon FEP 
treatment were significantly changed. In total, 24 genes were at least five-fold reduced and of 
these 13 genes upon both MEM and FEP treatment, 5 only upon MEM and 6 only upon FEP 
treatment (Sonnabend et al., accepted). Most of the identified genes are involved in PG 
recycling such as ampG and nagZ, which contribute to β-lactam resistance (Asgarali et al., 
2009; Korfmann & Sanders, 1989; Zamorano et al., 2011). The identified genes can be 
divided into three categories based on their localization or pathway, namely players in the 
periplasm, cytoplasm or players of the salvage pathway. Additionally, a category of 
uncharacterized players is presented. To validate the findings, in frame deletion mutants of 
selected genes were generated (mltG, mepM1, amgK, ygfB, tuaC, ctpA and ctpA/mepM1) and 
their susceptibility to β-lactam antibiotics using microbroth dilution assays was measured and 
their ampC activity was determined using a nitrocefin based assay as well as by measuring the 
mRNA quantity of ampC (Sonnabend et al., accepted). 
The cell wall recycling starts in the periplasm with three types of lytic enzymes that generate 
the PG muropeptides, which contribute to the transcriptional regulation of ampC. These are 
LTs such as MltG and Slt, LMM PBPs, EPs such as MepM1 and amidases such as AmpDh2 
and AmpDh3. They altogether cleave the PG layer to facilitate the insertion of new murein 
chains and simultaneously release soluble PG fragments into the cytoplasm (Dhar et al., 
2018). 
The antibiotic treatment of the ID40 Tn library caused the most profound effects on the LTs 
MltG and Slt. Slt was already shown to display decreased resistance against piperacillin (PIP) 
and cephalosporin antibiotics if inactivated (Cavallari et al., 2013), and MltG was recently 
shown to be inhibited by the sulfonated glycopeptide bulgecin, causing decreased MICs 
against CAZ and MEM (Dik et al., 2019). Additionally, the LTs MltF and MltD were 
identified to maintain resistance, but to a lesser extent than MltG and Slt. In contrast, SltB and 
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SltH were found to counteract the resistance. The findings of MltF and MltD confirmed 
previous studies which addressed theses LTs as possible drug targets to circumvent resistance 
(Lamers et al., 2015; Cavallari et al., 2013; Dik et al., 2019; Sonnabend et al., accepted). 
Furthermore, the generated mltG mutant showed reduced MIC values of all tested antibiotics 
and especially the MICs of FEP, PIP and PIP/tazobactam (TZP), IPM, CAZ and ATM were 
reduced below the breakpoint, rendering it to the best candidate for drug development. 
Moreover, its significantly reduced ampC expression and accompanying lower β-lactamase 
activity could underline the important role of MltG in ampC expression and PG recycling, 
since MltG acts as terminase to control PG chain length and thereby produces ampC inducing 
muropeptides (Yunck et al., 2016). In sum, it can be concluded that LTs represent one of the 
most promising targets to resensitize MDR Pa strains to clinically relevant β-lactam 
antibiotics, as previously demonstrated by DIK and colleagues using the LT inhibitor bulgecin 
(Dik et al., 2019; Sonnabend et al., accepted). 
The read counts of EP MepM1 (YebA, PA0667) were also reduced. MepM1 putatively 
modulates PG crosslinking and was found to be a substrate of the protease CtpA (Srivastava 
et al., 2018). Other substrates of the cross-links regulating protease are MepM3 
(PA4404/TUEID40_02316), MepH1 (PA1199/TUEID40_01414) and MepS/MepH2 
(PA1198/TUEID40_01415). The read counts of the latter were also reduced upon FEP and 
MEM treatment, but not like MepM1. Furthermore, the EP MepM2/TUEID40_04881, which 
was not evidenced as CtpA substrate in PAK (Srivastava et al., 2018), showed also reduced 
read counts in the screen, but only upon MEM treatment. Despite that, it might be involved in 
antibiotic resistance. However, EPs also take part in ampC induction. This study revealed for 
mepM1 the highest reduction in Tn insertion read counts, while Tn insertions in 
MepS/MepH2 showed only a slightly impact on the growth in the presence of MEM. Thus, 
deletion mutants of mepM1 and ctpA were generated to further analyse their role in ampC 
induction and antibiotic susceptibility. The microbroth dilution assays showed reduced MIC 
values of all tested β-lactam antibiotics in mepM1, except for IPM and MEM. The MIC of 
ATM and FEP were additionally reduced below the breakpoint. In contrast, the MIC values of 
ATM, FEP, PIP and MEM were increased in ctpA, causing hyperresistance. Likewise, loss 
of CtpA lead to elevated ampC expression and a higher β-lactamase activity. Thus, it is very 
likely that the increased activity of MepM1 or other CtpA substrates leads to increased 
resistance (Sonnabend et al., accepted). Moreover, the deletion of mepM1 in the ctpA deletion 
mutant showed reduced MIC values for ATM and PIP compared to ctpA, but still higher 
MIC values in comparison to mepM1. This indicates the contribution of other EPs in ampC 
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upregulation and may indicate that elevated MepM1 levels lead to stronger ampC expression. 
According to this, the inhibition of these EPs could be a possible strategy to break resistance 
against β-lactam antibiotics. Furthermore, the important role of CtpA in regulating EPs is 
emphasized by the hyperresistance of the mutant in ID40 (Sonnabend et al., accepted) and its 
impact could further be supported by SANZ-GARCÍA et al., who demonstrated the occurrence 
of mutations in ctpA under ceftazidime-avibactam challenge and consequently increased 
resistance (Sanz-García et al., 2018).  
Upon transport into the cytoplasm by the permease AmpG and partly AmpP (Perley-
Robertson et al., 2016), the muropeptides are catalysed by several enzymes to form the PG 
precursor UDP-GlcNAcMurNAc-pentapeptide (Dhar et al., 2018). In the first steps 1,6-
anhydro-MurNAc-peptides, which bind to the transcriptional regulator AmpR to induce ampC 
expression, are degraded by LdcA, NagZ and AmpD. The amidase AmpD cleaves the peptide 
chains of the muropeptides generating 1,6-anhydro-MurNAc, which is subsequently directed 
to the salvage pathway to catalyse the formation of UDP-MurNAc by the enzymes AnmK, 
MupP, AmgK and MurU (Gisin et al., 2013; Borisova et al., 2014). After that, the Mur 
enzymes transform UDP-MurNAc to UDP-MurNAc-pentapeptide, which binds AmpR to 
repress ampC expression (Dhar et al., 2018). The TraDIS experiment revealed increased 
susceptibility towards β-lactam antibiotics upon loss of ampG and nagZ, which has already 
been demonstrated to be reasoned in decreased amounts of 1,6-anhydroMurNAc-peptides 
(Asgarali et al., 2009; Zamorano et al., 2010). On the other hand, increased resistance is 
caused by the accumulation of 1,6-anhydroMurNAc-peptides upon loss of ampD, one of the 
most occurring mutations in MDR clinical Pa isolates (Jacobs et al., 1995; Langaee et al., 
2000; Juan et al., 2005; Sonnabend et al., accepted). 
The four genes anmK, amgK , mupP and murU of the salvage pathway, which mediates 
intrinsic resistance to FOS (Gisin et al., 2013), were identified in the TraDIS screen too. 
All genes of the pathway have been shown to lead to increased resistance to CAZ and CTX 
upon inactivation (Fumeaux & Bernhardt, 2017). This effect could not be explained so far, but 
it is suggested that the reduction of the steady state level of ampC repressor UDP-MurNAc-
pentapeptide creates this situation, so that 1,6-anhydro-MurNAc-peptides predominate and 
derepress ampC (Fumeaux & Bernhardt, 2017). In contrast, a study by BORISOVA et al. in Pa 
PAO1 (Borisova et al., 2014), as well as the present results showed no increased resistance to 
CAZ and IPM in PAO1 amgK. However, reduced MIC values for all -lactam antibiotics 
except for MEM and MICs below the breakpoint for ATM, FEP and CAZ could be obtained 
in ID40 amgK. Moreover, the role of amgK in FOS resistance could be confirmed and the 
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ID40 amgK mutant showed reduced ampC expression levels and reduced β-lactamase 
activity. At the moment this outcome seems to be counterintuitive and more detailed studies 
have to be done (Sonnabend et al., accepted). However, it is possible that the anabolic 
recycling pathway somehow counteracts the derepression of ampC expression in the dacB 
background of ID40. This finding leads to the assumption that the salvage pathway may also 
play an important role in the maintenance of β-lactam resistance (Sonnabend et al., accepted). 
The TraDIS screening additionally identified uncharacterized genes. Namely, a member of the 
glycosyltransferase 1 family TUEID40_05543/tuaC, and TUEID40_03245 encoding an YgfB-
like protein, which has not been characterized so far (Sonnabend et al., accepted). 
The deletion of tuaC displayed only minimal reduced MIC for TZP. Because of that we 
focused on TUEID40_03245, which shares similarity with the homologous gene ygfB in Ec. 
Hence, the unknown gene was termed ygfB and an in-frame deletion mutant was generated. 
The deletion of ygfB caused downregulated ampC mRNA levels and reduced β-lactamase 
activity resulting in reduced MICs for all tested β-lactam antibiotics and for ATM and FEP, 
below the respective breakpoint concentrations. To our knowledge, ygfB has not been 
mentioned so far in the context of antibiotic resistance, rendering it to an interesting candidate 
of drug development (Sonnabend et al., accepted). However, ygfB is located in an operon 
consisting of pepP; ubiH, PA14_68970 orthologue and ubiI. ubiH and ubiI are important for 
ubiquinone biosynthesis and pepP encodes an aminopeptidase. Such operons can be found in 
the same order in Ec, Acinetobacter baumannii (Ab) and Legionella pneumophila (Lp), 
whereas YgfB of Pa shares 33 % identity with Ec and Ab YgfB and 32 % with YgfB of Lp 
(Sonnabend et al., accepted). Interestingly, studies of Tn mutants in Pa PAO1 indicated a 
contributing role of YgfB for virulence in C. elegans (Feinbaum et al., 2012) and additionally 
TraDIS experiments in Pa PA14 by SKURNIK et al. revealed a potential role of ygfB 
orthologue PA14_69010 in effective colonization in the caecum of mice (Skurnik et al., 
2013). Thus, YgfB possibly effects virulence and is able to modulate antibiotic resistance, 
rendering it to a promising target of antibiotic adjuvants which might reduce antibiotic 
resistance and virulence at the same time (Sonnabend et al., accepted). Noteworthy, pepP was 
also identified in this approach, but lead to the suggestion that the inactivation of pepP might 
provoke hyperresistance (Sonnabend et al., accepted). 
To sum up, the performed TraDIS approach revealed a set of non-essential genes which are 
highly relevant for the induction of AmpC production and consequently β-lactam resistance. 
To our point of view, these genes are promising targets for anti-infective drugs to reverse 
multidrug resistance in Pa strains with high AmpC activity. Especially, the function of YgfB 
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and its specific role in antibiotic resistance and virulence will be further investigated 
(Sonnabend et al., accepted).  
 
Graphic Summary 
45 
 
4 Graphic Summary 
 
Figure 1. Biogenesis of β-barrel outer membrane proteins in Gram-negative bacteria 
and effects upon loss of SurA, BamB, BamC or HlpA. Nascent β-barrel outer membrane 
proteins (OMPs) are synthesized in the cytoplasm (C) and transported across the inner 
membrane (IM) into the periplasm by the Sec translocon. Subsequently, chaperones SurA or  
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HlpA (Skp in Ec) bind the OMPs and guide them through the periplasm (P) to the BAM 
complex, comprising BamA with POTRA domains P1-P5 and BamB-D, located in the outer 
membrane (OM). The BAM machinery then folds and inserts the OMPs into the OM. 
Misfolded OMPs or OMPs that fall off the SurA pathway are degraded by MucD (DegP in 
Ec). (A) Drastic effects upon SurA depletion; (B) Effects upon BamB depletion; (C) Minor 
effects upon BamC depletion; (D) No effects upon HlpA depletion. 
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Figure 2. TraDIS approach and validation. (A) Diagram of the experimental procedure to 
generate a Tn library in Pa ID40. (B) Growth of the ID40 Tn library under different 
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conditions (LB/ LB + FEP or LB + MEM) following extraction of genomic DNA and TraDIS. 
(C) Validation of TraDIS output by generating deletion mutants (∆mltG, ∆mepM1, ∆ctpA, 
∆ctpA∆mepM1, ∆amgK, ∆ygfB and ∆tuaC) and analysis by microbroth dilution assays and 
measurement of -lactamase activity (Nitrocefin- based assay) and ampC expression (qRT-
PCR). ↓ indicates reduction and ↑ indicates increase; the number of arrows illustrates the 
strength of the reduction or increase; nd, not detected. 
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Pseudomonas aeruginosa is one of the main causative agents of nosocomial infections
and the spread of multidrug-resistant strains is rising. Therefore, novel strategies for
therapy are urgently required. The outer membrane composition of Gram-negative
pathogens and especially of Pa restricts the efficacy of antibiotic entry into the cell
and determines virulence. For efficient outer membrane protein biogenesis, the β-barrel
assembly machinery (BAM) complex in the outer membrane and periplasmic chaperones
like Skp and SurA are crucial. Previous studies indicated that the importance of individual
proteins involved in outer membrane protein biogenesis may vary between different
Gram-negative species. In addition, since multidrug-resistant Pa strains pose a serious
global threat, the interference with both virulence and antibiotic resistance by disturbing
outer membrane protein biogenesis might be a new strategy to cope with this challenge.
Therefore, deletion mutants of the non-essential BAM complex components bamB and
bamC, of the skp homolog hlpA as well as a conditional mutant of surAwere investigated.
The most profound effects for both traits were associated with reduced levels of SurA,
characterized by increased membrane permeability, enhanced sensitivity to antibiotic
treatment and attenuation of virulence in a Galleria mellonella infection model. Strikingly,
the depletion of SurA in a multidrug-resistant clinical bloodstream isolate re-sensitized
the strain to antibiotic treatment. From our data we conclude that SurA of Pa serves as a
promising target for developing a drug that shows antiinfective activity and re-sensitizes
multidrug-resistant strains to antibiotics.
Keywords: SurA, Pseudomonas aeruginosa, virulence, multidrug resistance, antibiotics, outer membrane protein
biogenesis
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INTRODUCTION
The widespread use of antibiotics is causative for the rapid
development of multidrug-resistant strains. Particularly, the
emergence of carbapenem-resistant bacteria poses a significant
threat to public health (Pendleton et al., 2013). The Gram-
negative, opportunistic pathogen Pseudomonas aeruginosa (Pa)
belongs to the so-called ESKAPE group, comprising a group
of the most common and multidrug-resistant bacteria (Rice,
2008). Pa can cause infections in a wide range of animal and
plant hosts and is a leading cause of nosocomial infections,
which are almost exclusively found in immunocompromised
hosts (Lyczak et al., 2000; Lister et al., 2009). Pa displays
numerous intrinsic and acquired resistance mechanism against
antibiotics: (i) enzymatic and mutational resistance mechanisms
like the production of β-lactamases, (ii) overexpression of
eﬄux systems, and (iii) the low permeability of the outer
membrane (OM) that limits the penetration of antibiotic
molecules (Yoshimura and Nikaido, 1982).
The major challenge for drugs against Pa and Gram-negative
bacteria in general is to pass the bacterial OM. The OM
provides a highly effective barrier against foreign and harmful
molecules, allows import and export of essential substances
such as nutrients and iron, is necessary for communication
and harbors many virulence factors. The outer leaflet of the
OM is constituted mainly by lipopolysaccharides (LPS), whereas
the inner leaflet consists of phospholipids. This bilayer houses
a great variety of outer membrane proteins (OMPs) that
facilitate transport and other essential functions, and act as
virulence factors (Nikaido, 2003). Many OMPs are porins and
autotransporters. Both comprise a β-barrel domain and either
facilitate transport of molecules across the OM (Chevalier
et al., 2017) or can form cell surface exposed moieties that
shape the interaction with the host and the extracellular
environment (Leyton et al., 2012). For the insertion of these
β-barrel proteins, Gram-negative bacteria employ a conserved
transport system consisting of the periplasmic chaperones SurA,
Skp, and DegP, which protect and guide newly synthesized
proteins from the Sec translocon in the inner membrane to
the OM and the β-barrel assembly machinery (BAM) complex
(Sklar et al., 2007; Tashiro et al., 2009; Goemans et al.,
2014; Li et al., 2018). Both SurA and Skp act as chaperones
and are thought to form a partially redundant network. The
importance of SurA and Skp for the OMP biogenesis is
controversially discussed. At least in Escherichia coli (Ec) and
Yersinia enterocolitica (Ye), SurA plays the major and Skp a less
prominent role in folding and assembly of OMPs (Sklar et al.,
2007; Volokhina et al., 2011; Weirich et al., 2017). However,
in Neisseria mengitidis, Skp is more important for shaping
the OMP composition than SurA, indicating species-specific
differences (Tamae et al., 2008).
The BAM complex, which inserts the β-barrel proteins
into the OM, consists of the central component BamA
and the four lipoproteins BamB, BamC, BamD, and BamE
(Noinaj et al., 2017). Of these subunits, only BamA and
BamD are essential in most of the so far investigated Gram-
negative bacteria, except Borrelia burgdorferi and Salmonella
enterica (Wu et al., 2005; Malinverni et al., 2006; Fardini
et al., 2009; Dunn et al., 2015). BamA is a β-barrel protein
itself (Noinaj et al., 2017). Its C-terminal β-barrel domain is
connected to an N-terminal periplasmic domain which consists
of five polypeptide transport-associated (POTRA) domains.
The POTRA domains form several interactions with the other
Bam subunits, building up the BAM complex and interact
with both substrates and periplasmic chaperones such as
SurA (Gu et al., 2016). BamB directly binds to the POTRA
domains 2-5 of BamA and supports the stabilization of
nascent OMPs by binding and delivering OMP β-strands to
BamA (Heuck et al., 2011).
In Ec, the deletion of one of the non-essential BAM complex
components or the related periplasmic shuttle protein SurA
may lead to an altered protein composition in the OM and/or
disturbed OM integrity and therefore to a higher susceptibility
to various antibiotics (Behrens et al., 2001; Onufryk et al.,
2005). Using Ye we have previously shown that the deletion
of surA and bamB implies a significantly decreased virulence
and more efficient clearance of Ye infection by the host in vivo
(Weirich et al., 2017).
In Pa, BamA, and the BamE-homolog OmlA have already
been recognized to play a role in the stability of the OM
and susceptibility to environmental stress (Ochsner et al., 1999;
Yorgey et al., 2001; Hoang et al., 2011). For BamB of Pa, an
enhanced susceptibility against lysozyme and cell wall targeting
antibiotics as well as a decreased growth in vivo have been
demonstrated recently (Lee et al., 2017).
Thus, it is well recognized that the BAM complex itself as well
as chaperones in delivering proteins to the outer membrane are
critical for membrane integrity as well as antibiotic resistance
and could therefore be targets for drug development (Tamae
et al., 2008; Weirich et al., 2017; Storek et al., 2018; Vij et al.,
2018). Nevertheless, previous studies revealed species-specific
differences in the importance of individual components in OMP
biogenesis such as Skp and SurA (Sklar et al., 2007; Volokhina
et al., 2011; Weirich et al., 2017). In addition, for considering
such proteins as targets for Pa it would be mandatory to
affect multidrug-resistant strains and break resistance against
commonly used antibiotics.
To identify potential targets in order to possibly develop
new strategies to treat especially infections caused by multidrug-
resistant Pa, we investigated the role of components involved
in the assembly of proteins into the OM by deletion of the
non-essential BAM complex components BamB and a BamC
homolog as well as the periplasmic shuttle proteins SurA and
HlpA (a Skp-like protein) in Pa PA14. Depletion of SurA had
the greatest impact on OM integrity and caused profound
changes in the protein composition of the OM. These changes
broadened the spectrum of antibiotics that could be used for
treatment of Pa infection, and they lowered the minimum
inhibitory concentration of clinically important antibiotics.
Additionally, depletion of SurA enhanced clearance of Pa
infection by the host. Taken together, our findings indicate
that specifically SurA could serve as a novel antivirulence
and/or resistance-breaking target even in multidrug-resistant
strains of Pa.
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MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
Bacterial strains and plasmids used in this study are listed in
Table S1. Bacteria were cultivated overnight at 37◦Cwith shaking
at 200 rpm in lysogeny broth (LB) containing suitable antibiotics
but without any additives such as arabinose, if not otherwise
stated. Antibiotics were added at the following concentrations:
Tetracycline (Tet; AppliChem #A2228) 15µg/ml, ampicillin
(Amp; AppliChem #A0839) 100µg/ml and gentamicin (Gm;
AppliChem #A1492) 15µg/ml (Ec strains) or 75µg/ml for Gm
and 50µg/ml for Tet (Pa strains). If not stated otherwise,
overnight cultures were diluted 1:20 into fresh LB medium
containing suitable antibiotics (and/or additives like 0.2%
arabinose (Sigma Aldrich #A3256) for the conditional surA
mutant) and grown for 3 h at 37◦C and 200 rpm to obtain
subcultures in exponential phase (OD600 = 0.5). The growth of
bacteria in LB at 37◦C in a 24-well-plate was measured using
Tecan Infinite R© 200 PRO at 37◦C. To investigate the growth
under iron-restricted conditions, indicated concentrations of
2,2′-Bipyridyl (Sigma Aldrich #D216305) were added.
Generation of In-frame Deletion Mutants
In-frame deletion mutants were generated using the suicide
plasmid pEXG2 (Rietsch et al., 2005). The primers used in this
study are listed in Table S2. First, the flanking regions (consisting
of 30 bp at the 3′ end and 30 bp at the 5′ end of the gene of
interest plus ∼ 800 bp for each flanking region) and a pEXG2
fragment were amplified by PCR and ligated using Gibson
assembly (Gibson, 2009). In general, constructed plasmids were
verified by DNA sequencing, transformed into Ec SM10 λ pir and
subsequently mobilized by conjugation into PA14. Merodiploids
were selected on LB agar plates containing irgasan (25µg/ml;
Sigma Aldrich #72779) and Gm (75µg/ml). To achieve the
second cross-over, counter selection on no-salt lysogeny broth
(NSLB) agar containing 15% sucrose was performed (Sigma
Aldrich #S7903). Finally, the loss of the plasmid was tested by
streaking colonies on LB agar plates containing Gm (75µg/ml)
and in parallel on LB agar plates without antibiotics. In-frame
deletion mutants were confirmed by PCR using (i) a primer pair
flanking the target gene and (ii) a primer pair where one primer
binds to the coding region of the target gene.
Generation of Conditional Depletion
Mutants
As stated also in the results section, we were not able to create an
in-frame surA deletion mutant. Therefore, a conditional mutant
was generated, starting from a merodiploid PA14::pEXG2-surA
clone. For the integration of exogenous surA, the plasmid mini-
CTX1-araCPBAD-surA (PA14) was constructed. The mini-CTX1
(Hoang et al., 2000) is an optimized self-proficient integration
vector for Pa containing a ϕCTX attachment site for integration
of foreign genes into the chromosome. The coding sequence
(cds) of tolB of the vector mini-CTX1-araCPBAD-tolB (Lo Sciuto
et al., 2014) was replaced by the cds of surA using PCR
amplification and Gibson assembly. The mini-CTX1-araCPBAD-
surA construct was integrated into the attB neutral site of the
chromosome of PA14::pEXG2-surA as described recently (Hoang
et al., 2000; Lo Sciuto et al., 2014) in the presence of Tet
(50µg/ml), Gm (100µg/ml) and arabinose (0.2%). Afterwards,
the endogenous copy of the surA gene was deleted in-frame
under SurA-inducing conditions and confirmed as described
above. Excision of the mini-CTX1 backbone containing the
Tet resistance cassette was performed using Flp recombinase as
described (Hoang et al., 2000) and verified by PCR. Likewise,
a conditional surA mutant of the clinical Pa isolate ID72 was
generated, using mini-CTX1-araCPBAD-surA and the mutator
plasmid pEXG2-surA ID72. For the complementation of bamB,
the mini-CTX1 vector was used to introduce an arabinose-
inducible copy of bamB into the genome of PA14 bamB as
described for surA.
Electron Microscopy
A total of 5 x 109 bacteria were harvested and fixed in Karnovsky’s
fixative, embedded in agarose, cut in small blocks and fixed again
in Karnovsky’s fixative. After post-fixation and embedding in
glycid ether, blocks were cut using an ultramicrotome. Sections
(30 nm) were mounted on copper grids and analyzed using a
Zeiss LIBRA transmission electron microscope.
Generation of Overexpression Plasmids for
Protein Purification
The cds of PA14 surA was subcloned into the vector
pTXB1, resulting in pTXB1-surA-Intein. pET28a-bamB-His6
was generated by Genscript Inc. Both plasmids were transformed
into Ec BL21 (DE3) (Invitrogen #C600003). The sequence
encoding full-length plpD from Pa PAO1 was synthesized with
Ec codon optimization (ThermoFisher Scientific). The region
coding for the passenger and the POTRA domain (residues
18-406) were subcloned into the expression vector pET28a+
(Novagen #69864) using Gibson assembly with mutations
leading to an inactive lipase and encoding a C-terminal
hexa-histidine tag resulting in pET28a-plpD S60A/D207N-
His (Liu and Naismith, 2008).
Protein Purification and Generation of
Polyclonal Antibodies
For purification of SurA, Ec BL21 (DE3) harboring pTXB1-
surA-Intein was grown to an OD600 of 0.4, induced by the
addition of 100µM IPTG (Peqlab #37-2020) and grown for
another 4 h at 37◦C. Protein purification was performed using
the IMPACTTM kit (New England Biolab #E6901S) according to
the manufacturer’s instructions with subsequent size-exclusion
chromatography on a HiLoadTM 16/600 SuperdexTM 200 pg
column (GE Lifesciences). Fractions containing purified SurA
were pooled, concentrated and validated by SDS-PAGE. For
purification of BamB, Ec BL21 (DE3) harboring pTXB1-bamB-
His6 were grown to an OD600 of 0.6, induced by the addition
of 100µM IPTG and grown overnight at 37◦C. Bacteria
were pelleted and resuspended in buffer A [40mM HEPES
(Carl Roth #9105.4), pH 7.4; 150mM NaCl (VWR Chemicals
#27810.295)] following an incubation under stirring for 20min
at 4◦C with 10mM MgSO4 (AppliChem #A6414), 20 mg/ml
lysozyme (Sigma Aldrich #6876), protease inhibitor tablets
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(Sigma Aldrich #S8830) and a pinch of DNase (Sigma Aldrich
#DN25). Subsequently, bacteria were lysed using a French
pressure cell, followed by sequential centrifugation steps at
4◦C (4,500 × g, 15min; 20,000 × g, 20min; 40,000 × g,
1 h). Finally, the sterile-filtered (0.2µm filter, Sarstedt) His6-
tagged protein was subjected to metal affinity chromatography
(HisTrapTM HP, 5ml, GE Life Sciences) and concentrated.
Antibodies were raised in 2 rabbits each for SurA or BamB-His6
and subsequently affinity-purified against purified SurA or BamB
protein, respectively (Eurogentec).
For purification of PlpD lipase + POTRA domains, Ec BL21
Gold (DE3) cells (Agilent Technologies #230132) harboring
pET28a-plpD S60A/D207N-His were grown in autoinducing
ZYP-5052 medium (Studier, 2005) at 30◦C, harvested 24 h
post-inoculation by centrifugation and resuspended in running
buffer containing 40mM sodium phosphate (Carl Roth #K300.1),
400mM NaCl and 20mM imidazole, pH 8.0 (AppliChem
#A1073). For lysis, additional EDTA-free protease inhibitor,
1mM MgCl2 (Sigma Aldrich #M8266), 1mM MnCl2 (Merck
#8059300100), 0.1 mg/ml lysozyme and a pinch of DNase were
added to the buffer before application to a French pressure cell.
After centrifugation at 20,000 × g and 4◦C for 35min, the
sterile-filtered supernatant containing the His6-tagged protein
was applied to a HisTrapTm FF column (GE Healthcare) and
purified on an NGC Chromatography System (Bio-Rad). The
protein was eluted from the column using a gradient of imidazole
(to 0.5M) and further purified on a HiPrep 26/60 Sephacryl S200
HR size exclusion column (GE Healthcare, USA) using 20mM
Tris and 300mM NaCl at pH 7.5. The production of antibodies
was performed at the Section for Experimental Biomedicine
(University of Life Sciences, Oslo, Norway) with license of the
Norwegian Animal Research Authority (NARA) (http://www.
mattilsynet.no/dyr_og_dyrehold/dyrevelferd/forsoksdyr/).
NPN Assay
To determine changes in the OM permeability of the
generated mutants, the fluorescent, hydrophobic 1-N-
phenylnaphthylamine (NPN) (Acros organics #90-30-2)
was used as described (Konovalova et al., 2016). Subcultured
bacteria were washed and adjusted to an OD600 of 0.5 in
5mM HEPES buffer (pH 7.2). NPN was added to the bacteria
to a final concentration of 10µM. 200 µl of the bacterial
suspension were transferred to 96-well F-bottom, black, non-
binding plates (Greiner Bio-one #89089-582). Subsequently,
fluorescence (excitation and emission wavelengths 350 and
420 nm, respectively) was measured using the Tecan Infinite R©
200 PRO. Polymyxin B (PMB, Merck #A 231-40) served as
a positive control and was added to a final concentration
of 8µg/ml. Values obtained for a buffer-only control were
subtracted from all values.
Bile Salt Assay
To analyze the sensitivity to bile salts, 107 bacteria per well
were inoculated in duplicates into a 24 well microtiter plate
containing either 1ml LB or 1ml LB + 0.3 % bile salts (Sigma
Aldrich #B8756). The conditional surA mutant was additionally
supplemented with 0.2 % arabinose. The plate was incubated at
37◦C and shaking at 160 rpm for 8 h and OD600 was determined
using the Tecan Infinite R© 200 PRO.
Western Blot Analysis
5 × 108 bacteria per ml of subcultures grown for 3 h were boiled
in 2.5× Laemmli buffer (Bio-Rad #161-0747) containing 50mM
DTT (Thermo Fisher Scientific #R0861) at 95◦C for 10min.
SDS-PAGE was performed with 5 × 106 bacteria per lane using
a 10 % Mini-PROTEAN R© TGXTM Precast Protein gel (Bio-
Rad). Subsequently, proteins were transferred to a nitrocellulose
membrane. After blocking in 5% skim milk in TBS (10mM Tris-
HCL (Sigma #T1503), 150mM NaCl; pH 7.6), the membrane
was incubated with the primary antibody [rabbit anti-SurA,
1:200; rabbit anti-BamB-His6, 1:200; rabbit anti-OprD (kindly
provided by Thilo Köhler, University of Geneva; Epp et al.,
2001), 1:2,000; rabbit anti-PlpD serum 1:10,000; rabbit anti-RpoB
(Ec), 1:2,000 (Abcam #mAb EPR18704)] and afterwards with
the secondary antibody (horseradish-peroxidase-conjugated goat
anti-rabbit antibody 1:5,000, Thermo Fisher Scientific #31460).
ClarityTM Western ECL Substrate (Bio-Rad #170-5061) was
added and signals were detected using a Fusion Solo S imager
(Vilber). Protein bands were quantified via ImageJ. In contrast to
SurA and OprD, where RpoB was used as a loading control for
quantification, for PlpD the unspecific band of ∼75 kDa served
as a loading control.
Enrichment of OM Fractions
Preparation of the OM was conducted as described (Thein
et al., 2010; Oberhettinger et al., 2015; Weirich et al., 2017).
In short, PA14 strains including the conditional surA mutant
were grown overnight in LB. Subcultures (1:20 dilution) were
then grown in LB to an OD600 of 0.5–0.7. For complementation
of the conditional surA mutant 0.2% arabinose was added
in the subculture. After centrifugation, 2.5 × 1010 bacteria
were resuspended in 0.5ml of resuspension buffer (0.2M Tris,
1M sucrose, 1mM EDTA (Applichem #A5097), pH 8.0), then
5,000U lysozyme were added and incubated for 5min at
room temperature. Subsequently, 3.2ml H2O were added and
incubated for 20min at room temperature until spheroplasts
were formed. Then, 5ml of extraction buffer (2% Triton X-
100 (AppliChem #A4975), 50mM Tris, 10mM MgCl2, pH
8.0) together with 5 µl DNase I (Roche Applied Science
#03539121103) were added and incubated on a rotator for 20min
at room temperature to solubilize the inner membrane fraction
with Triton X-100 (Schnaitman, 1971; Page and Taylor, 1988).
The lysate was centrifuged at 85,000 × g for 1 h at 4◦C and
the pellet containing the OM fraction was washed three times
in 2.5ml H2O by centrifugation at 292,000 × g for 15min at
4◦C. The pellet containing the OM fraction was resuspended
in 300 µl H2O.
NanoLC-MS/MS Analysis and Data
Processing
The protein concentration of the OM samples was measured
using the PierceTM BCA Protein Assay Kit (Thermo Fisher
Scientific #23225). 10 µg of each sample was subjected to SDS-
PAGE and stained with Roti R©-Blue Colloidal Coomassie Staining
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Solution. OM fractions were analyzed as described previously
(Weirich et al., 2017) with slight modification: Coomassie-
stained gel pieces were digested in-gel with trypsin (Borchert
et al., 2010), and desalted peptide mixtures (Rappsilber et al.,
2007) were separated on an Easy-nLC 1200 (Thermo Scientific)
system coupled to an LTQ Orbitrap Elite mass spectrometer
(Thermo Scientific). The peptide mixtures were injected onto the
column in HPLC solvent A (0.1% formic acid) at a flow rate of
500 nl/min and subsequently eluted with an 127min segmented
gradient of 5-33-50-90% of HPLC solvent B (80% acetonitrile
in 0.1% formic acid) at a flow rate of 200 nl/min. The mass
spectrometer was operated in positive ionmode, and spectra were
recorded in a mass range from m/z 300 to 2000 with a resolution
of 120,000. The 15 most intense ions were sequentially isolated
and fragmented in the linear ion trap using collision-induced
dissociation (CID) and default CID settings. The target values
for MS scans and MS/ MS fragmentation were 106 and 5,000
charges, respectively. Sequenced precursor masses were excluded
from further selection for 60 s.
Acquired MS spectra were processed with MaxQuant
software package version 1.5.2.8 (Cox and Mann, 2008) with
integrated Andromeda search engine (Elias and Gygi, 2007).
Database search was performed against a target-decoy Pa
UCBPP-PA14 database obtained from Uniprot, containing 5886
protein entries, and 285 commonly observed contaminants.
Endoprotease trypsin was defined as protease with a maximum
of two missed cleavages. Oxidation of methionine and N-
terminal acetylation were specified as variable modifications, and
carbamidomethylation on cysteine was set as fixed modification.
Initial maximum allowed mass tolerance was set to 4.5 ppm (for
the survey scan) and 0.5 Da for CID fragment ions. Peptide,
protein and modification site identifications were reported at a
false discovery rate (FDR) of 0.01, estimated by the target/decoy
approach (Elias and Gygi, 2007). The label-free algorithm was
enabled, as was the “match between runs” option (Luber et al.,
2010). The detection limit was calculated as the mean of the
lowest label-free quantification (LFQ) values of each sample.
Multiple t-tests were performed and FDR of differences in the
log2 protein amount between mutant and wild type (WT) were
assessed using the two-stage step-up method (Benjamini et al.,
2006) with GraphPad Prism 7.04 software. Differences in protein
amount with a FDR< 0.1 were considered significant.
The mass spectrometry proteomics data have been
deposited to the ProteomeXchange Consortium via the
PRIDE (Vizcaino et al., 2016) partner repository with the dataset
identifier PXD011849 (Username: reviewer54276@ebi.ac.uk,
Password: i3rXLDrr).
RNA Isolation and qRT-PCR
5 × 109 bacteria grown as described for the mass spectrometry
analyses were resuspended in 1ml TRIzolTM Reagent (Thermo
Fisher Scientific #15596018). RNA isolation and DNase digestion
were conducted as described previously (Goerke et al., 2000;
Münzenmayer et al., 2016). The RNA (0.1 µg/µl in RNA storage
solution, Invitrogen #AM7000) was diluted 1:10 with RNase-free
water (Ambion #AM9937). To exclude samples with detectable
DNA contamination, a quantitative PCR using the QuantiFast
SYBR Green PCR Kit (Qiagen # 204054) for the house keeping
gene gyrB was performed. mRNA expression was assessed by
quantitative RT-PCR using the QuantiFast SYBR Green qRT-
PCR Kit (Qiagen # 204154) according to the manufacturer. A
standard curve was generated by a serial dilution of one sample.
Efficiency of the PCR and Cp values were calculated with the help
of LightCycler480 software (Roche). Relative quantification was
conducted as described by Pfaﬄ (Pfaﬄ, 2001). The used primers
are listed in Table S2.
Serum Killing Assay
A serum killing assay was performed using the BacTiter-GloTM
Microbial Cell Viability Assay (Promega) as described (Necchi
et al., 2017) with slight modifications. Normal human serum
(NHS) from healthy donors (Transfusion medicine, University
hospital Tübingen) was stored in aliquots at −80◦C. Heat
inactivated serum (HIS) was generated by incubating the serum
at 56◦C for 30min immediately before use. 5 × 106 bacteria
were incubated at 37◦C in 100 µl 10% HIS- or 10% NHS-PBS in
a 96 well V-bottom microtiter plate (Greiner bio-one #651101)
in triplicates for various time periods. After that, plates were
centrifuged at 3,500 × g for 5min and the pelleted bacteria
were resuspended in 100 µl PBS (GibcoTM #14040-091). To
determine the number of viable bacterial cells, 50 µl bacterial
suspension and 50 µl BacTiter-GloTM reagent (Promega #G8321)
were transferred to a white lumitrac 96 well F-bottom microtiter
plate (Greiner bio-one #655075) and the ATP levels inside the
bacteria were quantified with a Tecan Infinite R© 200 PRO.
Galleria mellonella Infection Model
Galleria mellonella (TruLarvTM) larvae were purchased from
Biosystems Technology. Subcultured bacteria were serially
diluted to 103/ml in PBS. Each G. mellonella larva was injected
with 10 µl of 103/ml bacterial dilution using a 30 gauge syringe
(BD Biosciences). The larvae were then incubated at 37◦C and
monitored for 3 days after infection. Larvae were considered dead
when no movement could be triggered by touching the larvae
with a forceps. Ten microliter aliquots of the bacterial dilutions
injected into the larvae were plated in triplicates on LB agar plates
and the CFU was determined. The mean administered bacterial
dose for all experiments was 12± 2 bacteria.
Antibiotic Susceptibility Testing
For determination of antibiotic susceptibility, bacterial strains
were grown at 37◦C overnight. Physiological sodium chloride
solution was inoculated to a McFarland standard of 0.5. From
this solution, bacteria were streaked with cotton swabs onto
Mueller-Hinton agar plates with or without 0.2 % arabinose.
E-tests (Liofilchem) were conducted according to CLSI standard
protocols to test the sensitivity of the different strains for
the following antibiotics: ampicillin/sulbactam (#92070);
piperacillin/ tazobactam (#92108); ticarcillin/ clavulanic acid
(#921171); doripenem (#92040); meropenem (#920840);
cefotaxime (#920061); cefepime (#921271); ceftazidime
(#921380); levofloxacin (#92081); ciprofloxacin (#920450);
fosfomycin (#920790); vancomycin (#920570); erythromycin
(#92051); trimethoprim/ sulfamethoxazole (#921231).
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Statistics
Statistics were performed using GraphPad Prism 7.04 software as
described for each experiment in the table or figure legends.
RESULTS
Generation of Pa Strains Carrying
Deletions for BAM Complex Components
and Periplasmic Chaperones
The BAM complex and associated chaperones may be interesting
targets for developing novel drugs against Gram-negative
bacteria. Their inhibition could possibly re-sensitize Gram-
negative pathogens to antibiotics to which they are resistant or
enable the use of antibiotics typically not being able to cross the
OM barrier and thus not applicable for treatment of infection
with Gram-negative pathogens (e.g., vancomycin) (Sydenham
et al., 2000; Rolhion et al., 2005; Fardini et al., 2009;Weirich et al.,
2017). Because of the clinical importance and increasing numbers
of multidrug-resistant strains we addressed the role of Pa BamB
(PA14_14910), BamC (PA14_51260), the Skp-like protein HlpA
(PA14_17170), and SurA (PA14_07760) for fitness and virulence
of Pa in order to determine which factorsmight be the best targets
for drug development. For this purpose we generated single gene
deletions, which were verified by PCR using genomic DNA as
template. Mass spectrometry analyses of OM fractions (typically
highly contaminated with cytoplasmic proteins) of the bamB,
bamC, and hlpA deletion strains compared to wild type (WT)
revealed the absence of the corresponding proteins (highlighted
in boldface in Table S3B).
Although we initiated numerous attempts, we were not able to
generate a surA deletion mutant. As an alternative, we created a
stable and unmarked PA14 surA conditional mutant harboring
an arabinose-inducible copy of the surA coding sequence,
resulting in the conditional surAmutant1surA araC-PBAD-surA
(Figure 1A), for convenience termed surA. Complementation
of surA was achieved by the addition of 0.2 % arabinose to
the culture media where appropriate (termed surA SurA+). To
check for expression of surA, mRNA levels were determined
by quantitative RT-PCR, using gyrB as a housekeeping gene
(Table S4). The relative number of mRNA transcripts of the
conditional surA mutant grown in the absence of arabinose
was reduced by 92 % compared to bacteria harvested after
growth in the presence of arabinose (surA SurA+). Therefore,
in the absence of arabinose surA is still expressed in a low
amount because the araC-PBAD promoter is leaky and cannot
be repressed by catabolite repression (Meisner and Goldberg,
2016). In addition, we assessed the presence of SurA protein in
whole cell lysates by Western blot analysis (Figure 1B). Using
the conditional surAmutant, SurA protein could not be detected
after growth in the absence of arabinose indicating a SurA protein
level below the detection limit of the Western blot analysis, while
production of SurA was restored in the presence of arabinose.
Growth of the (conditional) mutants was investigated at 37◦C in
LB medium (Figure 1C). Only a slight but significant reduction
in growth (p< 0.01) was observed between 6 h and 12 h after start
of the experiment for the conditional surAmutant, while all other
mutants grew comparably to the PA14 WT strain.
SurA and BamB Are Important for OM
Integrity
Integrity of the OM is a pivotal feature of Gram-negative
bacteria mediating protection against drugs and harsh
environments including mucosal surfaces with antimicrobial
peptide production. Since SurA delivers OMPs to the OM, where
they are inserted by the BAM complex, an inhibition of parts of
this pathway should result in an altered OM composition and
possibly a reduced OM integrity. To evaluate changes in OM
integrity induced by SurA depletion, or bamB, bamC or hlpA
deletion, we first performed a 1-N-phenylnaphthylamine (NPN)
assay. NPN fluoresces only in hydrophobic environments. Thus,
if the integrity of the OM is compromised in one of the mutant
strains, NPN can reach the phospholipid bilayer of the inner
OM leaflet more efficiently (Konovalova et al., 2016). Higher
fluorescence values therefore indicate a reduced OM integrity. It
was shown previously that disturbance of the OM by polymyxin
B (PMB) leads to a strong and significant increase of NPN
fluorescence. Therefore, PMB was used as a positive control in
our assay (Figure 2A). We found that the depletion of SurA,
but not the deletion of bamB, bamC or hlpA led to a significant
increase of fluorescence, compared to the wildtype strain
(WT). This means that only the depletion of SurA significantly
enhances the entry of NPN. The complementation of surA by
growing the strain in the presence of arabinose (surA SurA+)
resulted in a NPN fluorescence signal comparable to that of
PA14 WT, indicating that the phenotype can be fully restored by
the complementation.
Next we investigated the susceptibility to bile salts, which act
as physiological detergents in the intestinal tract (Merritt and
Donaldson, 2009). Treatment with 0.3% bile salts significantly
reduced the growth of the (conditional) surA, bamB, and bamC
mutants, but not of the hlpAmutant or surA SurA+ (Figure 2B).
For complementation of the bamB deletionmutant, amini-CTX1
plasmid expressing bamB under the control of an arabinose-
inducible promoter was introduced and induced with 0.2%
arabinose (bamB BamB+).
Depletion of SurA and BamB Induces
Morphological Changes of Pa
Since we had observed that both SurA and to a lesser extent
BamB have an impact on OM integrity of Pa, we were interested
if these changes result in obvious morphological changes.
For this purpose, PA14 WT, the bamB and the conditional
surA mutant strains grown in the presence or absence of
arabinose were harvested, fixed in Karnovsky’s fixative and
visualized by transmission electron microscopy (Figure S1).
The morphology of the PA14 WT strain was characterized by
regular-shaped cells with a continuous, plain surface without
any vesicles or protrusions attached. The BamB-deficient strain
very much resembled the phenotype of a corresponding Ye
mutant strain (Weirich et al., 2017). It was characterized by
numerous vesicles attached to the cell surface, probably a sign
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FIGURE 1 | Scheme of the conditional surA mutant, verification and impact of SurA, BamB, BamC and HlpA on Pa growth. (A) Schematic view of the genomic
organization of the conditional surA mutant. (B) Western blot analysis of SurA and RpoB of PA14 WT and the conditional surA mutant in the absence (surA) and
presence of 0.2% arabinose (surA SurA+). (C) Growth curves of indicated strains. Data depict the mean and SD of at least 3 experiments. Growth curve of the
conditional surA mutant is highlighted in red. ANOVA analyses revealed significant differences (p < 0.01) for both WT vs surA and surA SurA+ vs surA in the time
range between 6 and 12 h.
FIGURE 2 | Role of SurA, BamB, BamC, and HlpA for membrane integrity and sensitivity against bile salts. (A) NPN Assay. A conditional surA and bamB, bamC, and
hlpA deletion mutants were treated with NPN. Data depict the mean and SD of 3–5 independent experiments with triplicates. The fluorescence signal derived from
matched numbers of bacteria was compared to that of WT. Polymyxin B (PMB) was used as a positive control. Asterisks indicate significant differences (p < 0.05)
compared to WT using ANOVA analysis. (B) Bile Salt Assay. Growth of the indicated Pa strains was measured in the absence or presence of 0.3 % bile salts after 8 h.
Data depict the mean and SD of the growth reduction in 0.3 % bile salts in LB compared to LB alone of at least 3 independent experiments with duplicates. Asterisks
indicate significant differences (****p < 0.0001 or *p < 0.05) as analyzed by ANOVA analysis.
for envelope stress (Kulp and Kuehn, 2010). Cells of the SurA
depletion strain grown in the absence of arabinose also appeared
rather regular-shaped, however, they looked slightly bloated and
had some vesicles attached to their surface. Taken together,
both a bamB and a conditional surA mutant of Pa showed
visible changes in cell morphology, which corroborates previous
findings obtained with Ye.
Depletion of SurA Results in a Drastically
Altered Composition of OMPs
To analyze the OMP composition, OM fractions of WT and
mutants were prepared and semi-quantitative proteomic analysis
was performed using tryptic in-gel digestion and LC-MS/MS
analysis. The ratio of label-free quantification (LFQ) intensities
between the mutants and the WT was calculated. All differences
in log2 LFQ intensities with a false discovery rate (FDR) <0.1
were considered significant. A list of all significant alterations is
found in Table S3 (S3A: OMPs, S3B: all proteins). For the raw
data please refer to http://proteomecentral.proteomexchange.
org/cgi/GetDataset with the dataset identifier PXD011849.
The deletion mutant strains for hlpA, bamC and bamB
exhibited just minor changes. In the hlpA deletion mutant, only
HlpA was reduced in abundance, as it was no longer detectable in
the OM fraction. The bamC deletion led to a significant reduction
only of OmpH. Deletion of bamB led to a reduction of quite
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a number of proteins (e.g. FecA, OprB, PlpD) also found to
be reduced in the SurA-depleted strain, however these changes
were not significant according to our selection criteria. The
relatively mild alterations in the OM composition may explain
the comparably weak phenotypes of the hlpA, bamC and bamB
deletion mutants with regards to OM integrity.
More interesting were the effects observed for SurA: depletion
of SurA significantly altered the level of 42 proteins predicted to
be localized in the OM (Table 1). Essentially, three groups could
be differentiated: (i) proteins highly abundant in the OM of the
WT but not detectable in the OM fraction of the conditional
surAmutant (ratio surA/WT< 0.01). This group included TonB-
dependent receptors and the siderophore receptors FpvA, FiuA
and FecA, and Type V secretion systems (autotransporters).
(ii) Proteins highly abundant in the OM fraction of WT and
significantly reduced more than 3-fold in the OM fraction of
surA. This group included proteins of the BAM complex and
porins (e.g., OprD, OprF, OprH). Finally (iii) a small group of
proteins that showed higher protein levels in the OM fraction
of the conditional surA mutant (e.g., OprM, OpmG, OpmB)
compared to the WT.
In order to find out if the changes in protein abundance
were caused on the transcriptional level, we assessed the relative
mRNA levels of selected genes from the different functional
groups of OMPs of the SurA depletion strain (grown exactly
as for the mass spectrometry analyses) by quantitative RT-PCR
and compared to the WT (Figure S2). From the genes tested,
elevated amounts of mRNA transcripts were only found for hlpA
(2.4-fold), which might be a regulatory effect to compensate
the reduced level of SurA. The transcriptional level of all other
investigated genes was comparable for all WT, the conditional
surA mutant and surA SurA+. These results indicate that the
genes including the type Vd autotransporter PlpD (Salacha et al.,
2010) and porins such as OprD seem to be true substrates of
SurA and that their reduced abundance in the OM is probably
the result of degradation within the periplasm.
Validation of MS/MS Findings: Verification
of Selected OMP Levels by Western Blot
Analyses
To further validate the proteomics data, the protein levels
of SurA, OprD, and PlpD of the WT and the mutants were
determined in whole cell lysates by Western blot analysis
(Figures 3A,B). Comparable RpoB levels in all samples
demonstrate equal loading of the lanes. Under depleting
conditions (surA), no SurA was detectable by Western
blot analysis demonstrating that the depletion worked well.
Production of SurA in the surA SurA+ sample shows at least
a partial recovery (64%) compared to the PA14 WT strain. In
accordance with the proteomics data (Table 1 and Figure 3C),
we found a decreased amount of OprD (15%) and PlpD (24%)
in the whole cell lysate of the conditional surA mutant. As
the PlpD antibody resulted in several bands in Western blot,
a plpD deletion strain was employed to identify the band
corresponding to PlpD.
Validation of MS/MS Findings: Impact of
Reduced Siderophore Receptor
Abundance
As a consequence of the highly reduced levels of siderophore
receptors (FpvA, FiuA, and FecA) under SurA-depleted
conditions we assumed that the strain might suffer from a
defective uptake of siderophore-iron complexes. Under iron-
restricted conditions this should consequently lead to a growth
reduction. Therefore, we assessed the growth characteristics
of PA14 and the surA mutant under iron limitation. This was
achieved by the addition of various amounts of the iron chelator
2,2′-Bipyridyl (BiP) to the growth medium (Figure S3). As
assumed, under iron limitation (+BiP), the SurA-depleted strain
exhibited a significantly stronger BiP dose-dependent growth
defect compared to the WT.
Depletion of SurA Increases the
Susceptibility for Killing by the
Complement System
An important first line host defense against invading bacteria
specifically in bloodstream infection is the serum complement
system. Therefore, we investigated whether serum resistance of
Pa is altered in the (conditional) surA, bamB, bamC, and hlpA
mutants. To this end, serum killing tests using human serumwere
performed. The strains were incubated in 10% heat inactivated
serum (HIS) or 10 % normal human serum (NHS). Survival
of bacteria was then quantified at indicated time points over a
maximum period of 4 h (Figure 4A). While deletion of bamB,
bamC or hlpA had no impact on survival in active serum, the
conditional surA mutant was killed rapidly when grown in the
absence of arabinose (Figure 4B), indicating that the depletion of
SurA alters the OM in a way that renders Pa highly susceptible to
killing by the serum complement system.
SurA Is Important for Virulence of Pa in the
Galleria mellonella Infection Model
To address the importance of the investigated genes for virulence,
the Galleria mellonella infection model was used. For this
purpose, 12 ± 2 cells of PA14 WT or the (conditional) surA,
bamB, bamC or hlpA mutant were injected into the hemolymph
of G. mellonella larvae. Thereafter, the survival of the larvae was
monitored (Figure 5). Neither deletion of bamB, bamC, nor hlpA
altered the survival compared to infection with theWT.However,
infection with the conditional surA mutant led to a significant
delay in the time to death. The conditional surA mutant was
grown under two growth conditions prior to infection: (i)
arabinose induced–SurA present prior to infection (SurA+) or
(ii) uninduced–SurA absent prior to infection (SurA–). However,
no significant difference was found between the survival curves
of SurA+ and SurA–. This indicates that SurA production
may decline rather quickly under in vivo conditions without
continuous application of arabinose, which was not applicable in
our experimental setting. Therefore, we could not test whether
a complementation would fully rescue virulence. Nevertheless,
our data demonstrate that SurA is critical for virulence of Pa
in G. mellonella.
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TABLE 1 | Outer membrane proteins affected by SurA depletion.
Function Gene name Ratio surA/WT β-strands PDB ID**
Type V secretion PA14_32780 <0.01 16*
PA14_32790 <0.01 –
PA14_61190 0.23 16*
PlpD <0.01 16 5F4A, 5FQU
AaaA (PA14_04290) <0.01 12*
EprS (PA14_18630) 0.04 12*
EstA 0.20 12 3KVN
Siderophore receptors and other
TonB-dependent receptors
FpvA <0.01 22 2W75, 2W16
FecA <0.01 22 1PO0, 1PO3
FiuA 0.04 22*
PA14_34990 <0.01 22*
PA14_54180 <0.01 22*
PA14_26420 0.02 22*
BAM-complex BamD/ComL 0.30 –
BamA 0.31 16 4C4V
BamE/OmlA 0.31 –
BamB 0.35 –
BamC (PA14_51260) 0.84 –
Porins OpdO <0.01 18 2Y0K, 2Y06
OpdN <0.01 18 4FSO
OprG 0.07 8 2X27
OprE 0.11 18*
Porins OpdP 0.13 18 3SYB
OprD 0.14 18 3SY7
OprB 0.22 16 4GY, 4GF
OprQ 0.25 22*
OprC 0.28 22*
OprH 0.32 8 2LHF
OpdC (PA14_02020) 0.35 18 3SY9
OprF 0.47 8 4RLC
PA14_31680 0.55 –
OprM 1.52 4 3D5K
OpmB (PA14_31920) 1.88 4*
OpmG 7.37 4*
LPS bio-synthesis LptD 0.32 26 5IVA
LptE 0.38 –
T3SS ExsB (PA14 42400) <0.01 –
Others Gbt <0.01 4*
FadL (PA14_60730) <0.01 14 3DWO
PA14_13130 0.03 –
PA14_24360 0.04 –
PA14_36020 7.28 –
FusA (PA14_13520) >20.40 4*
OM fractions of PA14 WT and the conditional surA mutant derived from three independent experiments were analyzed by mass spectrometry. Table depicts proteins which are described
to be located in the OM and are significantly reduced or increased due to SurA depletion. Multiple t-testing was performed. Significant differences (FDR < 0.1) are shown in bold face.
Number of β-strands of β-barrel proteins is indicated. *Predicted with Boctopus (Hayat and Elofsson, 2012); **Accession number of protein data bank (www.rcsb.org) of indicated
proteins or orthologs.
Susceptibility to Antibiotics
The impermeability of the OM is the main reason that
many antibiotics are not effective against Gram-negative
bacteria, since they cannot pass the OM to reach their
target. To investigate whether the depletion of SurA or
BamB influences antibiotic susceptibility, we performed a
comprehensive analysis with E-tests using the bamB deletion
mutant, the conditional surA strains of PA14 and the clinical
multidrug-resistant Pa bloodstream isolate ID72 (Willmann
et al., 2018) [resistant against 3 classes out of the following:
(I) 3rd and 4th generation cephalosporines (e.g., cefotaxim,
ceftazidim), (II) acylureidopenicillins (e.g., piperacillin), (III)
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FIGURE 3 | Validation of proteome analysis by Western blot. (A) Comparison of protein levels between WT and mutants. Bacteria as indicated were sub-cultured for
3 h in the presence or absence of arabinose and samples were harvested for preparation of whole cell lysates. Western blot analysis was performed for RpoB, SurA,
OprD, and PlpD. (B) Quantification of immunoblots from 3 to 5 independent experiments using ImageJ software. Pixel intensity corresponds to protein levels.
Asterisks indicate significant differences (*p < 0.05, **p < 0.01, ***p < 0.001) between compared groups using ANOVA analysis. (C) Quantification of mass
spectrometry analysis for OprD and PlpD. Graph indicates the LFQ intensity of OM fractions of indicated proteins. Asterisks indicate significant differences compared
to WT by performing multiple t-tests with a FDR < 0.1 (n = 3).
FIGURE 4 | SurA deletion leads to increased serum sensitivity. Indicated bacterial strains were grown for (A) various time periods or (B) 2 h and subsequently,
luciferase activity (which is directly proportional to the ATP levels of viable cells in a sample) was measured. Data depict the mean and SD of luciferase activity
measured of 3 independent experiments performed in triplicates. Asterisks indicate significant differences (p < 0.0001) analyzed by one way ANOVA analysis.
fluorchinolones (e.g., ciprofloxacin), and (IV) carbapenems (e.g.,
imipenem, meropenem)] (Figure S4) and the corresponding
complemented strains compared to the WT control strains.
Our test set additionally included several antibiotics not
applicable for treatment of Gram-negative pathogens. However,
these substances (vancomycin, erythromycin) can be used
to detect OM defects in Gram-negatives (Wu et al., 2005).
The deletion of bamB reduced the MIC values at least 4-
fold for ampicillin/sulbactam, ceftazidime, fosfomycin and
vancomycin (Table 2). The complementation with arabinose-
induced BamB (bamB BamB+) restored the resistance
against these antibiotics with the exception of fosfomycin.
In summary, our data demonstrate that bamB deletion leads
to a moderate increase in antibiotic susceptibility against
several antibiotics.
Interestingly, for some of the tested antibiotics, we could
observe at least a 4-fold reduction of the MIC for both the
PA14 and the ID72 conditional surA mutant. This was the case
for ticarcillin/clavulanate (PA14 32→6 mg/l; ID72 >256→64
mg/l), ceftazidime (PA14 2→0.5 mg/l; ID72 >256→8 mg/l),
levofloxacin (PA14 0.38→0.094 mg/l; ID72 1.5→0.064 mg/l),
ciprofloxacin (PA14 0.19→0.038 mg/l; ID72 0.38→0.064 mg/l)
and vancomycin (PA14 >256→12 mg/l; ID72 >256→64 mg/l).
For the SurA-depleted strain in the PA14 background, we
additionally observed a reduced MIC for ampicillin/sulbactam
(PA14 >256→24 mg/l). Moreover, the mutant in the ID72
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FIGURE 5 | SurA deletion leads to attenuated virulence in the Galleria
mellonella infection model. In total, 60 G. mellonella larvae per group were
infected in 3 independent experiments with a CFU of 12 ± 2 for the indicated
time period and survival of larvae was monitored by touching with a forceps.
The conditional surA mutant strain was tested both when expressing SurA
(SurA+) and after depletion of SurA (SurA–) at the time point of infection.
Please note that the survival curves of WT, bamB, bamC, and hlpA are
identical. Statistical analysis was performed using a log rank test (Mantel-Cox
test). A significant difference between WT and the conditional surA mutant was
observed (p < 0.0001).
background displayed a reduced MIC for cefepime (>32→3
mg/l). Strain-specific differences mediated by SurA depletion
were found for ampicillin/sulbactam (increased sensitivity of
PA14 surA but not ID72 surA) and cefepime (increased sensitivity
of ID72 surA but not PA14 surA). Strikingly, in the SurA-depleted
multidrug-resistant clinical bloodstream isolate ID72, the MIC
values for cefepime, ceftazidime and levofloxacin were reduced
to such an extent that according to the current EUCAST Clinical
Breakpoint Tables (v. 8.1.), ID72 was re-sensitized to treatment
with these antibiotics. In the case of ticarcillin/clavulanate, the
MIC value was reduced. However, it did not drop below the
critical breakpoint. Taken together, our data demonstrate that
SurA depletion leads to an increased susceptibility against some
representatives of clinically relevant antibiotics, even in the case
of a multidrug-resistant Pa strain. Thus, SurA could possibly
be used as a drug target to re-sensitize resistant strains to
antibiotic therapy.
DISCUSSION
Pa is a difficult-to-treat pathogen and, compared to other Gram-
negative bacteria, associated with a higher mortality that cannot
be attributed to resistance only (Aloush et al., 2006; Willmann
et al., 2014; Thaden et al., 2017). Often colistin is considered as a
last resort antibiotic to defeat infections caused by Pa, however,
it has severe side effects and is rather nephrotoxic (Jeannot et al.,
2017). Therefore, novel drugs and drug targets are required to
control Pa infections (Perez et al., 2016).
The BAM complex and associated chaperones are responsible
for the transport and insertion of the great majority of OMPs
into the Gram-negative OM. Previous studies already highlighted TA
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the importance of the BAM complex as a putative drug target
for several Gram-negative bacteria (Vertommen et al., 2009;
Namdari et al., 2012; Hagan et al., 2015; Krachler, 2016; Weirich
et al., 2017; Storek et al., 2018). The delivery of OMPs to the BAM
complex is performed by the well-known chaperones SurA and
Skp. Interestingly, according to the literature there are striking
differences in the importance of these chaperones for OMP
biogenesis. In Ec and Ye, SurA seems to play a major and Skp
only a minor role for OMP biogenesis (Sklar et al., 2007). In
contrast, in Neisseria meningitidis Skp but not SurA seems to
play the major role for OMP biogenesis (Volokhina et al., 2011).
According to the importance of Pa in clinical settings, we wanted
to know which of the components of the BAM complex might be
more useful as a target.
Therefore, we analyzed the role of distinct components of
the BAM complex and the periplasmic chaperones HlpA/Skp
and SurA for OM integrity and composition, virulence and
antibiotic resistance. The main findings of this study are that
depletion of SurA severely alters Pa OMP composition, which
in consequence strongly influences OM integrity as well as
resistance to bile salts, complement activity and antibiotics,
which altogether leads to attenuated virulence and enhanced
susceptibility to several antibiotics even in a multidrug-resistant
bloodstream isolate of Pa.
A comparably lower impact of the bamB deletion on Pa
sensitivity against antimicrobial substances is perfectly in line
with the milder phenotypes and minor changes in OMP
composition of the bamB mutant. Similar findings have been
made with Ec and Ye (Charlson et al., 2006; Weirich et al.,
2017). Deletion of the skp homolog hlpA and the BAM complex
component bamC did not result in obvious phenotypes in our
hands. In addition, none of these deletion mutants showed
attenuation of virulence in theG.mellonella infectionmodel. This
is in line with previous studies on Skp in Ec where it was shown
that Skp/HlpAmay play only a minor role as chaperone to deliver
OMPs to the BAM complex (Sklar et al., 2007).
Recently, it was asked whether BamB might be the achilles’
heel for targeting Klebsiella pneumoniae (Kp) infection (Krachler,
2016). It was found that deletion of bamB led to a 15-fold
decrease in Kp adherence to retinal, intestinal and lung epithelial
cells and consequently decreased invasion. bamB deletion had a
pleiotropic effect on the profile of OMPs including a decrease
of some porins as well as of type I fimbriae. Moreover,
bamB deletion led to a significant attenuation of virulence
in mice challenged intraperitoneally with Kp (Hsieh et al.,
2016). Attenuation of virulence of a bamB deletion mutant
was also found during Ye infection (Behrens et al., 2001). In
vitro assays showed increased sensitivity against antimicrobial
components such as bile salts and complement activity. In
addition, bamB deletion mutants of Ye were sensitized to various
antibiotics (typically not active against Gram-negative bacteria),
such as vancomycin (Weirich et al., 2017). Like in Kp, several
porins as well as the autotransporter invasin were significantly
decreased in Ye. Another study addressing the role of BamB
in Pa PAO1 already showed that bamB deletion also leads to
sensitization against lysozyme, vancomycin and cefotaxime (Lee
et al., 2017), which could be confirmed in our study. However,
in contrast to Ye or Kp, neither increased sensitivity against
human serum nor attenuation of virulence was observed. A
common impact of bamB deletion in various species seems to
be the reduction of the abundance of some porins (Malinverni
et al., 2006; Hagan et al., 2010). In line with this, in the Pa
bamB deletion mutant, porins such as OpdO (>93% reduced)
and OprB (45% reduced) were found in lower levels in the
OM. Some autotransporters like AaaA (67% reduced) and PlpD
(52% reduced) were also found in lower levels in the OM. This
is in agreement with previous studies, where it was observed
that BamB-dependency of autotransporter proteins seemed to be
correlated with the number of β-strands contained. Especially
those proteins possessing a large number of β-strands were
negatively affected by the absence of BamB, whereas others were
not (Rossiter et al., 2011; Weirich et al., 2017). However, these
effects were rather moderate. Thus, BamB may contribute to the
assembly of porins and autotransporters in Pa, but in contrast to
the function of BamB in Kp or Ye, the rather mild phenotypes
we found upon deletion of bamB in Pa PA14 do not justify
considering it as a promising target for drug development from
our point of view. Nonetheless, given the results that have been
obtained with e.g., Pa PAO1 and Salmonella (Namdari et al.,
2012; Lee et al., 2017), it cannot be ruled out that the importance
of BamB for OM composition and consequently the resulting
phenotypes might vary significantly between strains and species.
The most interesting candidate as a putative drug target
addressed in this study was found to be SurA. We recognized
quite early during our studies that SurA might play an important
role in Pa PA14, because it was not feasible to generate an in-
frame deletion mutant of surA. This indicated that surA might
be essential in PA14, which would be in line with the findings of
various other groups since there was no viable surA transposon
mutant detected in their transposon libraries of different Pa
strains (Skurnik et al., 2013; Lee et al., 2015; Turner et al.,
2015) and also with own unpublished observations. Nevertheless,
there is one transposon library in PA14 that contains three
different mutants with transposons inserted into surA (Liberati
et al., 2006). The transposon mutant with the ID38436 included
in the available PA14NR set showed a similar phenotype like
the conditional surA mutant in various assays and no SurA
was detectable by Western blot analysis (data not shown). The
insertion site of this mutant is located at the very beginning of
the gene (at base pair 17), indicating inactivation of the gene.
One possible explanation that this mutant is viable might be that
compensatory mutations occurred in this transposon mutant.
Altogether, we assume that SurA in Pa is essential in contrast
to other Gram-negative bacteria. Nevertheless, the phenotypes
observed in the SurA depletion strain of Pa are very similar to
those of the deletion mutant in Ye (Weirich et al., 2017).
While bamB deletion only leads to mild alteration in the
OM composition, the depletion of SurA disturbed the insertion
of a wide variety of OMPs of different functions, resulting
in a drastically altered OM composition. Since the proper
composition of the Gram-negative OM is important for its
function as an impermeable barrier for many substances, it is
reasonable that the reduced amount of several OMPs resulted in
a higher permeability to the fluorescent dye NPN.
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The permeability barrier of the OM and the export of
substances by eﬄux pumps are the main reasons for the high
intrinsic resistance of Pa against many antibiotics (Nikaido, 1989;
Poole, 2001). The reduced integrity of the OM could be an
important reason, why the conditional surAmutants of PA14 and
ID72were better accessible to antibiotics such as vancomycin that
are usually not able to cross the OM of Pa and reach their target
inside the bacterial cell. Nevertheless, it cannot be excluded that
other effects such as alteration in OMP composition or stress
response may contribute to the increased antibiotic sensitivity.
Thus, an inhibition of SurA could possibly permit a re-purposing
of approved antimicrobials, currently active only against Gram-
positive pathogens, for use in Gram-negative bacteria. Of course
this could work only if (i) the current limitation of use is a
result of the inefficient entry and if (ii) the antimicrobial target is
conserved and also present in the Gram-negative species. These
data are in line with previous data found for the commensal Ec
K12 as well as Ye (Tamae et al., 2008; Weirich et al., 2017).
However, a critical precondition to consider SurA as a
target specifically in species like Pa would be to break the
resistance against therapeutically used antibiotics of multidrug-
resistant strains. By using a conditional ID72 surA mutant this
could indeed be demonstrated for various antibiotics such as
cephalosporins and fluoroquinolones.
In summary, from all the investigated factors, SurA was
identified as the best target candidate to restore the sensitivity
against some antibiotics by distortion of the OM specifically
in multidrug-resistant strains. In the surA conditional mutant
we found that the OM contained a higher amount of some
single proteins like the OprM family porins OprM, OpmB and
OpmG that are associated with the MexAB and MexXY eﬄux
pumps (Poole, 2000). They are involved in mediating resistance
against β-lactams, chloramphenicol, macrolides, quinolones
and tetracycline (Li et al., 1995; Masuda et al., 2000), and
aminoglycosides (Mao et al., 2001), respectively. Their increased
abundance indicates that these porins are no dedicated substrates
of SurA and their insertion into the OM may be facilitated in
a different way, independent of SurA. OprM actually assembles
into a trimer (Akama et al., 2004). It has been previously
observed that a distinct subset of OMPs belonging to the
TolC-like BAM substrates (i.e., multimeric with each monomer
having only few β-strands) were affected only weakly by the
absence of the non-essential Bam proteins and periplasmic
chaperones. However, they were highly dependent on the
essential Bam proteins BamA and BamD (Mahoney et al.,
2016; Weirich et al., 2017). This might also apply to OprM
family porins. Also the associated eﬄux pumps were found
in a relatively higher amount in the OM of the conditional
surA mutant, but this does not seem to influence its antibiotic
sensitivity (Table 2).
With the exception of OprM, OpmG, andOpmB,many porins
were detected in a significantly lower amount in the OM of the
conditional surA mutant, including the most striking reduction
observed for members of the OprD family (OpdO, OpdN,
OpdP, and OprD). This may lead to a deprivation of nutrients,
since most of these porins are specific transporters for different
nutrients like pyroglutamate (OpdO), glycine-glutamate (OpdP),
arginine (OprD and OprQ) and glucose (OprB) (Chevalier et al.,
2017) and could also contribute to attenuation.
Besides the porins, also other groups of OMPs were strikingly
affected by the depletion of SurA. We found that especially
siderophore receptors and other TonB-dependent receptors (e.g.,
FpvA or FecA) (Pederick et al., 2015; Luscher et al., 2018) as well
as different autotransporter proteins (e.g., PlpD or AaaA) were
absent or less abundant in the OM upon depletion of SurA. The
mRNA expression analysis suggested that the autotransporter
protein PlpD is also a true substrate of SurA, similar to the
autotransporter Inv of Ye (Weirich et al., 2017). This means that
these proteins are reduced in abundance because they cannot use
any alternative insertion pathway when SurA is depleted. Thus
they presumably are degraded by periplasmic proteases such as
DegP (Sklar et al., 2007).
The finding that so many proteins involved in iron acquisition
and transport were completely or almost completely absent in
the conditional surA mutant, including the pyoverdine receptor
FpvA, the ferric citrate transporter FecA and the ferrichrome
receptor FiuA, suggests a reduced fitness of the conditional
surA mutant under iron-limited conditions. This is in line with
our findings that SurA depletion strongly affects growth in LB
medium under iron-restricted conditions. In addition, it was
previously shown that deletion of fiuA, besides its involvement
in iron acquisition, leads to pleiotropic effects such as reduction
of elastase levels and reduced virulence in an airway infection
model (Lee et al., 2016). Therefore, the reduced abundance of
siderophore receptors and the associated downstream effects
could also contribute to attenuation of the SurA-depleted PA14
in the G. mellonella infection model.
Furthermore, the significantly reduced amount of the LptD/E
complex (Chimalakonda et al., 2011) in the conditional surA
mutant might result in an altered level of LptD in the OM (Lo
Sciuto et al., 2018). The stable LptD/E complex is present at
the OM and functions in the final stages of LPS assembly. The
lipopolysaccharide transport (Lpt) is responsible for transporting
LPS from the periplasmic side of the OM to the cell surface
(Balibar and Grabowicz, 2016; Andolina et al., 2018). In line with
previous studies (Vertommen et al., 2009; Weirich et al., 2017),
LptD was shown to be a true substrate of SurA. Furthermore,
it was shown that LptE depletion leads to reduced functionality
of LptD resulting in impaired cell envelope integrity, reduced
virulence and decreased antibiotic resistance (Lo Sciuto et al.,
2018), which identifies LptD as a promising target for drug
development. Actually, LptD is already addressed as a drug target
by the macrocyle inhibitor Murepavadin (Polyphor POL7080),
which is currently tested in a phase III clinical trial (Martin-
Loeches et al., 2018). This fact renders the concept of a SurA
inhibitor -which is able to significantly reduce the cellular LptD
protein levels- even more attractive.
The global changes in the OM composition of the conditional
surA mutant including the reduced levels of many porins
important for nutrient uptake, iron transport systems and
proteins involved in LPS transport may in sum accumulate in
reduced fitness. This is in line with the results of theG. mellonella
infection model, since the larvae showed a prolonged time to
death when infected with the conditional PA14 surAmutant. For
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the in vivo experiments, the leakiness of the araC-PBAD promoter
(Meisner and Goldberg, 2016), still resulting in some mRNA
expression, was actually a convenient feature: a partial reduction
of SurA simulates the potential inhibition of the protein by a
putative SurA inhibitor more realistically than a clean deletion.
Taken together, SurA is an important protein in Pa
determining proper composition of the OM and seems to be an
attractive target for an antiinfective drug. Its inhibition may lead
to reduced fitness, may dampen multidrug resistance and could
simultaneously render Pa accessible to various antibiotics that are
usually not effective because of the OM barrier.
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Abstract 
With the aim to identify potential new targets to restore antimicrobial susceptibility of 
multidrug-resistant (MDR) Pseudomonas aeruginosa (Pa), we generated a high-
density transposon (Tn) insertion mutant library in a MDR Pa bloodstream isolate 
(ID40). The depletion of Tn insertion mutants upon exposure to cefepime or 
meropenem was measured in order to determine the common resistome for these 
clinically important antipseudomonal β-lactam antibiotics. The approach was validated 
by clean deletions of genes involved in peptidoglycan synthesis/recycling such as the 
lytic transglycosylase MltG, the murein endopeptidase MepM1, the MurNAc/GlcNAc-
kinase AmgK and the uncharacterized protein YgfB that all were identified in our screen 
as playing a decisive role for survival of treatment with cefepime or meropenem. We 
found that the antibiotic resistance of Pa can be overcome by targeting usually non-
essential genes that turn essential in the presence of therapeutic concentrations of 
antibiotics. For all validated genes, we demonstrated that their deletion leads to the 
reduction of ampC expression, resulting in a significant decrease of β-lactamase 
activity and consequently these mutants partly or completely lost resistance against 
cephalosporins, carbapenems and acylaminopenicillins. In summary, the determined 
resistome may comprise promising targets for developing drugs that could be used to 
restore the sensitivity towards existing antibiotics specifically in MDR strains of Pa.  
 Introduction 
Pa is one of the most important pathogens involved in nosocomial infections, such as 
pneumonia, urinary tract infection, wound infections and potentially life threating blood 
stream infection. In particular, intensive care and immunocompromised patients are at 
risk to develop severe infections. MDR strains are emerging which makes treatment of 
Pa infection even more difficult. For this reason, the WHO ranked carbapenem-
resistant Pa into the top class of its list of priority pathogens for which new antibiotics 
are urgently needed (1). For an increasing number of cases colistin is the last treatment 
option despite its neuro-and nephrotoxic side effects. 
Pa employs various intrinsic and acquired antibiotic resistance mechanisms. The high 
intrinsic resistance is mainly caused by a very low permeability of the outer membrane 
(2) and the inducible expression of efflux pumps and enzymes mediating resistance 
like AmpC (3). ampC is expressed at a low level in wildtype strains but can be strongly 
increased in strains in which ampC is derepressed. Derepression of ampC is often 
caused by mutations in the transcriptional regulator AmpR, in AmpD (4, 5) or in the 
dacB gene encoding muropeptide amidase and penicillin-binding protein 4 (PBP4), 
respectively (6), leading to an increased pool of 1,6-anhydromuropeptides originating 
from the peptidoglycan (PG) recycling pathway (7). Moreover, ampC expression can 
be induced by β-lactam antibiotics and β-lactamase inhibitors leading to resistance 
against most β-lactam antibiotics (8). 
One strategy to reconsider antibiotics that have become ineffective caused by the 
development of resistance is the inactivation of the primary resistance mechanism. 
Thus, the combination of β-lactam antibiotics with β-lactamase inhibitors such as 
tazobactam, which block the activity of β-lactamases, makes it possible to reconsider 
antibiotics such as piperacillin. However, often such combinations fail again to kill 
microbial pathogens because of β-lactamases which are resistant against the β-
lactamase inhibitors (9-11). One upcoming strategy is to use a different class of 
antibiotic adjuvants. Such adjuvants would not inactivate a primary resistance 
mechanism but would rather act on a secondary resistance gene. Several examples 
for such a strategy have been described (12-16). In this study, we wanted to find out 
which proteins could serve as targets to resensitize MDR Pa strains to treatment with 
β-lactam antibiotics. 
To answer this question we performed Transposon-Directed Insertion Sequencing 
(TraDIS) using the clinical bloodstream isolate ID40, which is resistant against many 
β-lactam antibiotics, to assess the resistome of Pa in a similar approach described by 
Jana et al. (17). TraDIS has been shown to be a valuable tool under particular 
conditions and in various approaches to find genes responsible for growth (18-21). We 
constructed a Tn mutant library in the MDR ID40 strain and subjected it to cefepime 
(FEP) or meropenem (MEM). TraDIS revealed non-essential candidate genes 
including well-known as well as so far unknown genes whose inactivation breaks 
resistance against these antibiotics. Some candidates were verified by testing 
respective deletion mutants for their antibiotic sensitivity, β-lactamase activity and 
ampC expression. The presence of these genes seems to be crucial to achieve or 
maintain antibiotic resistance. These genes may comprise the most promising non-
essential target genes for the development of novel antibiotic adjuvants to reconsider 
β-lactam antibiotics in resistant strains of Pa. 
 
Results 
ID40 sequence and resistance profile 
To determine the resistome of a MDR Pa strain against β-lactam antibiotics, we used 
the bloodstream isolate ID40 (22). ID40 belongs to the sequence type ST-252 
(determined by MLST 2.0, Center for Genomic Epidemiology, DTU, Denmark (23)) and 
is resistant against piperacillin (PIP), piperacillin/tazobactam (TZP), cefepime (FEP), 
ceftazidime (CAZ), aztreonam (ATM), levofloxacin (LEV), ciprofloxacin (CIP) and 
imipenem (IMP). Moreover, ID40 is intermediate for meropenem (MEM) and sensitive 
against amikacin (AMI), gentamicin (GEN), tobramycin (TOB) and colistin (COL) 
(Table S1). The whole genome and the plasmid sequence were annotated and 
submitted to the European Nucleotide Archive (ENA) (https://www.ebi.ac.uk/ena; 
accession number PRJEB32702). 
The ID40 chromosome is 6.86 Mbp in size and encodes 6409 open reading frames 
and carries a plasmid of 57446 bp comprising 59 putative genes. Resistance genes 
were searched using ResFinder (24) revealing the following resistance genes: aph(3')-
IIb (neo) for aminoglycoside resistance, blaOXA-486 (bla) and OxaPAO1 (ampC, PDC-
3) for β-lactam resistance, crpP (crpP) for fluoroquinolone resistance and fosA 
(fosA_1) for fosfomycin resistance. Additionally, we found a point mutation in the dacB 
gene (PBP4; G-A nt1310, G437D), which is known to be responsible for resistance 
against β-lactam antibiotics as shown by an increased MIC for CAZ from 1 µg/ml to 32 
µg/ml in Pa PAO1 (6). Therefore, most likely the mutation in dacB rationalizes the 
different resistance level of ID40 in comparison to strain PA14, which comprises the 
same resistance genes but is sensitive to all β-lactam antibiotics. Other resistance 
mechanisms like reduced expression of oprD and overexpression of efflux pumps were 
not specifically addressed, but their contribution to resistance cannot be finally 
excluded. Analysis of the OprD sequence and comparison to the literature did not 
provide any clear evidence that OprD of ID40 is dysfunctional (25-28). 
 
Construction of a high-density mutant library and TraDIS sequencing  
Growth of the Tn library in LB revealed approximately 100000 unique Tn insertions 
distributed across the genome with an average of 18 Tn insertion sites per 1 kbp of 
coding sequences. Homogenous distribution of Tn insertions and homogenous 
coverage of the whole genome are shown in Figure S1.  
Analysis of the unchallenged Tn library showed that from 6468 genes 697 genes were 
determined to be essential for viability (10.8 %) (Data set S1) and 9 were determined 
to be ambiguous (0.14 %) (Data set S2). Among these, many genes were previously 
described to be essential, for example dnaA, gyrB or lolA (29, 30).  
 
Identification of genes important for resistance against meropenem and 
cefepime 
The contribution of non-essential genes to antimicrobial resistance was measured by 
quantifying the depletion of Tn insertion mutants upon exposure with FEP and MEM at 
the respective breakpoint concentration defining a Pa strain as sensitive according to 
EUCAST (FEP: 8 µg/ml, MEM: 2 µg/ml). For analysis of the TraDIS results we chose 
only genes in which the read number in LB control was > 10 in all three independent 
experiments and additionally showed a significant change in read counts upon 
treatment and had an adjusted p value < 0.05 (Data set S3). Genes that showed a 
significant change in read counts in comparison to the untreated sample are visualized 
in Figure 1. In total, 140 genes fulfilled these criteria upon MEM treatment and 102 
genes upon FEP treatment.  
Non-essential genes in which the read counts for Tn insertion were at least 5-fold 
reduced with a high level of significance (adjusted p value < 0.05) are listed in Table 1. 
In total, 24 such genes were identified. 13 of those genes fulfilled these criteria for both 
MEM and FEP, 5 only for MEM and 6 only for FEP. Most genes were found to be 
involved in PG synthesis and recycling. The most interesting genes identified in this 
screening were those which showed significant reduction in read counts after both 
MEM and FEP treatment. All TraDIS sequence data were uploaded to ENA 
(https://www.ebi.ac.uk/ena; accession number PRJEB32702). 
We found several genes dedicated to the PG recycling metabolism such as ampG and 
nagZ, known to be important for resistance against β-lactam antibiotics (31-36). In 
addition, the efflux pump genes mexA and mexB (Data set S3) as well as the porin 
OprF were also identified in our screen and have been described to be involved in 
antibiotic resistance (37) (Table 1). This points out that our approach can identify non-
essential genes involved in antibiotic resistance. 
A pathway that connects cell wall recycling to PG de novo biosynthesis is responsible 
for the intrinsic resistance of Pa to fosfomycin, inhibiting the synthesis of PG by 
blocking the formation of N-acetylmuramic acid (MurNAc) (38-41). This cell wall 
salvage pathway comprises anhydro-MurNAc kinase (AnmK), an anomeric cell wall 
amino sugar kinase (AmgK), MurNAc-6-phosphatase (MupP) and an uridylyl 
transferase (MurU), together converting 1,6-anhydro-N-acetylmuramic acid 
(AnhMurNAc) to uridine diphosphate (UDP)-MurNAc, thereby bypassing the 
fosfomycin-sensitive de novo synthesis of UDP-MurNAc. We identified all these four 
genes (Table 1) and conclude that the anabolic recycling pathway may play a critical 
role to maintain resistance against β-lactam antibiotics at least in strains with high β-
lactamase activity. 
Moreover, genes encoding the lytic transglycosylases (LTs) Slt and MltG were found 
to be associated with resistance upon treatment with MEM and FEP (Table 1). Loss of 
Slt was shown to reduce resistance against β-lactam antibiotics in PAO1 (42). MltG 
was described as one of several LTs to be inhibited by bulgecin, a sulfonated 
glycopeptide originally isolated from P. acidophila and P. mesoacidophila, resulting in 
a slightly reduced MIC of CAZ and MEM (16). 
MepM1 (YebA, PA0667) belongs to a group of murein endopeptidases (EPs) which 
putatively modulate PG crosslinking (43). A study revealed that the protease CtpA 
(PA5134) inactivates various EPs, namely PA0667/TUEID40_04290/mepM1, 
PA4404/TUEID40_02316, PA1198/TUEID40_01415, PA1199/TUEID40_01414 and 
thereby controls the level of PG crosslinking (43). TUEID40_01415 showed also 
reduced read counts upon treatment with MEM and/or FEP, but to a much lesser extent 
than MepM1 (Data set S3). In addition, the EP MepM2, which is not regulated by CtpA 
at least in the Pa PAK strain (43) seems also to be involved in maintaining antibiotic 
resistance (Table 1).  
Furthermore, we identified two so far unknown or uncharacterized candidate genes 
putatively involved in antibiotic resistance against both MEM and FEP: 
TUEID40_05543/tuaC belongs to the glycosyltransferase 1 family, and 
TUEID40_03245 encodes an YgfB-like protein with so far unknown function which will 
be referred here to as YgfB. 
 
Confirmation of selected genes involved in antimicrobial resistance 
To validate our TraDIS results, deletion mutants for mltG, mepM1, amgK, ygfB, tuaC 
as well as ctpA and a ctpA/mepM1 double mutant were tested for their sensitivity 
against β-lactam antibiotics. Microbroth dilution assays indicated that deletion of mltG, 
mepM1, ygfB and amgK reduced the MIC values for all tested β-lactam antibiotics 
(Table 2) except for IMP (ΔmepM1) and MEM (ΔmepM1, ΔamgK), while deletion of 
tuaC showed only a slight reduction in MIC for TZP. The MIC values were reduced 
below the breakpoint for FEP and ATM in ΔmltG, ΔmepM1, ΔygfB and ΔamgK and for 
CAZ in ΔmltG and ΔamgK. Additionally, ΔmltG showed MICs below the breakpoint for 
for PIP, TZP and IMP. These data confirm the validity of the TraDIS screen and 
demonstrate the contribution of these genes to resistance against β-lactam antibiotics 
in the ID40 strain.  
Deletion of ctpA increased MIC values for MEM, FEP, PIP and ATM. Thus, we 
hypothesize that increased activity of MepM1 and other CtpA substrates leads to 
increased resistance. The MIC values of the double mutant ΔctpAΔmepM1 for PIP and 
ATM were lower compared to those of ΔctpA but higher compared to those of the 
ΔmepM1 deletion mutant, indicating that the other substrates of CtpA might also 
contribute to resistance against β-lactam antibiotics and compensate for the loss of 
MepM1 without the inactivation of CtpA. According to the TraDIS data the most 
promising CtpA-regulated substrates which may, in combination with MepM1, 
contribute to β-lactam resistance are TUEID40_02316 and TUEID40_01415 (Data set 
S3). Furthermore, it could be confirmed that deletion of amgK results in reduced 
resistance against fosfomycin as previously described (Table 2 and S1) (39). 
For complementation, conditional mutants (ΔmltG::mltG, ΔmepM1::mepM1, 
ΔctpA::ctpA, ΔygfB::ygfB) under control of a rhamnose-inducible promoter were 
generated. In the presence of 0.1% rhamnose complementation could be achieved 
(Table S1).  
 
MltG, MepM1, AmgK and YgfB contribute to β-lactam resistance in ID40 by 
promoting ampC expression 
To assess in more detail the reason why the mutants show restored susceptibility to β-
lactam antibiotics, we measured the β-lactamase activity of ID40, the different deletion 
mutants as well as of the laboratory strain PA14, which is sensitive to all tested 
antibiotics (Table 2). As determined by a nitrocefin-based assay, β-lactamase activity 
was strongly reduced in ΔmltG, ΔmepM1, ΔygfB, and ΔamgK with the most profound 
reduction in ΔmltG showing a β-lactamase activity almost as low as the PA14 strain 
(Figure 2A), and being sensitive to all tested β-lactam antibiotics (Table S1). The β-
lactamase activity corresponds directly to the MIC values of the different mutants. 
Similarly, a higher β-lactamase activity was found in the hyperresistant ΔctpA mutant. 
Therefore, the changes in MICs are presumably caused by an altered β-lactamase 
activity in the mutants compared to ID40 wildtype. No significant change in β-
lactamase activity was found in ΔctpAΔmepM1 compared to ΔctpA, indicating that the 
uncontrolled levels of other CtpA substrates can compensate the lack of MepM1. 
In the ID40 genome, two β-lactamases are encoded (ampC and OXA-486/bla/poxB). 
For PoxB it has been shown that it does not contribute to β-lactam resistance (44). We 
quantified the expression level of ampC to investigate whether the lower β-lactamase 
activity is due to reduced ampC expression. Semi-quantitative RT-PCR revealed that 
deletion of mltG, mepM1, amgK or ygfB significantly decreased ampC mRNA 
expression (Figure 2B). Deletion of ctpA, presumably resulting in a higher level of 
MepM1 and its other substrates, caused an increase in ampC expression. The 
expression level of ampC in the different mutants is in agreement with the levels of β-
lactamase activity and the MICs of β-lactam antibiotics that we have measured. These 
results indicate that the different levels of resistance of the ID40 mutants are due to 
different levels of ampC expression. 
 
4 Discussion 
Here, we report the - to our knowledge - first application of TraDIS in a MDR 
Pseudomonas aeruginosa strain and the evaluation of its non-essential resistome 
upon exposure to two clinically relevant β-lactam antibiotics. The identified genes might 
represent targets that could be exploited to resensitize resistant strains for treatment 
with β-lactam antibiotics. 
Many of the genes important for high β-lactam resistance found in the TraDIS approach 
are part of the PG recycling pathway of Pa (45) showing its critical role for β-lactam 
resistance in ID40 (46). A simplified scheme of the PG recycling and synthesis pathway 
of Pa and the genes identified by the TraDIS approach as well as genes described to 
modulate resistance against β-lactam antibiotics is summarized in Figure 3.  
 
Players in the periplasm 
The precursors of the PG catabolites contributing to transcriptional regulation of ampC 
are generated in the periplasm. LTs (such as MltG and Slt) together with low molecular 
mass penicillin-binding proteins, EPs (such as MepM1) and amidases (such as 
AmpDh2 and 3) cleave the PG layer to facilitate the insertion of new glycan strands 
and simultaneously release PG degradation products from the matrix into the 
cytoplasm (45). 
Upon treatment with antibiotics, the strongest impact on LTs in the screening was 
found for mltG and slt. In addition, and in agreement with previous studies (16, 42, 47), 
we also found the LTs mltF and mltD to maintain resistance, but to a lesser extent 
compared to slt and mltG (Data set S3). On the other hand, sltB and sltH seem to 
counteract resistance (Data set S3). The recently described MltG may act as a 
terminase and determine PG chain length (48). Deletion of mltG in ID40 significantly 
reduced ampC expression and consequently β-lactamase activity and broke 
resistance against IMP, FEP, CAZ, PIP, TZP and ATM. These findings confirm the 
validity of our study and underline the importance of MltG for induction of ampC 
expression in ID40. As previously demonstrated, MltG, Slt and MltD are targets of the 
LT inhibitor bulgecin reducing the MIC against β-lactam antibiotics (16). According to 
our data, LTs represent one of the most promising targets for re-sensitization for 
treatment with β-lactam antibiotics. 
EPs may also contribute to the induction of ampC expression. As demonstrated, the 
protease CtpA inactivates and thereby determines the levels of four EPs that control 
PG crosslinking (43). Of this group, mepM1 showed the highest reduction of Tn 
insertion read counts when comparing treatment with antibiotics and control, while Tn 
insertions in PA1198/TUEID40_01415 had a minor impact on growth in the presence 
of MEM. In addition, mepM2/TUEID40_04881, a further EP which is not regulated by 
CtpA in PAK (43), also seems to contribute to resistance against β-lactam antibiotics. 
While deletion of mepM1 leads to reduced MIC values of β-lactam antibiotics, deletion 
of ctpA leads to hyperresistance probably by deregulating the levels of its substrates. 
The role of deleted or non-functional CtpA in mediating hyperresistance is further 
supported by Sanz-García et al. who showed that upon ceftazidime/avibactam 
treatment, mutations in the ctpA gene emerge which leads to resistance (49). 
Additional deletion of mepM1 in the ctpA mutant reduces MIC values compared to 
∆ctpA for PIP and ATM, but results in still higher MIC values compared to the mepM1 
deletion mutant, indicating that other CtpA-dependent EPs also contribute to 
upregulation of ampC expression. These data suggest that high activity of MepM1 
promotes increased ampC expression. Thus, inhibition of several of these EPs could 
be a possibility to break antibiotic resistance. 
 
Players in the cytoplasm 
After PG catabolites have been formed in the periplasm, they are transported into the 
cytoplasm by the permease AmpG and partly by AmpP (50). In the following the 1,6-
anh-MurNAc-peptides are degraded by LdcA, NagZ and AmpD. The amidase AmpD 
cleaves the peptide chain attached to 1,6-anhMurNAc so that the generated 1,6-
anhMurNAc can subsequently be recycled to UDP-MurNAc by the so-called cell wall 
salvage pathway via AnmK, MupP, AmgK and MurU which bypasses de novo 
biosynthesis of UDP-MurNAc (38, 39). Finally, UDP-MurNAc is modified by the Mur 
enzymes to form UDP-MurNAc-pentapeptide (45). Both 1,6-anhMurNAc-peptides and 
UDP-MurNAc-pentapeptide can bind to the ampC regulator AmpR. Thereby, 1,6-
anhMurNAc-peptides induce ampC expression, while UDP-MurNAc-pentapeptide 
bound to AmpR represses ampC expression. 
As observed in our TraDIS data and also shown previously loss of AmpG or NagZ 
results in decreased amounts of 1,6-anhMurNAc peptides and hence results in 
increased susceptibility towards β-lactam antibiotics (32, 47). On the other hand, loss 
of AmpD leads to accumulation of 1,6-anhMurNAc-peptides and therefore an 
increased ampC expression (51) and is a frequent cause of high ampC expression in 
clinical isolates of Pa (52, 53). 
 
Players of the cell wall salvage pathway 
The individual deletion of each of the 4 (anmK, mupP, amgK and murU) genes of the 
cell wall salvage pathway in PAO1 has been shown to lead to increased β-lactamase 
activity and a subtle increase of resistance against cefotaxime and CAZ (41). Although 
this effect could not be explained so far, it was proposed that it might be due to the 
reduction of the steady state level of the ampC repressor UDP-MurNAc-pentapeptide. 
Consequently, 1,6-anhMurNAc-peptides would be more likely to bind to AmpR and 
thereby induce ampC expression (41). In contrast, another study showed that the 
deletion of amgK also in Pa PAO1 had no impact on CAZ and IMP resistance (39), 
which could be confirmed in our study for all tested β-lactam antibiotics (Table S1). 
Interestingly, in our study we observed that Tn insertions in all genes of the MurU 
pathway reduce β-lactam resistance. Validation of the screening results using an amgK 
deletion mutant confirmed these results. This finding is indeed counterintuitive and 
more detailed explorations are necessary to clarify this issue. Presumably, the anabolic 
recycling pathway somehow counteracts derepression of ampC in the dacB 
background of ID40.  
 
Uncharacterized players 
Additionally, we identified several uncharacterized genes in the presented TraDIS 
screening. Since deletion of the gene tuaC showed only a slight reduction in the MICs 
against some β-lactam antibiotics, we focused on TUEID40_03245, which we termed 
ygfB due to its similarity to the homologous gene in Ec. Deletion of ygfB resulted in 
decreased ampC expression and β-lactamase activity and broke resistance against 
FEP and ATM in ID40. To our best knowledge, this gene was so far not described in 
the context of antibiotic resistance. ygfB is located in an operon together with the pepP, 
ubiH, PA14_68970 orthologue and ubiI. ubiI and ubiH are essential genes important 
for ubiquinone biosynthesis. Similar operon structures are found also in Ec, 
Acinetobacter baumannii (Ab) and Legionella pneumophila (Lp). Pa YgfB shares 33 % 
identical amino acids with Ec and Ab YgfB and 32 % with Lp YgfB. Interestingly, the 
aminopeptidase gene pepP, which is encoded adjacent to ygfB, was also identified in 
the TraDIS screening, but Tn insertion read counts indicate that lack of pepP might 
contribute to hyperresistance.  
Moreover, experiments with PAO1 Tn mutants suggested that Pa YgfB may contribute 
to virulence in a C. elegans infection model (54). In addition, a TraDIS experiment 
suggested that the ygfB orthologue PA14_69010 may play a role for effective 
colonization in the caecum of mice (55). Thus, the possible role in virulence as well as 
the ability to modulate antibiotic resistance could mean that this gene is of interest as 
a target to develop antibiotic adjuvants which might additionally reduce virulence. In 
further studies we will address the function of YgfB and its specific role in mediating 
antibiotic resistance. 
In conclusion, using TraDIS we identified a set of nonessential genes which are crucial 
for the induction of ampC expression and β-lactam resistance. As shown in a recent 
study, overexpression of ampC is the most frequent cause for the development of 
resistance in strains capable of expressing ampC as shown by the acquisition of 
mutations in dacB, ampD and mpl after exposure of Pa PAO1 WT to increasing 
concentrations of ceftazidime (56). However, there are additional mechanisms to 
develop resistance against β-lactam antibiotics which gain more importance when 
ampC expression is hindered. Mutations in ftsI leading to modification of PBP3, the 
target of β-lactam antibiotics, mutations or overexpression of the efflux pump MexAB-
OprM as well as large chromosomal deletions led to resistance against ceftazidime 
albeit to a lower level compared to β-lactamase-dependent resistance (56). This aspect 
will have to be considered for the development of adjuvants leading to decreased 
expression of ampC. 
Nevertheless, the genes identified in our study provide promising candidates as targets 
to develop novel adjuvants to restore the function of β-lactam antibiotics in MDR Pa 
strains with high AmpC activity. 
 
Material and Methods 
Bacterial strains and culture conditions 
Bacterial strains and plasmids used in this study are listed in Table S2. Bacteria were 
cultivated overnight at 37 °C with shaking at 200 rpm in lysogeny broth (LB) containing 
suitable antibiotics if necessary. Overnight cultures were diluted 1:20 into LB broth 
containing suitable antibiotics or additives like L-rhamnose and grown for 3 h at 37 °C 
and 200 rpm. The growth of bacteria in LB at 37 °C in a 24-well-plate was measured 
using a Tecan Infinite® 200 PRO. 
 
WGS of the ID40 isolate 
DNA isolation, library preparation and Illumina sequencing of the ID40 strain are 
described in Willmann et al. (22). 
For Nanopore sequencing, the DNA was isolated using the DNeasy UltraClean 
Microbial Kit (Qiagen). Library preparation was conducted using the Ligation 
Sequencing Kit (Oxford Nanopore Technologies). Sequencing was performed on a 
PromethION sequencer (Oxford Nanopore Technologies) on a FLO-PRO002 flow cell, 
version R9.  
The ID40 genome was assembled using a hybrid assembly approach that combines 
the Nanopore long reads with exact Illumina short reads. We used the hybrid assembly 
pipeline pathoLogic (57) with default settings and selected Unicycler (58) as the main 
assembly algorithm. Further manual scaffolding yielded a single circular plasmid and 
a circular chromosome. The assembled genome as well as the plasmid sequence was 
annotated using Prokka (version 1.11) (59, 60). 
 
Generation of the ID40 Tn library 
The ID40 Tn mutant library was generated as described previously (55, 61) with some 
modifications. The donor strain Ec SM10 λ pir containing pBT20 was grown in LB broth 
containing 15 µg/ml gentamicin (Gm) and the recipient strain ID40 in LB broth. Cell 
suspensions of both strains were adjusted to an OD600 of 2.0, mixed, and droplets of 
100 µl were spotted onto pre-warmed LB agar plates. After incubation at 37 °C for 3 h, 
mating mixtures were scraped off the plate and resuspended in 12 ml LB broth. 100 µl 
aliquots were plated onto 100 LB agar plates containing 25 µg/ml irgasan and 75 µg/ml 
Gm. After overnight growth at 37 °C, all colonies (approximately 5000 per plate) were 
scraped off the LB agar, resuspended and washed once in LB broth. To eliminate 
satellite colonies 1 l LB broth containing 75 µg/ml Gm was inoculated with the 
suspension to an OD600 of 0.1 and grown to an OD600 of 1.2. The bacteria were washed 
once, adjusted to an OD600 of 22 in LB broth containing 20 % glycerol and finally 
aliquots of 1 ml were frozen at -80 °C. 
 
Tn library antibiotic exposure 
One aliquot of the Tn library was centrifuged, resuspended in LB broth and grown in 
100 ml LB broth overnight. The overnight cultures were diluted 1:100 into 100 ml LB 
broth with or without 8 µg/ml FEP or 2 µg/ml MEM and grown at 37 °C. After 24 h, the 
cultures were diluted 1:100 into fresh LB broth and grown for another 24 h at 37°C to 
enrich viable bacteria. 
 
Library preparation for TraDIS 
Genomic DNA of 5 x 109 bacteria per sample was isolated using DNeasy® UltraClean® 
Microbial Kit (Qiagen).  
2 µg DNA per sample were sheared into fragments of 300 bp with a M220 Focused-
ultrasonicatorTM (Covaris) and a clean-up was conducted with a 1.5-fold volume of 
Agencourt AMPure XP Beads (Beckman Coulter). End repair, A-Tailing and adapter 
ligation were done using NEBNext® UltraTM II DNA Library Prep Kit for Illumina® (NEB). 
A splinkerette and the P7 indexed primer were used as adapters leading to an 
enrichment of Tn containing fragments in the PCR (62-64). Fragments were size-
selected using Agencourt AMPure Beads and amplified by PCR with one Tn specific 
and one index primer (Illumina®) in 20 cycles using Kapa HiFi HotStart ReadyMix 
(Kapa Biosystems). Proper size distribution and quality of the samples were assessed 
with the Agilent DNA High Sensitivity Kit on a 2100 Bioanalyzer (Agilent Technologies). 
After a final clean-up, concentration of total fragments and of Tn-containing fragments 
was measured by qPCR using Kapa SYBR® FAST qPCR Master Mix (2X) Kit (Kapa 
Biosystems) with one P5- and one P7-specific or one Tn- and one P7-specific primer, 
respectively. 
 
Sequencing 
Samples were adjusted to 4 nM in resuspension buffer (Illumina®), pooled and 
denatured with 0.2 N NaOH. Subsequently, the library was diluted to 8 pM in 
hybridization buffer (Illumina®) and sequenced with the MiSeq Reagent Kit v2 (50 
cycles) on a MiSeqTM (Illumina®) with a PhiX (Illumina®) spike-in of 5 % and dark cycles 
(62). 
 
TraDIS data analysis 
Sequencing reads containing the Tn tag were mapped against the ID40 reference 
genome, using the Bio::TraDIS pipeline (62) in order to determine the locations and 
numbers of Tn insertions. For each gene, an ‘insertion index’ was calculated by dividing 
the number of insertions in a gene by total gene length. The bimodal distribution of 
insertion indices allows the determination between essential and non-essential genes 
as recently described (15, 65). Genes that fulfilled the cut-off criteria of an insertion 
index < 0.0019 for essential or > 0.0026 for nonessential genes were categorized in 
these groups. All other genes were considered as ambiguous (Data set S2).  
Statistical analysis was performed using DESeq2 (https://bioconductor.org) (66). 
Differential genes expression analysis was performed for group comparisons MEM vs. 
control and FEP vs. control. Genes were categorized as differentially enriched or 
depleted if the adjusted p value was < 0.05. 
 
Generation of in-frame deletion mutants  
In-frame deletion mutants were generated using the suicide plasmid pEXG2 (67) as 
described in Klein et al. (68). Primers used in this study are listed in Table S3.  
 
Generation of complementation constructs 
For complementation of the ctpA, mepM1, mltG and ygfB mutant strains, the coding 
sequences were amplified by PCR from genomic DNA of ID40 and were assembled 
with the plasmid pJM220 (pUC18T-miniTn7T-gm-rhaSR-PrhaBAD) (69) by Gibson 
cloning. The constructed plasmids were transformed into Ec SM10 λ pir and mobilized 
by conjugation into the mutant strains as described (70) with some modifications. A 
triparental mating was conducted by combining the recipient strain together with the 
mini-Tn7T harbouring SM10 λ pir strain and SM10 λ pir pTNS3, harbouring a Tn7 
transposase. Insertion of the mini-Tn7T construct into the attTn7 site was monitored 
by PCR. Excision of the pJM220 backbone containing the Gm resistance cassette was 
performed by expressing Flp recombinase from a conjugative plasmid, pFLP2. Finally, 
sucrose resistant, but Gm and Cb sensitive colonies were verified by PCR.  
 
RNA isolation and qRT-PCR 
RNA isolation and qRT-PCR were performed as previously described (68).  
 
β-lactamase activity assay 
β-lactamase colorimetric activity assay (BioVision) based on nitrocefin turnover was 
performed according to manufacturers’ instructions after dissolving the bacteria in 
5 µl/mg β-lactamase assay buffer and diluting the supernatant of sonified bacteria 1:50 
in β-lactamase assay buffer. 
 
Antibiotic susceptibility testing 
For antibiotic susceptibility testing by microbroth dilution, bacterial strains were grown 
overnight at 37 °C in LB medium with or without 0.1 % rhamnose. Physiological NaCl 
solution was inoculated to a McFarland standard of 0.5 and subsequently 62.5 µl of 
the suspension were transferred into 15 ml MH broth (+ 0.1 % rhamnose for 
complementation strains) and mixed well. According to the manufacturers instruction 
50-100 µl of the suspension was transferred into each well of a microbroth dilution 
microtiter plate (Micronaut-S MHK Pseudomonas-2 #E1-099-100, Micronaut-S β-
Lactamases #E1-111-040 (Merlin Diagnostika); SensititreTM GN2F, SensititreTM 
EUX2NF (Thermo Fisher Scientific)). Microtiter plates were incubated for 18 h at 37°C 
and OD600 was measured using the Tecan Infinite® 200 PRO. Bacterial strains were 
considered as sensitive to the respective antibiotic concentration if an OD600 value 
below 0.05 was
 
measured. 
E-Tests (Liofilchem) were conducted as previously described (68). 
 
Statistics 
Statistics were performed using GraphPad Prism 7.04 software as described for each 
experiment in the table or figure legends. 
 
Data availability 
The whole genome and the plasmid sequence were annotated and submitted to the 
European Nucleotide Archive (ENA) (https://www.ebi.ac.uk/ena; accession number 
PRJEB32702. In similar all TraDIS sequence data were uploaded to ENA 
(https://www.ebi.ac.uk/ena; accession number PRJEB32702). A more detailed 
description of the files is shown in Table S4. 
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Figure legends 
Figure 1. Resistome of the MDR ID40 determined by TraDIS. 
The ID40 Tn library was grown in LB broth with or without 2 µg/ml MEM (A) or 8 µg/ml 
FEP (B) in 3 independent experiments and then the DNA of the surviving bacteria was 
used for sequencing of the Tn-genome junctions. Fold change and adjusted p value of 
the samples grown in antibiotics in comparison to the samples grown in LB broth were 
calculated with DeSeq2 for all annotated genes. All genes with significantly different 
(adjusted p value < 0.05) read counts in comparison to the LB control are colored in 
red. 
 
Figure 2. β-lactamase activity and ampC expression in selected deletion 
mutants. 
WT and deletion mutant strains were subcultured and β-lactamase activity was 
measured by nitrocefin turnover (A) or expression of the β-lactamase gene ampC was 
determined by qRT-PCR (B) in at least 3 independent experiments. Graphs depict 
means and SD. Student’s t-test was performed for each mutant strain in comparison 
to WT (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). 
 
Figure 3. Simplified scheme of PG recycling and synthesis pathway of Pa and 
illustration of proteins identified by TraDIS. 
The bacterial murein matrix is formed by chains of the two alternating amino sugars 
MurNAc (M) and GlcNAc (G), which are linked by β(1→4) glycosidic bonds. Attached 
to the MurNAc residues is a pentapeptide side chain which typically is composed of L-
alanine-ɣ-D-glutamate meso-diaminopimelic acid-D-alanyl-D-alanine (L-Ala-ɣ-DGlu-
m-DAP-D-Ala-D-Ala). Cross-links between adjacent glycans are mainly built by 
connecting m-DAP of one chain with D-Ala of the other chain. PG synthesis starts in 
the cytoplasm where fructose-6-phosphate is converted in several steps by GlmS, 
GlmM and GlmU to UDP-GlcNAc. UDP-GlcNAc is further converted to UDP-MurNAc 
by Mur enzymes A and B, and subsequently a peptide chain is added by Mur ligases 
C, D, E & F to form UDP-MurNAc-pentapeptide. An alternative route to generate UDP-
MurNAc-pentapeptide starts with the transfer of GlcNAc-1,6-anhMurNAc-peptides 
(muropeptides) along with GlcNAc-anhMurNAc into the cytoplasm by the permase 
AmpG. Some muropeptides (however not GlcNAc-1,6-anhMurNAc-peptides) or free 
peptides may also be transported through AmpP, but its function in cell wall recycling 
has not been elucidated so far. The imported muropeptides are subsequently 
degraded by NagZ, L,D-carboxypeptidase LdcA and AmpD, producing D-Ala, GlcNAc, 
L-Ala-iso-D-glutamate-mDAP-tripeptide and 1,6-anhMurNAc. AnmK then catalyzes 
the phosphorylation of 1,6-anhMurNAc, generating MurNAc-6P, which is further 
processed by MupP and the sugar kinase AmgK to MurNAc- -1P. The 
uridylyltransferase MurU then converts the latter to UDP-MurNAc, following the 
formation of UDP-MurNAc-pentapeptide. The phospho-MurNAc-pentapeptide moiety 
is then transferred by the cytosolic translocase MraY to the lipid carrier undecaprenol 
phosphate (Und-P) to generate lipid I, which is subsequently catalyzed by MurG to lipid 
II by adding GlcNAc to it. Lipid II is then flipped into the periplasm (likely by the putative 
flippase MurJ) where GlcNAc-MurNAc peptides are integrated into the growing PG by 
high molecular mass penicillin-binding proteins, glycosyltransferases (GTFs) such as 
FtsW and RodA, transpeptidases (TPs) and DD-carboxypeptidases (CPs). Low 
molecular mass penicillin-binding proteins, endopeptidases (EPs) as MepM1, lytic 
transglycosylases as MltG and Slt and amidases as AmpDh2 and AmpDh3 finally 
cleave the existing PG layer to facilitate the insertion of new glycan strands and 
simultaneously to release the PG degradation products from the matrix into the 
cytoplasm. Under normal conditions the PG precursor UDP-MurNAc-pentapeptide 
binds to AmpR causing repression of ampC transcription. In the case of β-lactam 
treatment, the turnover of the muropeptides is increased (by blockage of PG-
crosslinks) resulting in accumulation of 1,6- anhMurNAc-pentapeptide in the 
cytoplasm. The 1,6-anhMurNAc-muropeptides are able to displace UDP-MurNAc-
pentapeptides from AmpR causing derepression and hence activation of ampC 
transcription. YgfB also modulates ampC expression contributing finally to β-lactam 
resistance, but its specific role in mediating antibiotic resistance remains to be 
investigated. The proteins found via TraDIS are highlighted with a circle in red for 
proteins mediating repression and in green for proteins mediating derepression of 
ampC expression. The putative FtsW protein (so far not verified in Pa) and the 
unknown mechanism of YgfB are labeled with interrupted lines. OM, outer membrane; 
P, periplasm; IM, inner membrane; C, cytoplasm; PG, peptidoglycan; CPs, DD-
carboxypeptidases; GTFs, glycosyltransferases; EPs, endopeptidases; LTs, lytic 
transglycosylases. *AmgK, MupP and MurU cell-wall recycling enzymes found in Pa 
but not in enterobacteria such as Ec (38, 40, 41). 
Table 1. Meropenem and cefepime resistome in Pa ID40. Genes for which insertion sequence abundance was significantly (> 5-fold, 
adjusted p value < 0.05) reduced upon exposure with 2 µg/ml MEM or 8 µg/ml FEP. Differences in insertion sequence abundance are 
expressed as mean of the ratio of normalized sequence read numbers of antibiotic treated in relation to the normalized sequence read 
numbers of the LB control culture of the Tn library. In total three independent experiments were performed. 
Category    MEM vs LB FEP vs LB Orthologues 
 ID Gene Name/Function Ratio p value Ratio p value  
Genes with an adjusted p value < 0.05 and ≥ 5-fold reduction for MEM and FEP 
Resistance TUEID40_04486 ampC β-lactamase 0.07 0.00052 0.05 3.87E-5 PA14_10790; PA4110 
PG synthesis/ 
recycling 
 
TUEID40_05675 slt Soluble lytic transglycosylase 0.02 5.08E-12 0.03 3.61E-10 PA14_25000; PA3020 
TUEID40_05736 mltG Endolytic murein transglycosylase 0.02 1.32E-33 0.03 1.77E-41 
PA14_25730; 
PA2963 
TUEID40_04290 mepM1 Murein-DD endopeptidase 0.05 1.01E-07 0.07 2.29E-06 PA14_08540; PA0667 
TUEID40_02325 ftsW 
Synthesis of septal 
peptidoglycan during cell 
division 
0.11 2.76E-05 0.20 0.0019 PA14_57360; PA4413 
TUEID40_02305 ampG Permease 0.02 7.00E-24 0.03 1.01E-22 PA14_57100; PA4393 
TUEID40_05690 nagZ β-N-acetyl-D-glucosaminindase 0.07 1.56E-05 0.04 6.23E-06 
PA14_25195; 
PA3005 
TUEID40_04289 anmK Anhydro-N-acetylmuramic 
acid kinase 0.12 4.938E-10 0.20 1.62E-06 
PA14_08520; 
PA0666 
TUEID40_04233 amgK N-acetylmuramate/ N-acetylglucosamine kinase 0.08 3.05E-06 0.17 0.0085 
PA14_07780; 
PA0596 
TUEID40_04234 hddC/ 
murU 
Similar to N acetyl-muramate 
alpha-1-phosphate uridylyl-
transferase murU of 
Pseudomonas putida 
0.07 5.10E-05 0.15 0.0001 PA14_07790; PA0597 
LPS TUEID40_05537 wbpE 
UDP-2-acetamido-2-deoxy-3-
oxo-D-glucuronate 
aminotransferase 
0.10 1.58E-03 0.135 6.43E-03 PA3155 
Unknown TUEID40_03245 ygfB ygfB-like proteins, unknown 0.06 2.35E-19 0.06 5.56E
-20 PA14_69010; PA5225 
TUEID40_05543 tuaC Glycosyltransferase family 1 0.02 1.35E-09 0.02 7.79E-10 - 
Genes with an adjusted p value < 0.05 and ≥ 5-fold reduction only for MEM  
PG synthesis/ 
recycling TUEID40_04881 mepM2 
Murein DD-endopeptidase 
MepM, unknown function 0.14 3.60E-12 0.37 0.002 
PA14_15100; 
PA3787 
Type IV pili 
assembly TUEID40_03621 tsaP 
Type IV pilus secretin-
associated protein; anchors 
the outer membrane type IV 
pili secretin complex to the 
peptidoglycan 
0.02 1.02E-28 0.31 3.61E-10 PA14_00210; PA0020 
β-barrel 
assembly TUEID40_01638 
bepA/ 
ygfC_1 
β-barrel assembly enhancing 
protease 0.12 2.17E-07 0.24 1.20E-06 
PA14_51320; 
PA1005 
Unknown 
TUEID40_03216  putative zinc protease 0.14 6.06E-05 0.21 0.001 PA14_68640; PA5196 
TUEID40_05674 - Uncharacterized conserved protein YecT. DUF1311 family 0.19 9.84E-05 0.74 1.0 
PA14_24990; 
PA3021 
Genes with an adjusted p value < 0.05 and ≥ 5-fold reduction only for FEP 
PG synthesis/ 
recycling 
TUEID40_05519 gph_2/
mupP 
N-Acetylmuramic Acid 6-
Phosphate Phosphatase 
MupP 
0.27 0.14 0.185 4.12E-02 PA14_23210; PA3172 
TUEID40_03006 mrcA Penicillin binding protein 1 0.73 0.40 0.05 3.15E-12 PA14_66670; PA5045 
TUEID40_02335 lpoA Penicillin binding protein 
activator 1.03 1 0.20 6.87E-16 
PA14_57480;PA
4423 
Cell division TUEID40_03247 zapA Cell divison protein zapA 0.39 0.00017 0.17 1.00E-07 PA14_69030; PA5227 
Porin TUEID40_00776 oprF Outer membrane protein F 0,22 0.036 0.20 0.03 PA14_41570; PA1777 
Unknown TUEID40_01298 - 
Uncharacterized putative 
membrane-bound PQQ-
dependent dehydrogenase 
0.45 0.0018 0.16 1.80E-08 PA14_47350; PA1305 
 
Table 2. Susceptibility of ID40 WT and deletion mutants against β-lactam antibiotics. Minimal inhibitory concentrations (MICs) of 
ID40 WT and deletion mutant strains were determined by microbroth dilution or by E-Test for fosfomycin. MIC values of the deletion 
mutants lower than that of ID40 WT are highlighted in green and those below the MIC breakpoint in bold green and light green 
background. MIC values higher compared to that of ID40 WT are highlighted in red. 
 
MEM, meropenem; IMP, imipenem; FEP, cefepime; CAZ, ceftazidime; PIP, piperacillin; TZP, piperacillin/tazobactam; ATM, 
aztreonam; FOS, fosfomycin; *E-test 
S ≤ R >
MEM 2 8 8 4 8 16 16 4 8 8 <0.125
IMP 4 4 32 4 32 32 32 8 8 32 <1
FEP 8 8 16 4 4 32 32 8 8 16 <1
CAZ 8 8 32 2 16 32 32 16 8 32 <1
PIP 16 16 128 <4 64 >128 128 32 32 128 <4
TZP 16 16 128 4 32 128 128 32 32 64 4
ATM 16 16 32 2 16 >32 32 16 8 >32 8
FOS * - - 96 96 96 96 64 128 48 96 48
DamgK DtuaC PA14MIC Breakpoint (mg/L) ID40 WT DmltG DmepM1 DctpA DmepM1 DctpA DygfB
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